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The interest of nanomedicine has grown substantially over the last 30 years. Due to this 
growth, it has become very important to obtain analytic techniques to provide high resolution 
characterisation particles with nanoscale sizes. A promising approach is to fractionate 
nanoparticle distributions through the use of asymmetric field flow fractionation (AF4). This 
separation method is particularly useful for as allows detailed information to be obtained 
(such as concentration of particles, size and shape) on all particles within the system. In our 
research, three different nanomaterials are analysed by AF4, these are nanocomposites made 
of carbon nanotubes (CNTs) and polycaprolactone (PCL), poly(N-isopropylacrylamide) 
(PNIPAM) based nanogels and metallic particles with different sizes and shapes.    
 
The high-aspect ratio PCL-CNT nanocomposites were produced by developing a simple oil-in 
water emulsion solvent evaporation method. The high drug entrapment efficiencies of the 
nanocomposites offer the potential for these nanocomposites to be used in drug delivery 
applications. AF4 analysis showed good and reproducible separation of PCL-CNTs 
nanocomposites.  
PNIPAM based nanogels are a well-known temperature responsive type of nanogels that has 
been shown to present attractive properties for applications in drug delivery. In order to 
characterise PNIPAM nanogels a novel, versatile AF4 method was developed. The different 
nanogel samples with mean diameters between 65 and 310 nm were synthesised via free 
radical dispersion polymerisation by varying the amount of surfactant used during the 
polymerisation. The AF4 was combined with multi-angle light scattering (MALS) and dynamic 
light scattering (DLS) detectors to provide detailed size (hydrodynamic radius, Rh) and 
structural information (radius of gyration, Rg and shape factor, Rg/Rh) on the nanogels. A single 
AF4 method was then used to fractionate the samples and this revealed differences in the 
internal structures of the differently sized nanogels. 
The PNIPAM nanogels were also synthesized by RAFT polymerization dispersion 
polymerisation in the presence of a degradable crosslinker. We analysed our nanogel samples 
by AF4 varying the fractionation conditions (crossflow and detector flow rate). The 
degradation rate were analysed also by AF4 technique. Our findings reveal interesting 
behaviour of nanogels under AF4 analysis conditions.  
The AF4-MALS-DLS measurements also allowed for the analysis of anisotropic metallic 
particles with different shape and aspect ratio. Prior to this work, there have been very little 
research about directly investigating the shape and the size of particles and nanogels 
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1.1. Nanomedicine  
 
The interest of nanotechnology has grown over the past 30 years amongst scientists 
and researchers. Nanotechnology is now showing benefits in everyday life,1 with new 
materials being made available that could revolutionize many areas of 
manufacturing. One example is the  advances it has brought to electronic products, 
procedures and applications.2 A number of definitions exist related to ‘nano’ 
products, the most established is that of IUPAC (International Union of Pure and 
Applied Chemistry) stating that nanoparticles are particles of any shape with an 
equivalent diameter from 1 nm and 100 nm.3 Thus, nanotechnology is connected 
with the unique physical and chemical properties observed for particles in this size 
range.4,5 The key aspects of nanotechnology can be listed as follows: controlling of 
matter at the atomic range, studying the unique physical and chemical properties of 
nanomaterials and the synthesis of complex systems with novel properties.4 These 
benefits have been explored in medicine field known as nanomedicine. The first 
clinical example of a nanomedicine, doxorubicin containing liposomes helped to 
expand the interest of the global market in this field.6 Interestingly, the definition of 
nanomedicine is not globally agreed with at least two widely used definitions existing 
at present. The National Institute of Health has defined nanomedicine as ‘an offshoot 
of nanotechnology, [which] refers to highly specific medical interventions at the 
molecular scale for curing disease or repairing damaged tissues, such as bone, 
muscle, or nerve’.7,8 Another definition of nanomedicine, that does not directly map 
onto the IUPAC definition of nanomaterials has been proposed by European 
Technology Platform on Nanomedicine (ETPN) stating that “Nanomedicine is the 
application of nanotechnology to health. It exploits the improved and often novel 
physical, chemical, and biological properties of materials at the nanometric scale”.9,10 
Nanomedicine may be divided into five main sub-classes: analytical tools, 
nanoimaging, nanomaterials and nanodevices, novel therapeutics and drug delivery 
systems; for clinical, regulatory and toxicological issues.8 The most popular 
applications of this field of research are a generation of nanoscale materials for drug 
delivery systems, with particularly successful examples within anticancer 
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therapeutics,11,12 disease markers and several other therapeutic systems.13–15 
Therapeutic systems, refer to a process or method that allows for introduction of 
active pharmaceutical compounds in human or animals and help to achieve 
therapeutic effect.16,17 An ideal drug delivery system should deliver the therapy only 
to the targeted tissue or cell, be biocompatible, cause minimal side effects and 
reduce toxicity of medicines.18 To achieve this the drug delivery system should: 1) 
keep the drug concentration in the therapeutic window, 2) localise the therapeutic 
to the desired site of action to reduce the side effects, 3) have the ability to degrade 
or be cleared after administration and 4) improve medical adherence.19,20 Regulatory 
considerations are critical in the development of new therapeutic system and it is 
important to note that the Food and Administration agency (FDA) does not provide 
definitions of nanomaterial or nanotechnology.21 During the regulation of nano-
products, FDA considers following properties: “(1) whether a material or end product 
is engineered to have at least one external dimension, or an internal or surface 
structure, in the nanoscale range (around 1 nm to 100 nm); and (2) whether a 
material or end product is engineered to exhibit properties or phenomena, including 
physical or chemical properties or biological effects, that are attributable to its 
dimension(s), even if these dimensions fall outside the nanoscale range, up to one 
micrometer (1,000 nm)”.21,22 This thesis will therefore define nanomedicine as the 
application of materials at the nanometric scale (1-1000 nm) for healthcare 
applications.   
The design of nanomedicines is heavily influenced by the route of administration of 
which there are two most common route: parenteral route (through the skin by 
injection, avoiding the digestive system) and the enteral route (directly at some point 
of the gastrointestinal tract). Less local way of drug administration can be pulmonary 
(or respiratory), nasal, ophthalmic or vaginal. 23 Nanoparticles are currently widely 
investigated as drug delivery systems across all routes of administration and some 
systems have been approved for clinical use.24–26 Well-known examples of 
nanocarriers used as a drug delivery systems are: polymers and polymeric 
nanoparticles,13,27 dendrimers, magnetic nanoparticles28, liposomes29 and solid lipid 
nanoparticles30,31 (see Figure 1.1).32 Examples of these different nanoparticle drug 





Figure 1.1. Schematic representation of different categories and subcategories of 
nanomedicines for drug delivery. The structures of the nanomedicines shown are: 
(a), nanocrystal; (b), nanosuspension; (c), polymer drug conjugate; (d), polymer 
protein conjugate; (e), polymer micelle; (f), liposome; (g), solid lipid nanoparticle; 
(h), solid polymer nanoparticle; (i), nanogel; (j), gold nanoparticles; (k), 
dendrimer.10  
Reprinted from Nanoengineering Global approaches to Health and Safety Issues, 
2015, T. O. McDonald, M. Siccardi, D. Moss, N. J. Liptrott, M. Gardiello, S. P. 
Rannard and A. Owen, The Application of Nanotechnology to Drug Delivery in 
Medicine, 173-223, Copyright (2015), with permission from Elsevier. 
 
It is also possible to categorise nanoparticles as either ‘hard nanoparticles’ which 
keep their original shape and size during different processes and ‘soft nanoparticles’, 
made from material which can change size or shape when facing different biological 
conditions such as pressure, pH or ionic strength.33 The examples of hard 
nanoparticles and their application, which can be used in nanomedicine field are: 
silica nanoparticles (photodynamic therapy for treating cancer breast cells)34, gold 
nanoparticles (carrier and adjuvant for vaccines)35, quantum dots (sensor for the 
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detection of the CA-125 serum biomarker in patients with ovarian cancer)36and 
magnetic nanoparticles (detecting foodborne pathogens such as Salmonella 
enterica)37. The soft nanoparticles used for drug delivery systems include 
biodegradable polymers38, non-biodegradable polymers39, liposomes40, micelles41, 
lipid nanoparticles42 or micro and nanogels43.   
The theory of colloidal stabilisation for drug delivery systems are discussed in next 
subsection 1.2. Colloidal stability.  
1.2. Colloidal stability  
 
Understanding colloidal stability is critical to the design of viable nanomedicines. 
Colloidal systems typically possess both attractive and repulsive interactions. If the 
attractive forces between particles are greater than the forces dispersing the 
particles (repulsive) then aggregation can occur. Aggregation can be divided into 
coagulation (irreversible aggregation of particles), flocculation (weaker, often 
reversible aggregation) and coalescence (merging of droplets or bubbles). To prevent 
aggregation, the repulsive forces must be stronger that the attractive interactions. 
Repulsive interactions arise from steric stabilisation and/or electrostatic repulsion. 
Steric stabilisation can be obtained by the presence of solvated polymer chains on a 
particle, which can be either physically adsorbed or covalently bonded solvated 
polymers. When two particles with surface coating of solvated polymers approach 
one another eventually the polymer chains on the neighbouring particles will begin 
in interpenetration. If ΔGmix for polymer chain interpenetration is negative, then 
there will be the overlap of the adsorbed layers, will result in flocculation or 
coagulation. Therefore, in order to achieve effective steric stabilisation this polymer 
mixing should be unfavourable (ΔGmix should be positive). To do this, a number of 
conditions need to be required: high surface coverage, thick polymer layer, strong 
adsorption, good solvent for stabilising chain and low free polymer concentration. 
The second type of repulsive attraction is electrostatic repulsion. Particles often have 
a surface charge, derived from surface functional groups or adsorbed ionic surfactant 
molecules, which lead to repel each other. Electrostatic repulsion occurs as a result 
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of an electric double layer (see Figure 1.2) consisting a surface charge compensated 
by an unequal distribution of counter- and co-ions.44 
 
Figure 1.2. Stern-Grahame Model of the double Layer. 
 
An important measure of the surface charge and thus an indicator of electrostatic 
stability is the zeta potential, (ζ) which is difference in the potential between the bulk 
and the stationary layer around the particle. Zeta potential is typically measured in 
mV. A higher zeta potential will mean that there is stronger electrostatic repulsion 
between the particles. Provides a higher energy barrier for aggregation to occur.  
The opportunities to further improve the drug delivery and colloids for potential of 
nanomedicines has led to further research into the effect of shape on biological 
behaviour and the use of responsive systems. The following two sections will discuss 




1.3 Non-spherical carriers for therapeutic compounds 
 
The majority of drug delivery systems are spherical, due to the sphere being 
energetically favoured due to its lowest surface area to volume ratio for a volume. 
Spherical drug delivery systems have established clinical benefits. For example, 
liposomes have been used clinically since 1995 and have been shown to  provide 
improved bioavailability, limited toxicity and control over pharmacokinetics.45 
Polymer nanoparticles such as those made of poly(lactide-co-glycolide) (PLGA)  
or solid lipid nanoparticles have been used as drug delivery systems in chemotherapy 
of tuberculosis have shown benefits in the reduction of the dosing frequency of drug, 
feasibility of the versatile routes of drug administration and high stability  
of nanoparticles.46 However, in recent research, there is growing understanding that 
a shape plays a key role in the biological behaviour of nanomedicines and control  
of shape  might allow further benefits.47–50 For example, it has been shown that size 
and shape of particles influence the therapeutic effect, with the shape influencing 
the physical properties of the nanomedicine such as drug loading efficiency, drug 
release rate.51,52. For example, Cai et al. showed that polyethylene glycol-
polycaprolactone worm-like micelles could be loaded with two-fold higher 
anticancer drug paclitaxel compared to spherical ones.53 Yang et al. presented  
a study where a cross-linked worm-like vesicle had a slower drug release rate than  
a non-cross-linked one. 54 The size and shape have also been shown to influence 
biological behaviour such as targeting efficiency.55  Some of this behaviour may be 
linked to the understanding that shape and size of nanoparticles plays a crucial role 
in phagocytosis,56  the process by which a cell absorbs solid particle and in the process 
forms an internal component known as a phagosome.57 Studies have shown that 
particles with very high aspect ratio of size have decreased phagocytosis.56,58  
From therapeutic perspective, reducing phagocytosis can increase time for drug 
release. Moreover, there is a hypothesis that the rate of phagocytosis for a particle 
of desired geometry can be organ dependent, with different organs taking up shapes 
in different ways.59  Ellipsoidal particles has been found to show better adhesion to 
aortae than spherical micro or nanoparticles when tested in vivo.50,60 Geng et al. have 
shown that the shape of particles has effect on biodistribution.61 Elongated polymer 
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micelle assemblies described as filomicelles with a diameter 18 µm showed half-lives 
~5 days, which was 3 days longer compared with stealth spherical liposomes.61  
Muro et al. have shown that the elliptical disks with high surface-area-to-volume 
ratio obtained higher targeting specify for endothelial cells compared with spheres 
due to improved interaction.62 In a separate study, it was reported that rods targeted 
to ovalbumin, with two times more specific binding interactions than ovalbumin 
targeted spheres.63  
There are two approaches to synthesise nanomaterials, including non-spherical 
particles: “top-down” and “bottom-up”. The most popular top down method for 
preparation of ellipsoidal particles is film stretching.  Ho et al. prepared ellipsoidal 
polystyrene particles by embedding the particles in polyvinyl alcohol film.64  This 
matrix was then stretched using different forces at 200 °C. This temperature was 
chosen as it was above the Tg of polystyrene. The particles were then recovered by 
dissolving the film and were found to have ellipsoidal shapes with different aspect 
ratios from 1.5 to 2.6.64 The advantage of this method is the simplicity and speed to 
producing particles. An example of non-spherical polystyrene nanoparticles 
synthesised by stretching method was shown in Figure 1.3. 65 
 
 
Figure 1.3. Polystyrene non-spherical particles obtained by stretching method. 




Another example of bottom-up synthesis of non-spherical particles is seed-
meditated growth method, which is the most popular way of preparing gold 
nanorods (GNRs).66 This synthetic method was first introduced by Jana et al.  
in 2001.67  Firstly, a seed solution was prepared by the reduction of gold salt HAuCl4 
with NaBH4 in the presence of sodium citrate. The resulting citrate-capped gold 
nanoseeds with diameter 3-4 nm were then added to a growth solution of HAuCl4, 
cetyl-trimethyl ammonium bromide (CTAB, as the template), AgNO3 (for shape 
induction) and ascorbic acid (as the reducing agent). This strategy allowed for 
production of GNRs, different aspect ratios were synthesised by changing the 
volumes of seed solution in the sample. An advantage of gold nanorods over 
spherical gold nanoparticles was demonstrated in the application of photothermal-
triggered therapy. The photothermal absorption efficiency for the gold nanorod 
particles increased by tenfold compared with spherical gold nanoparticles which led 
to improvement of therapeutic efficiency.59,68  
 
1.3.1. Carbon nanotubes  
 
Carbon nanotubes (CNTs) are a type of high aspect ratio nanomaterial that possess a 
range of interesting properties including their fibre structure, large surface area and 
high mechanical stiffness. These properties have led to CNTs being investigated as 
drug delivery systems. CNTs have shown benefits in DNA delivery69, use as cancer 
theranostics70, small molecule drug delivery71 and regenerative medicine.72 CNTs can 
be classified by their structure into: single-walled (SWNT) and multi-walled (MWNT) 





Figure 1.4. TEM images of single walled carbon nanotubes and multiwalled carbon 
nanotubes.73 Reproduced with permission of the Wiley.  
 
CNTs can be covalently modified with drug molecules, or they can physically adsorb 
aromatic drugs via the strong π-π and hydrophobic interactions between the drug 
and the aromatic surface of the CNT.71 Such physical adsorption of drugs has been 
exploited for loading anthracyclines, a class of anticancer drug.71 However, in spite 
of their drug loading potential, the inherently hydrophobic nature of CNTs can limit 
their application in aqueous environments. As such, surface modification and coating 
is often utilised to improve the colloidal stability of CNTs.74 Polymers are typically 
used for surface modification and these have been grafted to the surfaces of CNTs by 
amidation, radical coupling, esterification and other reactions.75 Alternatively, 
grafting from the surface of CNTs by anionic/cationic polymerizations or atom 
transfer radical polymerization has also been used.76,77 Khoee et al.78 demonstrated 
the ability to carry out surface modification of carbon nanotubes by using thermo 
and reduction-responsive polymers as poly(N-isopropylacrylamide) (PNIPAM) and 
poly(2-hydroxyethyl methacrylate) (polyHEMA) with the degradable crosslinking 
agent N,N’-bis(methacryloyl)-L-cystine (SS). The nanoparticles of poly(NIPAM-HEMA-
SS)/MWCNT were used as carriers for doxorubicin (DOX), which is commonly used as 
an anticancer therapeutic. The research showed that the greater release of DOX 
occurred in the presence of dithiothreitol (DTT) at higher temperature than at 
physiological temperature (37 ˚C) within the absence of DTT. The in vitro cytotoxicity 
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studies showed that the poly(NIPAM-HEMA-SS)/MN-MWCNTs were biocompatible 
with blood and no toxicity was seen in the liver or kidneys of mice. 
Complexes of CNTs/DOX showed increased cell death for human cancer breast cells 
(MCF7) treated with the compared to application of DOX alone.79 Moreover, many 
tests in vitro and in vivo showed that functionalized CNTs are compatible with 
biological media.79–81 The cytotoxicity and biocompatibility of CNTs has been shown 
to be dependent on many factors such as the route of administration, the size and 
type of the CNTs (MWNT or SWNT) and presence of any surface modification;82,83 
generally higher surface functionalisation of CNTs reduced cytotoxicity.84  
The other example of material which possess interesting properties and it showed 
potential as drug delivery systems are poly(N-isopropylacrylamide) polymers and 
nanogels.85,86 In next subsection (1.3), there is more information about poly(N-
isopropylacrylamide)  nanocarriers.   
 
1.3. Poly(N-isopropylacrylamide) nanogels    
 
In addition to shape, the ability to respond to an external stimulus or multiple stimuli 
provides the opportunity to achieve highly targeted drug release. Thermoresponsive 
behaviour is an example of this and it provides the opportunity to use temperature 
changes as a stimulus to trigger drug release. Thermoresponsive polymers exhibit 
either a lower critical solubility temperature (LCST) and an upper critical solubility 
temperature (UCST) in aqueous medium.87 The LCST is the temperature when the 
polymer is soluble below a critical temperature, and insoluble above. For UCST 
polymer, it is the opposite – polymer is soluble above a critical temperature. The 
LCST/UCST temperature of the solution provides information if a polymer chains 
interact more with another polymer chain or with the surrounding solvent. In the 
case where polymer-polymer interactions prevail, the polymer chains tend to 
associate together and eventually phase separate out from the solution, thus leading 
to a turbid suspension. 88 For UCST polymers, the polymer chains are well solubilised 
above the UCST. They maintain a high affinity with the surrounding medium and the 
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solution is transparent.89 An example of phase diagram for thermoresponsive 
polymers is presented on Figure 1.5.  
 
 
Figure 1.5 Simplified phase diagrams of thermoresponsive polymers. Outside the 
region delimited by the binodal curve, there is a homogeneous solution of 
solubilized polymer in aqueous solution (1 phase). Inside the region, the solution 
is not stable anymore and the polymer phases out (2 phases). 
 
A common type of thermoresponsive nanoparticle is nanogels. Nanogels are 
nanoscale, three-dimensional hydrogel particles, made of cross linked polymer 
chains that swell in a good solvent such as water.90 Hydrogels or nanogels can be 
prepared by physical or chemical crosslinking and are used widely in biomedical 
applications. The interactions in physically crosslinked nanogels are intermolecular 
reversible interactions such as electrostatic,91 hydrophobic/hydrophilic,92,93 
crystallisation/stereocomplex formation,94 metal coordination,95 π–π stacking96 and 
hydrogen bonding between polymer chains.97–100 The network gel prepared by 
physical crosslinking is usually reversible and is attractive is cases where crosslinking 
is undertaken within biological systems (such as cell scaffolds or in situ gelling 
systems). The absence of chemical crosslinking agents avoid potential cytotoxicity 
from unreacted chemical crosslinkers.100,101 Up to now, some chemical crosslinking 
methods were reported such as free radical polymerization induced crosslink,102 
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enzymatic induced crosslink,95 Diels–Alder “click” reaction,44 Schiff base 
formation,103 oxime formation,104 Michael type-addition105 and 
photopolymerisation.106 Chemically cross-linked hydrogels allows absorption of 
water and/or bioactive compounds without dissolution and permits drug release by 
diffusion98,107 and it also shows high stability under physiological conditions.100   
 
A popular example of a thermoresponsive nanogel, based on a chemically crosslinked 
network is made from poly(N-isopropylacrylamide) (PNIPAM) (see structure in Figure 
1.6).  
 
Figure 1.6. Chemical structure of poly(N-isopropylacrylamide) (PNIPAM) 
 
PNIPAM nanogels have shown potential as drug carriers, biosensors and for 
applications in enzyme encapsulation.108,109 PNIPAM nanogels are sensitive to the 
temperature, showing de-swell response for volume phase transition temperature 
(VPTT).110 The VPTT can be explained as briefly as a temperature at which the 
behaviour of the nanogel is altered as a result of its intramolecular interactions. 
Below the VPTT, the nanogels are hydrophilic due to the favourable hydrogen 
bonding between the amide group and water. Above the VPTT, the particles de-swell, 
expel solvent and decrease size as a result of the polymer-polymer hydrogen bonding 
becoming more favourable (see Figure 1.7 ). The VPTT for PNIPAM nanogels is around 
34°C, depending on factors such as the crosslinker structure and crosslinking density. 
Leobandung et al.111 synthesised PNIPAM nanogels with the presence of 
poly(ethylene glycol) 1000 methacrylate as the comonomer and poly(ethylene glycol) 
400 dimethacrylate as crosslinker. Insulin was encapsulated into microgels and 
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stability of insulin was studied. The in vitro data showed that drug delivery system 
can protect insulin from denaturation, which makes them good carrier for insulin.  
PNIPAM nanogels can also display dual responsive behaviour in which they undergo 
a different transition in the presence of two stimuli simultaneously (see Figure 1.7).  
Typically, the PNIPAM nanogels possess steric and electrostatic stabilisation.  
The electrostatic repulsion between nanogels provides colloidal stability even above 
the VPTT. However, in the presence of the salt like PBS, the charges are screened and 
flocculation occurs.112 This transition behaviour can be used as an advantage for 
forming in situ implants upon injection into the body, where the nanogels are at body 
temperature (above the VPTT) and in the presence of salt.112 
 
Figure 1.7. Dual responsive behaviour of PNIPAM nanogels. 113 The nanogels in 
the water medium near the VPTT deswell and the diameter of nanogels decrease. 
In the presence of salt, PNIPAM nanogels form a depot near the VPTT. 
 
 
A disadvantage of PNIPAM nanogels in drug delivery applications is their  
non-degradable nature. PNIPAM nanogels are typically crosslinked using  
N,N'-methylenebisacrylamide (BIS) which provides no opportunity for degradation. 
One approach investigated to address this is by using N,N’bis(acryloyl)cystamine 
(BAC) as the crosslinker. This crosslinker introduces disulphide bonds between 
polymer chains which are degradable in the presence of reductant dithiothreitol 
(DTT) – a molecule that mimicks the role of glutathione (GSH) in the body.114 The 
15 
 
mechanism of DTT in the cleavage of disulphide crosslinkers is given in Figure 1.8.  
This means that nanogels might be slowly degraded in an extracellular environment, 




Figure 1.8.  Disulphide Cleavage Mechanism by dithiothreitol (DTT) 
 
PNIPAM nanogels are typically prepared using either precipitation or dispersion 
polymerisation.115 These polymerisations can be by free radical polymerisations,116 
radiation induced117 and reversible addition−fragmentation chain transfer (RAFT) 
polymerisation.118 Precipitation/dispersion polymerisation and RAFT polymerisation 
were used to prepared PNIPAM nanogels during this research. Information about 
those types of polymerisation is covered in the following subsections.  
 
1.4.1. Precipitation and dispersion polymerisation of NIPAM 
 
Heterogeneous free-radical polymerisations are typically used to obtain PNIPAM 
cross-linked, non-soluble nanogels in water from water-soluble NIPAM monomers.119 
The most common types of heterogeneous free-radical polymerisations used for 
PNIPAM nanogels are precipitation or dispersion.116 Precipitation polymerisation is a 
process where insoluble polymer is synthesised from a monomer that is soluble in 
the reaction medium (usually water). For this method an ionic initiator is commonly 
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used and at the start of the reaction all the compounds are soluble in the reaction 
solvent. However, the solvent is a poor solvent for the polymer. Upon initiation, the 
polymer chains grown in the medium and the hydrophilic initiator-containing chain 
ends concentrate at the surface of the particles, increasing surface charge density. 
The particle grows until the colloidal stability is achieved, thus creating polymeric 
particles. A scheme of precipitation polymerisation of PNIPAM is shown in Figure 
1.9a.120  
 
Figure 1.9. Schematic representation of a) precipitation and b) dispersion 
polymerisation to produce PNIPAM nanogels, i) formation of precursor particle 
and ii) coagulation of precursor particles and oligomers to colloidally stable 
particles.113,121 
 
The crosslinker plays a crucial role for synthesis of homogeneous nanogels.  For 
example, the concentration of crosslinker can control morphology, polydispersity or 
even gel properties like the equilibrium swelling of nanogel particles.119,122 Senff et 
al.123 showed that if the concentration of crosslinker was increased in the synthesis 
of PNIPAM nanogels then the polymerisation produced smaller diameter nanogels 
with the typical diameters of particles synthesised by precipitation polymerisation is 
in the range of 130 nm to 2.4 µm.124 Dispersion polymerisation can be classified as a 
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sub-type of precipitation polymerisation that gives sub-micron monodisperse gels 
and particles. Dispersion polymerisation differs from precipitation in that it also uses 
a surfactant in the reaction media. This surfactant can be either provide stabilisation 
by steric and/or electrostatic means. A polymeric stabilizer may act as a steric 
stabilizer, forming   barrier on the surface of polymer, leading the colloidal stability 
and the particle size. A common example of steric stabiliser used in dispersion 
polymerisation is poly(vinyl alcohol).125 Electrostatic stabilisation can be obtained 
further the use of an ionic stabiliser. Pelton et al. showed that higher concentrations 
of the electrostatic stabiliser, sodium dodecyl sulphate (SDS) decreased the size of 
PNIPAM nanogels.126 These two types of colloidal stability play a key role in 
dispersion polymerisation by reducing the amount of precursor particles that must 
coagulate to reach a colloidal stable particles (Figure 1.9b).127 The typical diameters 
of particles are in range 100 nm to 15 µm.119,128 Many polymeric nanogel systems are 
fabricated by precipitation and dispersion polymerisation. 43,128–134   
 
1.5. Reversible addition-fragmentation chain transfer 
polymerisation (RAFT) of crosslinked particles and nanogels 
 
A type of living polymerisation that has been gaining popularity in recent years is 
reversible addition−fragmentation chain transfer (RAFT) polymerisation.135 RAFT 
polymerisation is based on a conventional radical polymerization which is mediated 
by a RAFT agent which is essentially a chain transfer agent (CTA) that fragments in 
presence of free radical from initiator. The general structure of RAFT agent is shown 
in Figure 1.10. The typical RAFT agent is a thiocarbonylthio compound [RSC(Z)=S]. 
They consist of an R group, a radical leaving group which is able to reinitiate 





Figure 1.10. General structure of a RAFT agent. 
 
There are several steps in a RAFT polymerization: initiation, pre-equilibrium, re-
initiation, main equilibrium, propagation and termination. The mechanism of RAFT 
polymerisation is presented on Figure 1.11. The initiation step begins with the 
creation of radicals (I•), which react with a single monomer molecule to yield a 
propagating (i.e. growing) polymeric radical, denoted as Pn•. Further monomer 
molecules, M, are added to the radical molecules Pn• to form longer propagating 
radicals.  In next step Pn• reacts with the RAFT agent to achieve equilibrium between 
active and dormant species. The addition of a propagating radical (Pn•) to the 
thiocarbonylthio compound [RSC(Z)=S (4)] leads to fragmentation of the 
intermediate radical. This may undergo a reversible fragmentation in which the 
intermediate RAFT adduct radical is capable of losing either the R group (R•) or the 
polymeric species (Pn•) (1-3). If a polymeric thiocarbonylthio compound [PnSC(Z)=S 
(6)] and a new radical R• are formed, the reaction of this radical (R•) with the 
monomer induces a new propagating radical (Pm•). The quick equilibrium between 
the active propagating radicals (Pn• and Pm•) and the dormant polymeric 
thiocarbonylthio compounds (6) assure equal probability for narrow polydisperse 
polymers. The resulting polymers have well-defined length, molecular weight and 
low polydispersity (PdI < 1.15).136,137 After the finishing of polymerisation, the 
majority of chains retains the thiocarbonylthio end group and can be isolated as 





Figure 1.11. The mechanism of RAFT polymerisation.135 
 
A RAFT agent needs to meet the following criteria to allow for achievement for an 
efficient, controlled polymerisation; it needs to have a reactive C=S double bond 
(high kadd) and a weak S-R bond for rapid fragmentation (high kß). The R group should 
be characterised as a good leaving group (kß ≥ k-add) and should re-initiate 
polymerisation. RAFT polymerisation can be performed in a range of solvents 
(organic and aqueous) and in the absence of metals. RAFT polymerisation has been 
used to synthesise different polymer architectures such as blocks, gradients, 
statistical, combs, brushes, stars, hyperbranched, and network copolymers.138 It has 
shown also potential for synthesis of smart materials and biological application.139 
To date, there are few articles on the synthesis of PNIPAM hydrogels by RAFT 
polymerisation. This was the main motivation to conduct the research which is 
described in Chapter 4 (The synthesis of degradable poly(N-isopropylacrylamide) 




Lu et al. demonstrated the synthesis of bulk PNIPAM hydrogels by RAFT 
polymerisation in the presence of crosslinker N,N-methylenebisacylamide (BIS),  
4-cyanopentanoic acid dithiobenzoate as chain transfer agent (CTA) and 1,4-dioxane 
as solvent. The swelling property of PNIPAM hydrogels was tested showed that the 
presence of CTA may cause the acceleration of shrinking kinetics of PNIPAM 
hydrogels produced by RAFT polymerisation compared with PNIPAM hydrogels 
prepared by free radical polymerisation.140 Xu et al. have shown the synthesis  
of PNIPAM nanogels by RAFT dispersion polymerization in cononsolvents water–
ethanol (75 : 25, v:v) solution.86 The RAFT dispersion polymerisation was conducted 
in the presence of poly(N,N-dimethylacrylamide) (PDMA) as the macro-molecular 
CTA, showing good control of molecular weight and polydispersity. The approach of 
polymerisation of NIPAM in the presence of N,N′-methylenebis(acrylamide) (BIS) was 
presented and PDMA-b-P(NIPAM-co-BIS) nanogels were successfully synthesised. 
Two macro RAFT agents with different DPs (PDMA64 and PDMA35) were used during 
the RAFT synthesis. The results showed that the length or molecular weight of macro-
CTA had effect on the diameter and colloidal stability of nanogels.141–143  
Generally, it was shown that higher DPs of the PNIPAM block, higher molar ratios of 
[BIS]:[MacroCTA], and higher solid contents led to synthesis of defined nanogels 
using PDMA64 compared with PDMA35. The size of nanogels became smaller with 
increasing degree of polymerisation (DP). 141  
The study of copolymerisation of NIPAM and N,N’-bis(acryloyl)cystamine (BAC) by 
RAFT polymerisation was carried out by Sumerlin et al. 144 Their research showed that 
redox and thermoresponsive hyperbranched copolymers can be used to prepare 
core-crosslinked star copolymers by chain extension in N,N-dimethylacrylamide.  
The self-assembly of thermoresponsive copolymers was determined by DLS and 
turbidity measurements. Degradation studies were conducted in the presence of DTT 
in water at 25 °C and 45 °C for 5 h. To determine the degradation behaviour, the 
hydrodynamic diameter and the number average molecular weight (Mn) were 
analysed by DLS and SEC, respectively showing decreasing in size from 52 nm to 23 
nm at 25 °C and 24 nm at 45 °C and Mn SEC decreased from 1 372 000 to 34 400 
g/mol.   
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The approach of using RAFT polymerisation showed well controlled Mn of polymers, 
nanogel size and colloidal stability and it has potential to be used in the field of 
nanomedicine.  
The effects of nanoscale drug delivery systems in living systems are complex, and in 
order to design successful nanomedicines it is crucial to understand the biological 
behaviour of a nanocarrier and the drug it is delivering. Therefore, the development 
within the field of nanomedicine also requires the improvement of the analytical 
tools for characterising nanoparticles in complex environments. For example, 
methods are required for separating and analysing single components from complex 
biological samples.145–147 It is also critical to understand the chemical and physical 
properties of potential drug delivery systems.  
 
1.6. Principles of asymmetric flow field flow fractionation (AF4) 
  
In the field of nanoscience, it has become very important to obtain analytic 
techniques to provide high resolution characterisation of particles with nanoscale 
sizes. A promising approach is to fractionate nanoparticle distributions using field 
flow fractionation (FFF), a technique that allows the separation of molecules  
and colloids based on their diameter. Field flow fractionation was invented in 1966 
by J. Calvin Giddings, but the first commercial use took place in 1987.148  
FFF techniques were classified as belonging to chromatography category where 
separation is based on hydrodynamic principles.149 The most widely used  
is asymmetrical field flow field fractionation (AF4).  The advantages of AF4 compared 
with other chromatographic techniques like size exclusion chromatography (SEC) can 
be for example: absence of stationary phase and minimisation of shearing forces,150–
152 no need for filtration in sample preparation,149 the ability to undertake analysis of 
in complex mixtures, the ability to analysis sensitive and soft particles like proteins,153 
and the high resolution characterisation that the method provides. The separation of 
particles by AF4 take place in a narrow, ribbon and trapezoid channel. The typical 
dimension of channel are 50 cm in length, 2 cm in width and the channel height can 
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be between 50 and 500 µm. The scheme for separation of particles in the AF4 channel 
is presented in Figure 1.12.   
 
Figure 1.12. Schematic structure of AF4 channel illustrating the principle of 
hydrodynamic separation.  
 
In the channel, there is a membrane acting as an accumulation wall which is 
supported by a porous plate. A spacer is used to determine the channel height and it 
is clamped between porous frit and the (typically transparent) impermeable wall.  
The simple construction of the channel and transparent wall allow for visual 
controlling of separation especially for colourful samples. Typically, molecules with 
sizes between 1 nm and 100 µm can be separated by AF4.154 However, the lower size 
limit is determined by the size cut-off of the used membrane (typical 10 kDa) and the 
upper size limit is determined by the channel thickness.148 The typical fractionation 
of injected sample in AF4 is as follows: an eluent is pumped from the inlet through 
the channel, creating a parabolic laminar Newtonian flow profile, moving the 
molecules towards the outlet.145,149 The second, perpendicular flow of mobile phase 
called cross-flow is applied in order to fractionate and retain particles according to 
their different diffusion coefficients which is associated with the size of particles. In 
this way, components are split by their hydrodynamic volume, size, density and 
surface properties which are visible at different retention times.155,156 The eluents 
shall be chosen to give the same electrical polarity between sample and the 
membrane. The repulsion between analyte and accumulation wall of membrane 
must be sufficient. Appropriate selection of the cross-flow is important, the cross-
flow should be sufficient to fractionate particles but it also should not be too high 
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due to the possibility of accumulation of particles in the membrane wall.  
The combination of retention theory and Stokes−Einstein equation allow to define 





          (1) 
 
where kB is the Boltzmann constant, tR is retention time, T is the absolute 
temperature, η is the dynamic viscosity of the solvent, ω is the channel thickness, 
and Fx/Fc is the ratio of the cross-flow rate Fx to the channel flow rate Fc.  
 
1.6.1. Different detector types for AF4 
 
Early systems used the retention time to calculate the particle sizes. However 
nowadays, AF4 systems are typically coupled to a range of different detectors so the 
retention time is now rarely used to determine sample diameter.  Commonly used 
detectors include multi angle light scattering detector (MALS), dynamic light 
scattering (DLS), refractive index (RI) detectors, UV-VIS detectors, inductively 
coupled plasma mass spectrometry (ICP-MS) etc. to obtain the desired information 
about molecules. 158 
MALS is one of the most widely used with the AF4 technique. MALS is based on static 
light scattering and determines the scattered light intensity as a function of the 
scattering angle. By using photo-detectors around the flow-cell in a multi-angle 
geometry, measurements can be performed over a broad range of angles, the 
schematic of MALS detector is shown in Figure 1.13. MALS measures the scattered 
light intensity at many angles then extrapolates back to 0˚, giving molecular weight 





Figure 1.13. Schematic of MALS detector.159 The figure shows inlet and outlet, 
flow cell, laser and detectors located around the flow cell.  
 
The Rg is defined as is the distance from the centre of mass of an object at which the 
whole mass could be concentrated without changing its moment of rotational inertia 
about an axis through the centre of mass.160 To understand more about Rg, some 
more information about light scattering theory will now be discussed. The 
relationship between the intensity of scattered light by sample and its molar weight 










Where: C the sample concentration, Ɵ the measurement angle, 𝑅ɵ the Rayleigh ratio 
(the ratio of scattered light intensity to incident light intensity) at the measurement 






K is a constant and along with  𝑃Ɵ (the particle scattering factor) are more complex 








Where : 𝜆0  the wavelength of laser in vacuum; 𝑁𝐴  Avogadro’s number, 𝑛0  is the 
refractive index of the solvent, dn/dc which is a measure of the difference in 













 Where: 𝑛0 the refractive index of the solvent, Rg the sample’s radius of gyration, 𝜆0
2 
the wavelength of the laser in a vacuum, Ɵ measured angle  
When an object is small compared to the wavelength of light (size less than <1/20th 
of laser wavelength) as in Figure 1.14A, the light is scattered with even intensively all 
directions. Such objects are therefore isotropic scatterers. The second type of 
scatterer is called anisotropic and it refers larger molecules, i.e. size of particles is 
more than >1/20th of the laser wavelength. In large molecules, the light is scattered 




Figure 1.14. A. An isotropic scatterer is small relative to the wavelength of the 
light and scatters light evenly in all directions. B. An anisotropic scatterer has 
significant size compared with the wavelength of the incident light and scatters 





 as a function of 𝑠𝑖𝑛2(
Ɵ
2
) for larger molecules, the change in scattering 
intensity with angle can be visible and 1/Mw can be calculated from 
𝐾𝑐
𝑅ɵ
 at the 
intercept (see Figure 1.15).161,162  From the initial slope of the line, the Rg can also be 
calculated. Unfortunately, at small molecular sizes (<1/20th of the laser wavelength; 
<10-15 nm radius), the slope will be very small and the noise may hide the data. The 
most important factor for making measurements using MALS is the form of the 
extrapolation. It is extremely important that a MALS instrument should have as many 
low angles as possible as this will provide the most accurate extrapolation back to 0°. 
Generally, in order to maximise the accuracy of the extrapolation, having more 
angles is beneficial. The intercept of the line is 1/Mw and the initial slope of the line 





Figure 1.15. A Guinnier plot shows KC/RƟ as a function of sin2(Ɵ/2). The intercept 
of the line is 1/Mw and the initial slope of the line is related to Rg.159 
 
The measurement at multiple angles can increase the confidence in the data for 
MALS measurements. MALS offers insights into the angular dependence of the 
scattered light for large molecules (>10-15 nm radius) enabling the highest quality 
and most accurate measurement of Rg, characterising structure for these large 
molecules. MALS detectors can measure the molecular weight of molecules from 
small (Rg > 10 nm) to large (Rg <~ 500 nm) since any angular dependence in the light 
scattering is always accounted for. A second type of detector that is commonly 
coupled to AF4 system is dynamic light scattering (DLS), also called as quasi-elastic 
light scattering (QELS) equipment. In DLS, a laser is directed into the dispersion of the 
particles and the scattered light is collected at one angle over time. The random 
movement of the particles due to Brownian motion leads to random variations of the 
intensity of the scattered light. From these fluctuations an autocorrelation function 
is derived, which is converted for assessment of particle diffusion coefficient and size, 
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in case that the analytes are spherical. The correlation signal G depends on the 
diffusion of the particles being measured.  
 





Where: B = is the baseline, A is the amplitude, D is the translational diffusion 
coefficient and q is scattering vector.  
 










where: 𝑛 is solvent refractive index, λ0 is the vacuum wavelength of the laser, and 
Ɵ is the scattering angle.  
 
 
The hydrodynamic radius can be converted from diffusion coefficient D using Stock-






Where: k is Boltzmann’s constant, T is the absolute temperature, ɳ coefficient of 
viscosity and D is the diffusion coefficient. 163 The DLS measurements can be obtained 
in batch or in flow mode.164 Nowadays, DLS can measure the size for spherical 
particles in diameter from a few nm to 1 µm.159 It was shown before that Rg/Rh, 
defined as shape factor (ρ), can give information about shape of particles and internal 
structure.165,166 The examples of different material shape and values of ρ are placed 







Table 1.1. The examples of shape particles with values of shape factor (ρ) 
  




Stiff rod 2.36167 
Oblate ellipsoids 0.875 to 0.987168 
Prolate ellipsoids 1.36 to 2.24168 
Core-shell particles <0.7169 
 
The application of AF4 for fractionation and analysis of different molecules using 
MALS and DLS instruments are discussed in next subsections. In subsections 1.6.2. 
AF4 the state of art technique, the areas where AF4 has been used and showed a 
promise. In subsection 1.6.3. the application of AF4 on nanogels were discussed. In 
subsection 1.6.4. the potential of AF4 on analysis non-spherical particles were 
mentioned.   
 
1.6.2. AF4 – state of art technique 
 
The AF4 showed a promise in the range of different fields as: biotechnology 
(viruses,170 aggregates,171 cell organelles,172 bioparticles173), pharmacy (proteins,174 
antibodies,174 liposomes,175 drug delivery,176 micelles177), environment (humic and 
fulvic acid,178 environmental colloids,179 clay particles180), material science (latex 
beads,181 nanoparticle182) and polymers (biopolymers,183 starches,184 
polyelectrolytes185). There is also increasing interest in AF4 as a state of art technique 
in nanomedicine application.186 One application of AF4 have been used to 
understand the formation of the protein corona on nanoparticles. When a 
nanomedicine is exposed to physiological fluid the proteins in the liquid absorb on 
the surface of the particle. It has been suggested that there two types of protein 
coronas exist: strongly bound proteins (hard corona) or loosely bound proteins (soft 
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corona). Weber et al.187 showed that it was possible to use AF4 to separate the soft 
protein corona from hard corona. AF4 has also been used to separate biological 
material. Hawe et al. showed that they could separate immunoglobulin G and its 
aggregates.188 Another interesting example of AF4 an application in nanomedicine 
field was published by Engel et al.189 In their work, the release of poly(D,L-lactide-co-
glycolide) (PLGA) nanoparticles from tablets were studied by AF4. This research 
provided information on the particle size and indicated that AF4 is a useful technique 
for analysis of for drug release from different nanocarriers.  In next subsections, the 
application of AF4 on nanogels and the potential of AF4 on analysis non-spherical 
particles are discussed.  
 
1.6.3. AF4 and nanogels 
 
Thus far, there is relatively a small body of literature that is concerned with analysing 
nanogels by asymmetric flow field flow fractionation. AF4 coupled with different 
detectors like MALS, DLS, RI can give information about size, shape molecular weight 
and distribution of particles. Shimoda et al.190 have prepared crosslinked 
polysaccharide–PEG hybrid nanogels (CHPOA–PEGSH) and analysed these particles 
by dynamic light scattering (DLS), AF4-UV-VIS-MALS to determine the particle size 
and degradation kinetics.  The AF4 and DLS measurements showed good separation 
with a regenerative cellulose membrane in eluent phosphate buffered saline (PBS) 
buffer at pH 7.4. The different diameters of CHPOA-PEGSH hybrid nanogels were 
obtained i.e. from 78 to 108 nm, depending on the ratio of the reagents.  
Hartlieb et al.191 prepared of poly(2-oxazoline)-based block copolymers consisting of 
a cationic (PAmOx) block and hydrophilic segments (PEtOx) and studied their self-
assembly in different organic solvents. A schematic of the synthesis is shown in Figure 
1.16. AF4 was used to investigate the Mn of polymers and Rg, Rh and shape factor for 
crosslinked nanostructures. The value of shape factor was different for two solvents 
dependent upon its nature used for assembly, showing results for ρ less than 0.8 for 
CHCl3 which they suggested indicated compact micellar structure, and around 1.0 for 
isopropanol which was assigned to a soft structure with the architecture of a vesicle. 
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Authors showed a limitation for MALS detector as the particles with Rg of less than 
approximately were 15 nm not detected.147,191 Unfortunately, the chosen membrane 
cut-off was 10 kDa and seems to be too high for a polymer with Mn between 9200 
and 13600 due to low recovery (around 75%).    
 
Figure 1.16. Schematic representation of the self-assembly of P(EtOx-b-AmOx) 
followed by cross-linking and quenching/loading. Reproduced from M. Hartlieb, D. 
Pretzel, M. Wagner, S. Hoeppener, P. Bellstedt, M. Görlach, C. Englert, K. Kempe 
and U. S. Schubert, J. Mater. Chem. B, 2015, 3, 1748–1759 with permission from 
The Royal Society of Chemistry. 
 
 
The group of L. Andrew Lyon have contributed a few research articles regarding the 
analysis of PNIPAM nanogels by AF4. Their articles are discussed below. Their paper 
by Blackburn et al. studied core/shell nanogels made of PNIPAM crosslinked with BIS 
and copolymerised with acrylic acid.132 The size of particles was controlled by 
changing the concentration of initiator and surfactant providing samples from 100 
nm to 280 nm in diameter. The analysis of the samples by AF4-MALS showed that the 
nanogels had monomodal and narrow distributions. Unfortunately, the paper 
provides limited details about separation conditions like eluent or cross-flow for 
method. In another paper from the same group by Smith et al.192 they synthesised 
PNIPAM nanogels by precipitation copolymerisation with degradable crosslinker 
N,O-dimethacryloylhydroxylamine (DMHA). The degradation of particles was tested 
under different pH and temperature conditions and then characterised using AF4-
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MALS-DLS. The authors also determined the shape factor for the particles. They 
showed that values of ρ for PNIPAM nanogels of ~1.4 for non-crosslinked chains 
below the volume phase transition temperature (VPTT) and between 0.54 to 0.85 in 
the swollen state. The ρ values for PNIPAM-DMHA was 0.6 at 20 °C which indicated 
that particles have denser core and less dense shell. The degradation studies showed 
a decrease in the normalized scattering intensity for AF4-MALS measurements for 
PNIPAM-DMHA nanogels incubated at 37 °C and pH values higher than 7, which 
indicated that particles degraded faster at higher pHs. By measuring a MALS90ᵒ signal 
before and after degradation they found changes in intensity thus demonstrating 
how much of nanogels were degraded. The most degradable nanogels showed that 
around 20% of nanogels left in pH 8.4. However, these results were limited to 
measurements of Rg and Rh and are therefore not representative of molecular weight 
of degradable products. Molecular weight analysis of degradation products would 
have been valuable in an attempt to solve issue with mechanism of nanogels erosion.   
In a follow up study, Lyon et al.114 demonstrated the ability to synthesis PNIPAM 
nanogels with disulphide based crosslinker N,N′-bis(acryloyl)cystamine (BAC) by 
aqueous, redox-initiated precipitation polymerization approach. To improve the 
control over disulfide incorporation a non-degradable cross-linker  
N,N-methylenebis(acrylamide) (BIS) was used to synthesise thiol-bearing microgels. 
These microgels were characterised by using AF4-MALS and batch DLS techniques. 
The degradation of particles was triggered by dithiothreitol (DTT) and measured by 
AF4-MALS in phosphate buffer at pH 7.  The molecular mass of nanogels was found 
to decrease in the presence of DTT, indicating that swelling was accompanied by 
mass loss. This change in the nanogels caused the decrease in light scattering 
intensity in MALS (see Figure 1.17. ). The erosion was also found in the presence of 
cysteine, although in slower mode. The AF4-MALS-DLS measurement showed 
potential in analysis of degradation for PNIPAM nanogels and it was much powerful 
than DLS batch analysis due to fractionation of particles and presentation of range 




Figure 1.17. A4F-MALS separation of pNIPMAm-BAC (5%) microgels formed by the 
(a) thermal and (b) redox initiation methods. Incubating the particles with DTT 
increased retention of the thermally initiated particles yet led to degradation of 
the redox-initiated. Reprinted with permission from L. A. Lyon, Macromolecules, 
2012, 45, 39–45. Copyright (2012) American Chemical Society.  
 
1.6.4. AF4 and non-spherical particles  
 
A growing body of literature is concerned with fractionation of non-spherical and 
particles with different shapes by AF4 measurements. By far, the most 
comprehensive article of separation gold nanorods by flow field flow fractionation 
technique is the work of Gigault et al.193 Their work investigated the influence of 
composition of eluent and flow ratios on the separation of positively charged non-
spherical gold nanoparticles. The different molar ratios of ammonium nitrate 
(NH4NO3) and cetyl trimethyl ammonium bromide (CTAB) were used as the eluent in 
the system. Gigault et al. showed that mobile phases consisting of 30 % CTAB and  
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70 % of NH4NO3 gave the best reproducibility and recovery. The samples used in their 
research were gold nanorods with range of aspect ratio obtained from SEM/TEM 
(from 1.4 to 4.4). The chosen cross-flow for separation of gold nanorods was fixed at 
0.5 mL/min as optimised due to the size of particles and recovery. The elution time 
was found to be shorter for longer rods. The experimental data obtained from AF4 
measurements were compared with the values from theoretically calculated 
Brownian model. The results suggested that the fractionation of non-spherical 
particles was made by a combination of diffusion coefficient and aspect ratio due to 
the steric-entropy contribution associated with their orientation. A possible 
explanation is that the longer rods have a concentration profile further removed 
from the accumulation wall compared to the shorter rods, and consequently elution 
is faster.  
Weiss et al. 194 showed the acylation of biodegradable poly(glycerol adipate) (PGA) 
with different fatty acids (laurate, stearate and behenate) to create range of different 
polymer structures. The polymers were characterised by AF4-MALS and also with the 
range of different techniques including: DLS and zeta potential measurement.  
The AF4 measurements showed a range of shape factors and it agreed with aspect 
ratio obtained from SEM images. For spherical particles, shape factor values were 
between 0.7 and 0.8, while for more non-spherical particles the values increased to 
around 0.99.  This article showed potential for AF4 technique to obtain shape factor 
as information about structure and shape of nanomaterials.  
Mathaes et al.167 gives some reliable methods and techniques to characterise 
polystyrene non-spherical particles. In this research, non-spherical poly(1-
phenylethene-1,2-diyl (polystyrene) particles over a wide size range (40 nm, 2 µm 
and 10 µm) were successfully  synthesised by a film stretching method. The authors 
used 350 spacer and a 30 kD a cut-off regenerated cellulose membrane. Focusing 
period was 7 min with an applied focus flow of 2 mL/min. For the analysis of particles, 
the mobile phase consisted of 0.5% SDS in water was used. The critical micelle 
concentration (CMC) of SDS is 8.2 mM at 25°C,195 therefore, the concentration of SDS 
used in their research resulted in the formation of micelles which might have 
influenced the results as micelles are easy detected by AF4-MALS-DLS 
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measurements. Nevertheless, the shape factor for non-spherical particles was 
around 0.99, indicating more rod structure in agreement with SEM images. Mathaes 
et al. gave sufficient detail on the method for separation of particles which would 
allow the data to be reproduced. This is noteworthy as often articles in AF4 literature 
do not give sufficient information on the methods to allow reproduction. Typical 
missing details can be values and changes of cross-flow, temperature or type of 
membrane.  Another typical issue, which can be seen in the literature for AF4 
measurements, is lack of information about fit used for calculation Rg. 
A comprehensive article about analysis of biohybrid structures of avidin and 
biotinylated glycodendrimers based on poly(propyleneimine) (GD-B) was published 
by Boye et el.157 AF4 coupled with DLS and MALS detectors was used to characterise 
biohybrid structures consist of single components (avidin, differently valent GD-B) 
and nanostructures (see Figure 1.18. ). It was shown that the differences in shape 
factors, Rg and Rh revealed the molecular shape of biohybrid structures was changed 
from rod-like to spherical. The Rh was obtained by two different strategies by online 
DLS and by calculation from retention theory. Both methods provided comparable 
results for single components. Authors put attention on weakness of online DLS 
measurements suggesting that for high molar masses, DLS measurements 
underestimated Rh.  
 
Figure 1.18. A structures of biohybrid analysed by AF4. Reprinted with permission 
from S. Boye, F. Ennen, L. Scharfenberg, D. Appelhans, L. Nilsson and A. Lederer, 




The issue of underestimation of Rh by DLS was also published previously by Sitar et 
al.196 The size and shape of soft particles of various size and type: polystyrene 
nanoparticle size standards, lipid droplets (LDs), and large unilamellar vesicles (LUVs) 
were analysed by AF4-MALS-DLS. Three different detector flow rates were used in 
this study, (0.2, 0.5, and 1 mL/min) and were shown to have no significant influence 
on the shape factor and Rg of spherical nanoparticles. On the other hand, the 
expected Rh was obtained experimentally only for the lowest flow rate at the 
detector (0.2 mL/min). The difference in the expected and measured Rh was largest 
for the larger particles (diameter 200 nm). These finding suggest that the detector 
flow should be used in relatively low values to obtain realistic values from online DLS 
measurements. It should be noted that this finding, the inaccuracy of Rh 
measurement for larger colloids has been contested by one of the AF4 manufacturers 
(PostNova Analytics Ltd. ), however, to date there have not been any publications 
that refute the findings of Sitar et al.196 
Few attempts were also made to characterise carbon nanotubes by asymmetric flow 
field flow fractionation.197–199 Gigault et al. 199 studied multi-walled carbon nanotube 
(MWCNT) length dispersion state in aqueous medium by AF4-UV-MALS technique. 
Fractionation key parameters like mobile phase composition, spacer thickness, range 
of cross-flows were studied to obtain a robust method for evaluation of 
nanomaterials. Cross-flows between 1.8 and 2.5 mL/min were tested, obtaining 
lengths of MWCNTs from 200 to 1100 nm. The MWCNTs were dispersed in SDS 
aqueous solution to give more a hydrophilic character to the samples. Two different 
mobile phases with different concentrations were tested in this work (NH4NO3 and 
SDS). Various ionic strengths were also tested to obtain the best reproducibility, size 
fractionation and detection. The most appropriate results in terms of reproducibility 
was obtained in 1.10-5 mol/L  NH4NO3 mobile phase and 250 µm thickness of spacer 
due to the highest recovery of particles (>90%). The recovery (<70%) and 
reproducibility in SDS were poor. The results are visible in Figure 1.19. The article 
showed the ability of powerful analytical technique to evaluate MWCNT aqueous 
dispersion giving information about the number and size of different populations, as 




Figure 1.19. a) Typical fractograms of MWCNT obtained for two different 
mobile phase natures with an ionic strength of 1.10−5 mol/L b) MWCNT 
recoveries R (%) for different ionic strengths and two salt natures. 
Reprinted by permission from Springer, J. Gigault, B. Grassl and G. Lespes, 
Anal. Bioanal. Chem., 2011, 401, 3345–3353. Copyright 2011.  
 
 
1.7. Research objectives and thesis overview  
 
The shape and structure of nanomedicines have a considerable impact on their 
biological behaviour.200 Therefore, it is a challenge in the field of nanomedicine to 
develop new methods for synthesising and characterising nanomaterials with non-
spherical and controlled internal structures. This challenge is the motivating factor 
for the research presented in this thesis. The aim of the work described in this thesis 
is to synthesise nanoparticles, nanocomposites and nanogels with different sizes and 
morphologies that might have potential applications in nanomedicine. These 
nanomaterials will then be analysed by AF4 to provide insight into their size, shape 
and degradation behaviour that could not be provided by alternative 
characterisation techniques. This analysis using AF4 will also provide new methods 
to those in the growing field of AF4 and a better understanding of the fractionation 
behaviour of complex (core-shell structures and non-spherical) nanomaterials.  
This thesis contains four results chapters:  
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In Chapter 2, nanocomposites of multiwalled carbon nanotubes/ polycaprolactone 
particles were synthesised by a facile oil-in-water emulsion solvent evaporation 
route. These nanocomposites were then loaded with the anti-cancer drug docetaxel. 
The nanocomposite composition and novel morphology of the particles were 
characterised by DLS, SEM, AFM and AF4. This work provides a novel method for 
preparing non-spherical nanocomposites. The AF4 measurements showed analysis 
for different shapes and morphology of nanoparticles. This was a motivation to 
continue of development of AF4 methods for analysis of different materials like 
PNIPAM nanogels.  
In Chapter 3, the research about the development of a versatile AF4 method to 
characterize PNIPAM nanogel sample with mean diameters from 65 to 310 nm were 
presented. This approach would also provide insight into the internal structures of 
samples. Therefore, the evaluation of separation conditions using different mobile 
phases and crossflows with inline MALS and DLS detectors for analysis were tested.  
The aim of Chapter 4 was to produce degradable PNIPAM nanogels by RAFT 
polymerisation with well-defined length of polymer chains. The nanogels were 
characterised by DLS, nuclear magnetic resonance (NMR) and AF4. The degradation 
studies were conducted in the presence of DTT by AF4-MALS and DLS.  
Chapter 5 is focussed on the analysis of a range of nanoparticles made of different 
materials with different sizes and shapes, with the aim of establishing methods that 
can be used to provide size and shape information on different types of metal 
nanoparticles. The particles were fractionated by AF4-MALS-DLS, with the aim of 
better understanding the relationship between particle size, shape and separation 
behaviour. The samples analysed were gold nanoparticles, gold nanorods, silver 
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The use of nanomaterials for applications in drug delivery has been shown to offer  
a wide range of potential benefits such as encapsulating both hydrophilic and 
hydrophobic substances, improving the stability of drugs and providing targeted 
delivery.1 These benefits have been particularly well demonstrated in the treatment 
of cancer where a large number of therapies are now used clinically.2,3 However, 
effectively maximising the dose of the drug at the target site versus systemic 
distribution still remains to be a considerable challenge for any therapy. Recently, 
there has been growing interest in the influence of the geometry and stiffness of 
nanomaterials on their interaction with cells and tissues.4–11 A wide range of 
geometries and structures are synthetically possible such as nanoparticles,12–14 
nanotubes,15–17 nanodisks,18 nanoshells19,20 and nanowires.21 The size, shape, 
stiffness and surface chemistry of nanomaterials has been shown to influence 
cytotoxicity,22 drug release,23 targeting and imaging contrast efficiency.24 Generally, 
high aspect ratio (length/diameter) nanomaterials can provide improved drug 
delivery potential in comparison to spherical nanoparticles.4,5 
Carbon nanotubes (CNTs) are a type of high aspect ratio nanomaterial and they 
possess a range of interesting properties including their nanoscale size, unique fibre 
structure, large surface area and high mechanical stiffness.15 These properties have 
led to CNTs being investigated as drug delivery systems.16,25 CNTs have shown 
benefits in DNA delivery,26 use as cancer theranostics,27,28 small molecule drug 
delivery16 and regenerative medicine.29 CNTs can both be covalently modified with 
drug molecules, or they can physically adsorb aromatic drugs via the strong π-π and 
hydrophobic interactions between the drug and the aromatic surface of the CNT. 
Such physical adsorption of drugs has been exploited for loading anthracyclines, a 
class of anticancer drug.16 However, in spite of their drug loading potential, the 
inherently hydrophobic nature of CNTs can limit their application in aqueous 
environments. As such, surface modification and coating is often utilised to improve 
the colloidal stability of CNTs and to minimise their inherent toxicity.30 Polymers are 
typically used for this purpose, with the polymers usually introduced onto CNTs by 
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covalent approaches consisting of either “grafting to” or “grafting from” the surface 
of the CNT. The former approach involves binding polymers to CNT surfaces by 
amidation, radical coupling, esterification and other rections.31 While the latter, 
“grafting from”, applies in-situ polymerizations of immobile monomers on the CNTs 
surfaces by anionic/cationic polymerizations or atom transfer radical polymerization 
(ATRP).32 For example, Gao et al. used “grafting from” to modify the surface of 
multiwalled carbon nanotubes (MWNTs) with poly(Ɛ-caprolactone) (PCL).33  
An alternative approach is to modify the CNTs by a non-covalent functionalisation. 
This approach is particularly attractive due to the relative simplicity of process, 
additionally it has also been shown to introduce fewer defects to the graphitic 
structure of the CNTs.34 A few examples of this approach have been shown, these 
include coating the CNTs with poly(ethylene glycol)-phospholipid conjugates,35 
forming a biopolymer coating using layer-by-layer assembly,36 or stabilising the 
surface with Pluronic F-127, a commercially available surfactant.37 However, one 
issue with non-covalent modification is that the forces between the coating and the 
CNT are typically weak and desorption may occur.38 A useful coating for CNTs would 
be PCL, a polymer that has been widely investigated for drug delivery12 and  
is currently used as a component of clinically approved devices.39 PCL nanoparticles 
can be prepared by the oil-in-water emulsion solvent evaporation method. In this 
process the polymer solution is emulsified and particles are formed upon 
evaporation of the solvent for the polymer.40 Using this oil-in-water emulsion solvent 
evaporation method with CNTs would potentially provide a solid PCL coating that 
would not be easily desorbed. Additionally, PCL nanoparticles can provide 
entrapment efficiencies exceeding 80% and drug loadings of up to 20%.41 The 
potential for combining CNTs with their high modulus and drug loading with PCL, a 
polymer with proven medical usage and drug delivery potential may provide a unique 
nanomaterial for applications in medicine. 
In this study, we demonstrate a facile approach to produce high-aspect ratio 
nanocomposites comprising of CNTs and PCL, with the aim of combining the benefits 
of both materials and encapsulating the anti-cancer drug docetaxel. We investigate 
the formation of nanocomposites by an oil-in-water emulsion solvent evaporation 
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route (Figure 2.1) and examine how to control the size and morphology of the 
particles. The nanocomposite composition and novel morphology of the particles are 
characterised by DLS, SEM, AFM and AF4. Finally, we investigate the potential for 
loading the nanocomposites with docetaxel and monitor the in vitro drug release. 
 
 
Figure 2.1. Scheme for the preparation of PCL-CNTs nanocomposites by an oil-in 
water emulsion solvent evaporation method. The solution of PCL and dispersion 
of CNTs (both in DCM) was emulsified in an aqueous surfactant solution. The 










2.2.1. Materials  
Polycaprolactone (PCL, molecular weight 14,000 g/mol), sodium dodecyl sulphate 
(SDS), ammonium nitrate were purchased from Sigma-Aldrich. Non-functionalised 
multiwalled carbon nanotubes (MWCNTs) were purchased from Nanostructured & 
Amorphous Materials Inc. (Houston, USA) at 95% purity (Stock no. 1237YJS). 
According to the manufacturer, MWCNTs have an outside diameter 20-30 nm and 
length ranging between 0.5 and 2µm. Docetaxel was purchased from Chemleader 
Biomedical. Dichloromethane (DCM) (analytical reagent grade), acetone, acetonitrile 
(HPLC grade) were purchased from AgraNova. Milli-Q water obtained from a water 
purification system had a resistivity of > 18 MΩ cm-1 (PURELAB option R, Veolia).  
10 kDa dialysis membrane was purchased from Spectrum Labs. 
2.2.2. Synthesis of PCL-CNTs 
 
Nanocomposites of PCL and CNTs were prepared by an oil-in-water emulsion solvent 
evaporation method. CNTs were dispersed in DCM (1 mL) to form a dispersion with 
a concentration of 0.5 mg/mL.  The dispersion of CNTs was sonicated for 30 s using a 
Hielscher UP400s ultrasonic processor (400 Watts, 24 kHz, 45% of amplitude, 1 cycle). 
Next, the specific amount of PCL was dissolved in DCM (total volume 1 mL) to form 
the organic phase. The aqueous phase was prepared by dissolution of SDS in 4 mL of 
distilled water. The two organic phases were transferred into 14 mL glass vials 
containing the aqueous phase, dropwise through a needle (21G). In the next step, 
the immiscible phases were homogenised for 30 s using a Hielscher UP400s 
ultrasonic processor (400 Watts, 24 kHz, 45% of amplitude, 1 cycle) to obtain an 
emulsion. The nanodispersion was mixed by magnetic stirring (500 rpm, hotplate 






2.2.3. Synthesis of PCL NPs 
 
Nanoparticles of PCL were prepared by an oil-in-water emulsion solvent evaporation 
method. The specific amount of PCL was dissolved in DCM (total volume 1 mL) to 
form the organic phase. The aqueous phase was prepared by dissolution of SDS in  
4 mL of distilled water. The two organic phases were transferred into 14 mL glass 
vials containing the aqueous phase, dropwise through a needle (21G). In the next 
step, the immiscible phases were homogenised for 30 s using a Hielscher UP400s 
ultrasonic processor (400 Watts, 24 kHz, 45% of amplitude, 1 cycle) to obtain an 
emulsion. The nanodispersion was mixed by magnetic stirring (500 rpm, hotplate 
model: Stuart US152D) overnight (~16 h) to allow evaporation of DCM. Next, samples 
were purified by centrifugation for 50 min at 8,500 rpm and 20 °C in distilled water. 
This procedure was repeated 3 times. 
 
2.2.4. Encapsulation of docetaxel into PCL-CNTs 
nanocomposites 
 
PCL-CNTs nanocomposites with encapsulated docetaxel were prepared by an oil-in-
water emulsion solvent evaporation method as previously described in the synthesis 
of PCL-CNTs method. CNTs were dispersed in 1 mL of DCM to form a dispersion with 
a concentration of 0.5 mg/mL. Next, the specific amount of PCL was dissolved in DCM 
(total volume 1 mL) to form the organic phase. Docetaxel (DCX) (see structure Figure 
2.2) was dissolved in 1 mL of acetone. The aqueous phase was prepared by dissolving 
SDS in 4 mL of distilled water. The three organic phases were transferred into 14 mL 
glass vials containing the water phase, dropwise through a needle (21G). In the next 
step, the immiscible solution was homogenised for 30 s using a Hielscher UP400s 
ultrasonic processor (45% of amplitude, 1 cycle) to obtain an emulsion.  
The nanosuspension was mixed by magnetic stirring (500 rpm) overnight ~16 h to 







Figure 2.2. The structure of docetaxel – anticancer drug. 
 
 
2.2.5. Characterisation  
 
A Hitachi S-4800 cold Field emission (FE-SEM) scanning electron microscope (SEM) 
was used to image PCL NPs and PCL-CNTs. The samples to be analysed were 
centrifuged at 9000 rpm for 1 hours and washed with deionised water three times 
prior to addition (concentration 1 mg/mL) to glass coverslips stuck onto an 
aluminium stubs using carbon double-sided sticky tabs from Agar Scientific, Essex, 
UK and left to evaporate overnight. The prepared samples were coated with gold for 
2.5 minutes at 20 mA using an EMITECH K550X Sputter Coater.  
 
Asymmetric flow field flow fractionation experiments were performed on an MT2000 
with RI and UV-Vis detectors from Postnova Analytics, Landsberg/Germany. The sizes 
of the samples were obtained by dynamic light scattering (DLS) using a Malvern 
Zetasizer Nano ZS (running Malvern Zetasizer software V7.11) (Malvern Instruments, 
Malvern, UK) with 633 nm He–Ne laser and the detector positioned at 173°, coupled 
online to the MT2000. A 350 µm spacer and 10 kDa regenerated cellulose (RC) 
membrane were installed in the separation channel. The conditions used for the 
separations was based on a method existing in the literature.42 Briefly, the eluent 
was 1 x 10-5 mol/L NH4NO3 in Milli-Q H2O. Type I distilled water was obtained from a 
water purification system had a resistivity of > 18 MΩ cm-1 (PURELAB option R, 
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Veolia). The injected volume was 30 µL of 1 mg/mL sample. The injection/focussing 
time was 5 min using a cross flow of 2 mL min-1. The cross-flow rate was 2 mL min-1 
for the first 15 min (t0-t15) in constant manner, and thereafter, the cross flow was 
linearly decreased from its initial value to 0 over a period of 5 min. Following the 
complete reduction in cross flow, the tip-flow continued for an additional 35 min. 
The UV-Vis detector measured wavelength were monitored for 300 nm.  
The z-average diameter and count rate were measured by an inline Malvern Zetasizer 
ZS DLS at 3 second intervals. DLS calculates the z-average size of particles using the 
Stokes-Einstein equation. 
AFM measurements of the samples were performed with the samples deposited on 
glass coverslips which were adhered to mica substrates. The samples were prepared 
on the glass coverslip stuck onto mica substrates. A few microliters of suspended 
sample (concentration ~ 1 mg/mL) were pipetted onto the mica surface and left to 
dry by exposing to air overnight (~16 h).  AFM imaging was conducted using a Bruker 
Multimode 8 instrument (Bruker, Santa Barbara, USA), operated in ambient 
conditions with a Bruker RTESPA-525 probe using the Peakforce Quantitative 
Nanomechanical Mapping (PFQNM) method.43,44 The RTESPA-525 probe has a 
nominal spring constant of 200 N/m and a tip radius of 8 nm. All scans were 
conducted at a scan rate of 0.576 Hz with a scan size of 2.00 µm.43 
Thermo-gravimetric analyses (TGA) were performed in a simultaneous thermal 
analyser (STA) 449F1 Jupiter (Netzsch GmbH), which includes a thermo-gravimetric 
analyser. Samples of unprocessed CNTs, PCL nanoparticles and the PCL-CNT 
nanocomposites (5-15 mg) were added to platinum pan. In the case of the PCL 
nanoparticles and the PCL-CNT nanocomposites, these dispersions were prepared 
using the usual method and were then freeze-dried prior to addition of the dry 
powder to the analysis pans. The atmosphere of the samples, the pan and the sample 
holder were evacuated and purged with argon three times to remove the air before 
analysis. The samples were then analysed by heating at a heating rate of 10˚C/min to 
700˚C in an atmosphere of argon flowing at 20 mL/min, whilst monitoring weight 
changes at a resolution of ±25 ng.   
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2.2.6. Quantification of docetaxel by HPLC 
 
HPLC measurements were performed with the use of a PerkinElmer Series 200 
instrument. The chromatographic conditions were used as previously described in 
the literature.45 The chromatograph column used was an Agilent Zorbax Eclipse Plus 
C18. Solvent A contained HPLC grade water and solvent B consisted of HPLC grade 
acetonitrile. The flow rate of the mobile phase was 1.0 mL/min. The HPLC gradient 
was kept as T/%B (T is time and B is a percentage of acetonitrile solvent): 0/35, 15/65, 
25/75, 30/95, 35/100, 39/100 and 40/35 with a post run time of 5 min. The column 
was maintained at 25 °C. The detection wavelength was 230 nm. The injection 
volume was 10 µL. The diluent used was a 1:1 mixture of water and acetonitrile.  
A calibration curve was prepared for docetaxel from 14 standard solutions. Samples 
were prepared by dissolving the appropriate amount of docetaxel in 1:1 mixture 
water and acetonitrile. A linear calibration plot for the above method was obtained 
over 3.9 μg/mL to 250 μg/mL. The correlation coefficient was 0.99. 
In order to calculate the encapsulation efficiency of the samples the amount of ‘free’ 
docetaxel (i.e. not encapsulated in the nanoparticles) was measured. Firstly, the 
samples loaded with docetaxel were freeze dried for 24 h to remove the water. After 
that, the freeze-dried samples were dispersed in 2 mL of HPLC methanol for 15 min. 
The methanol was then transferred to a spin filter tube (cut off 3.5 kDa) and 
centrifuged at 6,000 g for 1h at 20 °C. The filtered solution was then analysed by HPLC 









2.2.7. In vitro drug release  
 
Briefly, 4 mL of PCL, CNTs and PCL-CNTs–PLGA nanoparticles solution (1 mg/mL) were 
introduced into dialysis membrane bag (12-14 kDa, Spectrum Laboratories Inc.)  
The end-sealed dialysis bag was incubated into 500 mL of distilled water in the 25˚C. 
Every 24 h, 250 mL of water was taken and freeze dried to remove water. After that, 
the freeze-dried samples were dispersed in 2mL of 1:1 mixture water and 
acetonitrile. Solution was analysed by HPLC, using the same method as described in 
HPLC method section. The release media was changed every 24h. 
2.3. Results and Discussion 
 
2.3.1. Factors controlling the diameter of PCL NPs  
 
This section is divided into 2 subsections. In the first section, the impact of the 
concentration of PCL on the diameter of nanoparticles is discussed. Secondly, the 
effects of the concentrations of different types of surfactants were investigated. The 
method used in this research is fast, simple and can be used to preparation polymer 
nanoparticles from solution of polymers dissolved in non-water-miscible organic 
solvents. Formation of nanoparticles occurred when the organic solvent with 
dissolving the polymer evaporated at the water/air interface resulting in solid 
polymer nanoparticles.  
2.3.1.1. Effect of varying the concentration of PCL on 
the nanoparticle properties 
 
Firstly, the effect of varying the concentration of PCL on the nanoparticle properties 
was investigated. The composition for these samples was as follows: the amount of 
PCL changed from 1 mg/mL to 10 mg/mL dissolved in DCM, and the amount of 
surfactant (SDS) was fixed 0.75 mg/mL in distilled water. The particles were then 
analysed by DLS to provide the mean particle diameter and polydispersity index (PdI) 




Figure 2.3. The relationship between the concentration of PCL in the organic 
phase and the resulting nanoparticle size and PdI. 
 
With increasing concentration of PCL, the diameter of particles was increased. This 
trend was likely caused by increasing of viscosity in the polymer solution.46 The PdI 
of the nanoparticles was found to be independent of the polymer concentration and 
varied from 0.15 to 0.25, the highest value for PdI was obtained for 8 mg/mL of 
polymer. The mean particle size of samples prepared by miniemulsion has been 
shown to be dependent on the size of the droplets produced during sonication,47 it 
appears that varying the polymer concentration did not influence the broadness of 
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2.3.1.2. The effect of surfactant types and 
concentration on the diameter and 
polydispersity of PCL nanoparticles 
 
The effect of varying the concentration and type of surfactant were then tested. For 
this research surfactants with different hydrophilic-lipophilic balances (HLBs) were 
checked. HLB value is a measure of the degree to which non-ionic surfactants 
are hydrophilic or lipophilic, determined by calculating values for the different 
regions of the molecule. 




Where MWh is the molecular weight of the hydrophilic component and MW is the 
molecular weight of the complete surfactant. For oil in water methods, the best 
theoretical value for a surfactant should be between 8-16.48 The HLB values of 
surfactants and types used for this research are included in Table 2.1. 
Table 2.1. Name, structure and HLB value for used surfactants. 
Commercial 
name 
Chemical name Structure HLB 
value 

























Figure 2.4A shows influence of surfactant concentration on the diameter of PCL 
particles for each of the particular surfactants and Figure 2.4B shows the relationship 
for the PdI of the different samples. Particles obtained by using SDS are characterised 
by the lowest diameter (~ 100 nm) and the lowest PdI (< 0.2). It suggests that during 
the formation of the emulsion, droplets created by added SDS have the lowest size. 
This evidence exists in the literature.53 DLS data also revealed that increasing the 
concentration of surfactants tended to give a very slight decrease in the diameter of 
the nanoparticles likely as a result of lower surface tension.54 The difference in size 
and polydispersity between the surfactants may be due to the higher surface 
tensions for the some of the surfactants.55 Samples with higher PdIs indicate poorer 
colloidal stability as the droplets or particles have coalesced or aggregated. Given the 
low diameter and PDIs obtained for nanoparticles using SDS, this was selected as the 





 Figure 2.4. A) The effect of concentration of different surfactants on the diameter 
of PCL nanoparticles with 2 mg/mL of PCL  B) The effect of concentration of 
different surfactants on the PdI of PCL nanoparticles with 2 mg/mL of PCL.  
 
2.3.2. Influence of the concentration of SDS, CNTs 
and PCL on particle size and morphology of 
composites 
 
The synthesis of PCL-CNTs nanocomposites was attempted by an oil-in water 
emulsion solvent evaporation method (see Figure 2.5), PCL and CNTs were contained 
in DCM which was then emulsified by sonication with an aqueous phase of the 
surfactant sodium dodecyl sulphate (SDS). The DCM was then left to evaporate under 
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ambient conditions. Two variables were initially investigated: the concentration of 
SDS in the aqueous phase and the concentration of CNTs in the oil phase, with the 




Figure 2.5. Scheme for the preparation of PCL-CNTs nanocomposites by an oil-in 
water emulsion solvent evaporation method. The solution of PCL and dispersion 
of CNTs (both in DCM) was emulsified in an aqueous surfactant solution. The 




We observed that samples containing higher concentrations of CNTs produced a 
turbid emulsion which was a darker grey-black in colour. The samples were then 
purified by centrifugation to remove any excess surfactant before being analysed by 
DLS. The analysis of the samples by DLS provided the mean hydrodynamic diameters 
of the particles and a measure of the broadness of the particle size distribution, 





Figure 2.6. The effect of changing the concentration of CNTs and SDS on the Z-
average diameter (A) and the PdI (B) of the resulting nanoparticles as measured 
by DLS. The concentration of PCL was 6 mg/mL. 
 
It was found that particles without SDS had the largest diameters and that there was 
a further increase in the size as the CNT concentration increased from 0.03 mg/ml to 
0.9 mg/ml of CNTs, with a diameter ranging from 289 to 434 nm respectively (Figure 
2.6A). The same effect was visible for PdI results; the absence of surfactant resulted 
in the highest PdI values (Figure 2.6B). The data from DLS measurements in presented 
in SI, Table 2.3. Without SDS, the high interfacial tension between water and DCM 
would result in an emulsion with low stability, this will have led to droplet 
coalescence upon evaporation of the DCM, giving a higher mean particle diameter 
and broad particle size distribution. An SDS concentration of 1.5 mg/mL produced 
the smallest particles and the lowest PdIs for all of the three CNT concentrations. 
Concentrations above 1.5 mg/mL of SDS did not reduce particle size further 
suggesting 1.5 mg/mL was sufficient concentration of surfactant to minimise droplet 
coalescence, further increases in concentration generally increased the mean 
diameter or polydispersity index (Figure 2.6). At the lowest concentration of SDS 
tested (below 0.5 mg/mL) and a high concentration of CNTs (above 0.6 mg/mL) 
particles were obtained with larger mean diameters. The presence of the CNTs which 
had a mean length of 425 nm (Figure 2.7) in the DCM may have resulted in non-
spherical droplets with a larger apparent hydrodynamic diameter. DLS analysis 
generally showed monomodal distributions for the samples (Figure 2.7) with the PdI 
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ranging between 0.169 (6 mg/mL PCL 0.03 mg/mL CNTs and 1.5 mg/mL SDS) and 
0.428, a multimodal distribution (6 mg/mL PCL, 0.9 mg/mL CNTs and 0 mg/mL SDS). 
The concentration of SDS significantly impacted the results. When there was no SDS, 
broad size distributions were obtained, whereas present when the SDS concentration 
was above 1.5 mg/ml smaller particles and a narrower distribution was obtained.   
 
 
Figure 2.7. Intensity size distribution by DLS for samples of varying composition. 
A) Samples consisting of: 6mg/mL PCL, 0 mg/mL CNTs and either 1.5 or 3 mg/mL 
of SDS. B) Samples consisting of: 6 mg/mL PCL, 0.03 mg/mL CNTs and either 0, 1.5 
or 3 mg/mL of SDS. C) Samples consisting of: 6 mg/mL PCL, 0.3 mg/mL CNTs and 
either 0, 1.5 or 3 mg/mL of SDS. D) Samples consisting of:  6 mg/mL PCL, 0.9 
mg/mL CNTs and either 0, 1.5 or 3 mg/mL of SDS. 
 
Selected samples were then further characterised by scanning electron microscopy 
(SEM) to provide information on the morphology and particle size in the dried state, 
as shown in Figure 2.8. In order to minimise charging during imaging the samples 
were sputter-coated with gold. All the samples appeared to have agglomerated upon 
drying. The length and width of the particles was then determined from the SEM 
images. When no SDS was used large spherical particles (392-659 nm depending on 
CNTs concentration) were obtained with diameters approximately matching those 
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determined by DLS. As previously mentioned, it is likely that in the absence of 
surfactant the interfacial tension between the water and DCM resulted in droplet 
coalescence. When the concentration of the CNTs was increased it resulted in 
particles with more irregular, less spherical morphology. At higher concentrations of 
SDS (1.5 mg/mL and 3 mg/mL) and with CNTs present, rod-like morphologies were 
observed for all samples, these structures closely resemble those previously reported 
in the literature for PCL-CNT nanocomposites prepared by a covalent modification 
with either a “grafting from” approach56 or click chemistry method.57 This behaviour 
was likely due to the SDS lowering the interfacial tension between the DCM and the 
aqueous continuous phase resulting in smaller emulsion drops. The CNTs will 
preferentially be wetted by DCM rather than water due to the hydrophobic nature 
of CNTs.58 As the diameter of a DCM droplet approaches the length of the CNT 
dispersed within the droplet there is the potential for the CNT to be exposed to the 
surrounding aqueous continuous phase as the DCM evaporates. Minimisation of the 
interfacial energy of the system will lead to the DCM-water interface growing rather 
than create new CNT-water interface. This behaviour would likely result in a non-
spherical droplet being formed. It can then be expected that as the DCM continued 
to evaporate the PCL would be deposited onto the surface of the CNT. These 
experiments suggest that the presence of the surfactant would have allowed smaller 
droplets of DCM containing the PCL and CNTs to form, upon evaporation of the DCM 
non-spherical nanomaterials were then formed (see Figure 2.9 for a visual 




Figure 2.8.   SEM images of the nanomaterials showing the influence of SDS and CNT concentration on the different sizes and morphologies of the nanocomposites of 
PCL/ CNTs. a) 6 mg/mL of PCL, 0.03 mg/mL of CNTs and 0 mg/mL SDS b) 6 mg/mL of PCL, 0.03 mg/mL of CNTs and 1.5 mg/mL of SDS c) 6 mg/mL of PCL, 0.03 mg/mL of 
CNTs and 3 mg/mL of SDS d) 6 mg/mL of PCL, 0.3 mg/mL of CNTs and 0 mg/mL of SDS e) 6mg/mL of PCL, 0.3 mg/mL of CNTs and 1.5 mg/mL of SDS f) 6 mg/mL of PCL, 
0.3 mg/mL CNTs and 3 mg/mL of SDS g) 6 mg/mL of PCL, 0.9 mg/mL of CNTs and 0 mg/mL of SDS h) 6 mg/mL of PCL, 0.9 mg/mL of CNTs and 1.5 mg/mL of SDS i) 6 





Figure 2.9. Cartoon representation of how the surfactant concentration during the 
emulsification process influences the morphology of the nanocomposites. 
 
The PCL-CNT nanocomposites displayed colloidal stability in water for at least 5 days with very 
little change in the mean diameter and polydispersity over that time period (Figure 2.10. 
Graph shows hydrodynamic diameters (nm) and polydispersity (PdI) versus time (h) obtained 
from DLS for samples in distilled water at 37 ˚C.). Graphs shows hydrodynamic diameter (nm) 
and polydispersity index (PdI) versus time (h) obtained from DLS for samples in distilled water 
at 37 ᵒC. In phosphate buffered saline, a common mimic for physiological fluids, the 
nanocomposites showed colloidal instability as the ions in the salt screened out the 





Figure 2.10. Graph shows hydrodynamic diameters (nm) and polydispersity (PdI) versus 
time (h) obtained from DLS for samples in distilled water at 37 ˚C. 
 
 
Figure 2.11. Graph shows size i.e. hydrodynamic diameters [nm] versus intensities [%] 
obtained from DLS for samples in distilled water and Phosphate buffer saline (PBS) 







































It is likely that this issue with aggregation in PBS could be addressed in the future by the use 
of a polymer stabiliser that will provide steric stabilisation to the nanocomposites. The 
reproducibility of synthesis of the PCL-CNT samples was also tested, three selected samples 
were reproduced, in these the concentration of PCL used 3 mg/mL and with differing 
concentrations of CNTs (0.01-0.3 mg/mL) and SDS (0-1 mg/mL). In each case the standard 
deviations (σ) of the replicates were found to be less than 10% of the mean diameter of the 




Figure 2.12. Example of results for reproducibility for samples obtained with 3 mg/mL of 
PCL. The synthesis was repeated 3 times. 
 
This consistent reproducibility showed that the oil-in water emulsion solvent evaporation 
method is a robust and reliable process for obtaining non-spherical nanomaterials. From the 
range of concentrations that were tested, a single formulation was selected for each type of 
nanodispersion: PCL alone nanoparticles, a CNT alone dispersion and a PCL-CNT 
nanocomposite (see Table 2.2). These samples were then prepared for further analysis and 
comparison between the properties of the different nanostructures. 
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Table 2.2. Summary of the concentrations and compositions of the samples of PCL 
nanoparticles, CNT dispersion and PCL-CNT nanocomposites prepared for further 
investigation. 




PCL CNTs SDS PCL CNTs 
PCL 10 0 1.5 100 0 
CNTs 0 0.9 1.5 0 100 
PCL-CNTs 10 0.9 1.5 93 7 
   
 
2.3.3. The morphology and properties of the sample as studied 
by AFM, SEM and TGA 
 
SEM and AFM characterisation were then conducted to further investigate the surface, 
morphology and mechanical properties of the PCL-CNT nanocomposite; this was compared 
to PCL nanoparticles and CNTs alone (Figure 2.13). The same regions of each sample was 
imaged by both SEM and AFM, however, it was not possible to image precisely the same 
location with both techniques. In the preparation of these samples no gold coating was used 
for the SEM as this would invalidate the mechanical characterisation of the sample by AFM 
analysis. Therefore, in order to prevent surface charging the SEM was operated in 
deceleration mode, which led to a slight reduction of the image quality. As before, the sample 
of PCL alone consisted of spherical particles with a mean diameter of 382 nm and appeared 









Figure 2.13. Analysis of the PCL, CNT and PCL-CNT (93% PCL, 7% CNTs by mass) 
nanocomposites by SEM and AFM (inset): A) PCL alone, B) CNTs and C) PCL-CNTs 
composites. The AFM images are based on the peak force error measurements. The AFM 
images were not obtained from the same region shown in the SEM image, but have been 
inset so as to assist direct comparison with the morphologies revealed both techniques at 
the same scale. The scale bar applies to both the SEM images and inset AFM images 
 
 
Analysis of the sample of CNTs alone revealed fibres with varying lengths (200-795 nm with a 
mean length 324 nm and width 53 nm) (Figure 2.13B), a similar morphology was observed for 
the nanocomposite sample containing both PCL and CNT (Figure 2.13C) where the sample 
consisted of high aspect ratio fibres with a mean width of 55 nm and mean length of 172 nm 
(see SI, Figure 2.20- Figure 2.22). Due to the agglomeration upon drying, the length 
measurements should be interpreted with caution because it was often unclear where one 
non-spherical nanoparticle ended, however, the larger widths of the PCL-CNTs 
nanocomposites compared to the CNTs alone suggested that the PCL has deposited on the 
surface of the CNTs. The SEM characterisation data provides an evidence that the process of 
combining the PCL and CNTs in the same phase during the oil-in water emulsion solvent 
evaporation method results in nanocomposite rods that consist of CNTs coated in PCL. 
In order to provide more evidence for the preparation of PCL/CNT nanocomposites AFM was 
utilised to characterise the samples and measure the elastic modulus of all three samples 
(AFM images are shown as insets in Figure 2.13). Literature values for the elastic modulus of 
PCL and CNT are 600 MPa59 and 1 TPa60 respectively. AFM nanomechanical analysis measures 




approximately 600 MPa was expected in the event of successful PCL-CNT nanocomposites. 
The Peakforce quantitative nanoscale mechanical method relies on the selection of an 
appropriate stiffness cantilever depending on the expected elastic modulus of the sample. 
However, no probe of an appropriate stiffness was available for the CNTs. Hence, we 
conducted all the AFM experiments using the same probe. The probe used in this experiment 
(TAP525) is recommended by the manufacturer (Bruker) for samples with elastic modulus 
values in the range 1-20 GPa. Therefore, it was not possible to obtain reliable modulus values 
for the CNTs alone. However, analysis of the DMT61 modulus for both the PCL and PCL-CNT 
nanocomposite provide comparatively similar values of 770 and 560 MPa respectively, 
indicating that all the CNTs have been coated with at least 2 nm of PCL. The moduli of both 
samples were consistent across the surfaces, and no regions of very high modulus were 
observed in the nanocomposite sample which would have indicated uncoated CNTs (see 





Figure 2.14. Analysis of the PCL and PCL-CNT nanocomposites by AFM to provide the DMT 
modulus and surface height. (A and B) show the DMT modulus for PCL and PCL-CNT 
nanocomposites. (C and D) show the heights for PCL and PCL-CNT nanocomposites. 
 
While the nanocomposites showed a similar surface modulus to that of PCL, it is likely that 
high modulus of the CNT would mean that the bulk modulus of the nanocomposites would 
be comparable, this could be of particular interest for drug delivery applications as it has 
previously been shown that materials with higher moduli display greater cellular uptake.62 
The fibrous morphology observed for the PCL-CNT sample by SEM and the stiffness as 
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determined by AFM further supports the concept that the CNTs have been coated with PCL 
to give high aspect ratio nanocomposites. Thermo-gravimetric analysis (TGA) was also used 
to provide information on the thermal stability and CNT content of the PCL-CNT 
nanocomposites.56,63,64 The decomposition behaviour of the CNTs and PCL nanoparticles and 
PCL-CNT nanocomposites are shown in Figure 2.15. The CNTs were found to show thermal 
stability over the temperature range tested, in agreement with the literature.65 Literature 
data on SDS alone has previously shown to display a mass loss commencing at 200°C until 
300°C at which 73% of the mass of the compound has been lost,65 while PCL has been shown 
to degrade when heated above 360°C under inert atmosphere with no residue mass 
remaining at 500°C.66 In the context of this information, the start of degradation for the 
sample of PCL nanoparticles stabilised by SDS began at approximately 210°C which was likely 
due to the degradation of the SDS up to approximately 300°C where the data exhibits a 
shoulder. This TGA curve steepens abruptly at ca. 345°C that is likely associated with the start 
of the degradation of the PCL. Above 400°C very little further mass loss was noted and the 
residue mass of 19.6% at 600°C was due to the SDS. For the PCL-CNT nanocomposite sample, 
the onset of the mass loss was approximately 220°C which also corresponded to the 
degradation SDS within the nanocomposite. The increase in the degradation temperature of 
the SDS could potentially suggest that the formation of the nanocomposite structure has 
increased the thermal stability of the SDS in the nanocomposite. A slight shallowing of the 
TGA curve was observed at 290°C which may be associated with completion of the SDS 
degradation. The curves steepen again around 345°C, which may be associated with the PCL 
beginning to degrade. This effect was less pronounced in the PCL-CNT nanocomposite 
compared to the PCL nanoparticles which may be due to the presence of the CNT in the 
nanocomposite altering the degradation behaviour of the PCL.57 Above 400°C no further mass 
loss was seen for the nanocomposite and the residue mass at 600°C was 29.2%. The PCL-CNT 
nanocomposite showed a higher residue mass compared to the PCL alone nanoparticles. This 
9.6% of the mass can be attributed to the CNTs present within PCL-CNT nanocomposites, 
which matches a literature value of 10% for PCL grafted CNTs.57 This mass is higher than 
expected (the theoretical composition of the sample was 93% PCL, 7% CNTs by mass) and may 
be attributed to a slight increase in the concentration of the CNT dispersion due to some 




Figure 2.15. Analysis of the PCL-CNT (93% PCL, 7% CNTs by mass) nanocomposite and its 
constituents by TGA. The concentrations used during preparation were 10 mg/mL of PCL 
and 1.5 mg/mL SDS for PCL; 10 mg/mL of PCL, 1.5 mg/mL SDS and 0.9 mg/mL CNTs for 
PCL-CNTs. CNTs consists of 0.9 mg/mL CNTs alone 
 
2.3.4. Fractionation of the particles by asymmetric flow 
field flow fractionation and measurements of 
hydrodynamic diameters 
 
Next, the PCL alone and the PCL-CNT nanocomposite samples were further analysed by 
asymmetric flow field flow fractionation with the aim of obtaining high resolution sizing of 
the nanoparticles in the dispersed state. High resolution sizing would make it possible to 
determine if the PCL/CNT nanocomposites consisted of a single population of particle rather 
than resulted in two separate populations of PCL or CNTs alone. Asymmetric flow field flow 
fractionation separates samples based on hydrodynamic diameter67 with smaller particles 
eluting before larger particles, the fractionated sample then passes through inline detectors 
to determine the diameter of the particles. The separation conditions were chosen from 
previous studies of CNTs.42 Figure 2.16 shows the data for the asymmetric flow field flow 
fractionation analysis of the samples combining the absorbance from UV-VIS detector and  
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Z-average diameter as measured by inline DLS. The UV-Vis detector was set to a wavelength 
of 300 nm, chosen based on absorbance spectra of PCL and CNTs, and thus provides 
information on the concentration of the particles. The samples showed good separation and 
the absence of a void peak revealed that aggregation has not occurred in the system. The 
sample that consisted of PCL alone was found to consist of a higher dynamic diameter 
distribution between 11 nm and 115 nm, with the mode of the UV-Vis measurement equating 
to a diameter of 93 nm. The size range of PCL-CNTs sample was between 11 nm and 350 nm 
with the mode of the UV-Vis measurement equating to a diameter of 138 nm. A sample of 
CNT alone was also analysed but is not directly comparable to the PCL and nanocomposites, 
the uncoated CNT surface will likely have a different interaction with the membrane in the 
AF4 compared to the other samples with the PCL coating which may have resulted in different 
elution behaviour. The CNTs alone consisted of a distribution of 16 to 187 nm (see Figure 
2.17).  
 
 Figure 2.16. Fractogram of PCL and PCL-CNTs (93% PCL, 7% CNTs by mass) obtained from 
asymmetric flow field flow fractionation coupled online with UV-VIS detector. 






Figure 2.17. Fractogram of CNTs obtained from asymmetric flow field flow fractionation 
coupled online with UV-VIS detector. Hydrodynamic diameters were obtained from DLS 
coupled online. 
 
The PCL-CNT nanocomposites were found to have larger hydrodynamic diameters compared 
with pristine CNTs and PCL alone. The measurements obtained from the detector coupled 
online with asymmetric flow field flow fractionator showed higher intensity for PCL-CNTs 
compared to the PCL and CNT, which was due to the higher concentration of PCL-CNTs 
composites in the sample than PCL and CNT alone.  
As previously stated, asymmetric flow field flow fractionation separates a sample based on 
the hydrodynamic diameter; particles of the same diameter should elute at the same time. 
However, as shown in Figure 2.16, PCL or PCL-CNT nanocomposite particles with the same 
hydrodynamic diameter eluted at considerably different times. The PCL-CNT nanocomposites 








































has been published by Gigault et al. in which they showed that longer gold nanorods (GNRs) 
with the same diameters eluted earlier than shorter GNRs.68 It has been suggested that 
elution of non-spherical particles depends on an aspect ratio and steric-entropy contribution 
associated with their orientation. Gigault et al. suggested that GNRs located higher in the 
channel elute faster than associated closer to the membrane. We believe that the earlier 
elution of the PCL-CNT nanocomposites compared to the spherical PCL alone nanoparticles 
was due to their higher aspect ratio of the nanocomposites. 
2.3.5. Drug loading and release  
 
Finally, the drug loading and release from PCL, CNTs and PCL-CNTs nanocomposites was 
investigated. In this work docetaxel, an effective anticancer drug69–71 was used. Docetaxel 
(DCX) has some clinical limitations associated with its poor water solubility.72 The anticancer 
drug was encapsulated in the nanocomposite carriers, while PCL alone and CNTs alone were 
also tested as controls. Drug encapsulation was achieved by including DCX into the oil phase 
for the particle preparation. The resulting DCX loaded samples were analysed by DLS (as an 
unfractionated sample) to provide a mean diameter, PdI and distribution plot. Table 2 shows 
the DLS results for PCL, CNT and PCL-CNTs. The nanocomposites showed larger mean 
diameters compared with PCL and pristine CNT. The DLS distribution graph for the PCL alone 




Figure 2.18. Graph shows size i.e. hydrodynamic diameters (nm) versus intensities (%) 
obtained from DLS for unloaded and loaded with DCX particles of PCL, CNTs and 
composites. 
 
The CNTs and PCL-CNTs have a PdI of 0.33 which means that the distribution is broader than 
the PCL alone particles, this is likely due to the polydisperse nature of the CNTs themselves 
which gave a PdI value of 0.33. Hydrodynamic diameter and PdI of the three samples were 
also measured after encapsulation of DCX. The size and PdI of CNTs alone were higher 
compared with unloaded CNTs alone. These results potentially indicate that molecules of anti-
cancer drug adsorbed to the surface of the CNTs may have possibly resulted in some 
aggregation of the CNTs. The properties of CNTs have previously shown that loading via π- π 
stacking is possible for DCX.73 It was found that after encapsulation, PCL and PCL-CNTs showed 
a lower diameter and PdI. In this case it is possible another type of interaction between the 
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PCL/CNTs and DCX may have altered the size of the PCL - DCX nanoparticles and PCL-CNTs -
DCX nanocomposites. The entrapment efficiency (EE) was also analysed by HPLC (EECNT = 95%, 
EEPCL= 81% and EEPCL-CNT = 89%). 
Table 2.3. Summary of the diameter and PdI for samples without and with encapsulated 






























In vitro release experiments were then conducted to observe the drug release behaviour of 
the nanocomposites.  The drug released over time is presented in Figure 2.19.  
 
Figure 2.19. The graph presents docetaxel releasing study (% of drug released vs. time) for 
CNTs, PCL and PCL-CNTs (93% PCL, 7% CNTs by mass) obtained from HPLC analysis. The 




The nanocomposites and CNT alone encapsulated more anti-cancer drug compared with PCL 
alone. The release of DCX from different systems has been studied previously.74,75 In those 
studies, the authors showed that pH, temperature, solvent and type of carrier have an effect 
on drug release. Our release data showed that DCX is released most rapidly from the PCL-
CNTs. The slowest profile was found with the CNTs alone with 31% of the drug released in 96 
hours matching the DCX release behaviour from CNTs previously shown in the literature.76,77 
The difference in the release profiles between the CNTs and the PCL-CNT nanocomposites 
may be due to the different structures of the nanocarriers. In the case of the PCL-CNT 
nanocomposites, the PCL coating the surface may have disrupted the ability for the DCX to 
adsorb onto the CNT. This is supported by the literature in which it is stated that drug release 
behaviours from CNTs are altered when different polymer surface functionalisations are 
present.76 No degradation of the drug was detected after the drug release from all of the 
samples (examples of the chromatograms obtained from HPLC analysis are shown in the SI, 
Figures 2.23-Figure 2.26). These findings show that not only can the PCL-CNT successfully 
encapsulate DCX but also has the ability to release it. More interestingly, the difference in the 
release behaviour of DCX from the different samples suggests that there is a potential to tune 




In this chapter, PCL nanoparticles were prepared by oil-in-water emulsion solvent 
evaporation method. The different concentration of PCL and concentration of different 
surfactant have been checked whether they have influence on hydrodynamic diameter and 
PdI of nanoparticles.  The presence of surfactant SDS in the synthesis showed the ability to 
create the smallest size and PdI (<0.2) for PCL nanoparticles. PCL-CNT nanocomposites were 
prepared by a facile oil-in water emulsion solvent evaporation method. This approach 
produced rod-like, non-spherical nanoparticles. Different sizes and morphologies of 
nanoparticles were produced depending on the concentration of SDS, CNTs and PCL. The 
samples with rod-like morphologies and the lowest diameter and PDI were synthesised using 
1.5 mg/mL of SDS, 0.9 mg/mL of CNTs and 10 mg/mL PCL. The AFM analysis revealed that the 
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incorporation of the CNTs in the nanocomposites did not increase the modulus of the 
particles, including the successful surface coverage of the CNTs with PCL.  In addition, TGA 
analysis of the PCL-CNT nanocomposite also showed that they contained 9.6% CNTs by mass. 
Asymmetric flow field flow fractionation measurements showed good separation of particles 
and the PCL-CNTs had higher hydrodynamic diameters than PCL and CNTs alone. DCX loading 
in PCL, CNTs and PCL-CNTs were determined by HPLC and showed high entrapment 
efficiencies (CNT = 95%, PCL= 81% and PCL-CNT = 89%). Moreover, faster release of DCX from 
PCL-CNTs was observed with about 90% of the drug released from the nanocarriers after 
approximately 100 h.  
To the best of our knowledge this is the first example of producing high-aspect ratio PCL-CNT 
nanocomposites using a simple oil-in water emulsion solvent evaporation method. The high 
entrapment efficiencies of the nanocomposites offer the potential for these nanocomposites 
to be used in drug delivery applications. We hypothesise that the needle-like morphology and 
high modulus of the nanocomposites will enhance the cellular uptake of anticancer drugs and 
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Figure 2.20. The picture presents the measurements of diameter for PCL particles 















Table 2.3. The data for effect of changing concentration of CNTs and SDS on Z-average 






[mg/mL] SDS [mg/mL] 
Z-ave 
[nm] PdI 
CNTs042 6 0.03 0 288.6 0.326 
CNTs043 6 0.03 1.5 122.03 0.169 
CNTs044 6 0.03 3 143.43 0.279 
CNTs045 6 0.3 0 403.5 0.475 
CNTs046 6 0.3 1.5 134.77 0.278 
CNTs047 6 0.3 3 186.57 0.347 
CNTs048 6 0.9 0 434.07 0.428 
CNTs049 6 0.9 1.5 166.77 0.375 





























Chapter 3  
 
Insights into the Internal Structures of Nanogels Using a 
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3.1. Introduction  
 
Nanogels and microgels are colloidal particles consisting of solvated, crosslinked 
polymeric networks. The terms nanogel and microgel are typically used 
interchangeably and we will use nanogel from this point onwards. Nanogels 
composed of hydrophilic polymers have shown promise in a wide range of biomedical 
applications,1 but also in other applications such as enhanced oil recovery and 
sensing.2 Poly(N-isopropylacrylamide) (PNIPAM) based nanogels are a particularly 
well-known thermoresponsive nanogel. These particles undergo a deswelling 
transition upon heating to their volume phase transition temperature (VPTT) which 
is typically around 32°C. The proximity of this temperature to human body 
temperature has been exploited for applications in drug delivery.3 For example, 
PNIPAM nanogels have been shown to provide triggered release of macromolecules4 
and can produce long acting drug delivery implants upon injection into physiological 
environments.5,6 It has been shown that the internal structure of nanogels may be 
determined by their environment during formation; in particular, the formation of 
nanogels with core-shell type structures is highly  dependent on synthesis 
conditions.7 Differences in the internal structure of nanogels may have a considerable 
impact on their properties,8 particularly in their use in in situ forming implants.5,6 
In the field of nanoscience, it is important to obtain high resolution characterization 
of particle sizes and information about internal structure. A promising approach to 
achieve this is to fractionate samples through the use of asymmetric field flow 
fractionation (AF4). AF4 offers reduced shear forces, avoids the need for stationary 
phases and can provide separations over a wide size range within the colloidal 
domain.9 These advantages have led to considerable growth in interest of field flow 
fractionation in fields such as nanomedicine.10–15 AF4 systems can be easily coupled 
to different detectors such as dynamic light scattering (DLS), multi-angle light 
scattering (MALS), UV-Vis spectrophotometry and inductively coupled plasma mass 
spectrometry (ICP-MS). These hyphenated approaches provide detailed information 
on a sample such as concentration of particles, size, molecular weight and shape for 




The use of AF4 for the analysis of aqueous nanodispersions is reasonably well 
established.17 However, despite the extensive amount of research undertaken on 
PNIPAM nanogels there are surprisingly few papers that have studied these materials 
by AF4. Smith et al. used AF4 to characterize the degradation of PNIPAM based 
nanogels with a hydrodynamic diameter of 132 nm.18 They used 3 mM NaN3 as the 
eluent with a two-step separation process. Firstly, a cross-flow of 1.0 mL/min was 
used which retained the nanogels while eluting degradation products. The nanogels 
were subsequently eluted in the second stage using a reduced cross-flow of 0.25 mL/ 
min. MALS was used for online characterization with batch measurement of the 
hydrodynamic radius by DLS.18 Gaulding et al. used a 10 mM ionic strength aqueous 
buffer (containing NaNO3 and NaN3), and a variable cross-flow method from 1.0 
mL/min to 0.1 mL/min to separate nanogels with hydrodynamic diameters of 96-146 
nm from degraded polymer chains.19 In a later paper, Gaulding and coworkers used a 
15 mM ionic strength pH 3.3 formate buffer to fractionate core-shell nanogels with 
hydrodynamic diameters of ~ 260 nm. They achieved particle separation using a 
constant cross-flow of 0.25 mL/min.20 It is clear from these methods that there is 
considerable differences between existing published separation conditions, this 
makes it difficult for researchers to select appropriate conditions for their PNIPAM 
nanogel samples. 
AF4 also offers the opportunity to obtain information on the internal structure or the 
polymer architecture of a colloidal system.21,22 This understanding of size and 
morphology of particles is extremely valuable. Of particular interest for obtaining 
insight into the internal structure of samples is the combination of DLS and MALS.21,23 
These techniques provide the hydrodynamic radius (Rh) and the radius of gyration 
(Rg) respectively. Information about the shape and conformation of particles can then 
be determined from the ratio ρ= Rg/Rh. This is a dimensionless value sometimes 
referred to as the shape factor.24 For particles, a shape factor of 0.78 indicates a hard 
sphere, while values ~1 can indicate soft spheres and ~ 2 reveals that the particles 
are potentially stiff rods.25,26 Alternatively, soluble polymers in a random coil 
confirmation tend to give shape factor values in the range of 1.50-1.78.27 Thereby, 
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determination of shape factor may give useful information about internal structure 
of nanogels. The shape factor of PNIPAM nanogels has previously been determined 
by using a combination of online and offline (batch) techniques. Static light scattering 
and DLS measurements below the VPTT have been used on nanogels with 
hydrodynamic diameters of 100-310 nm. This research has shown that increasing the 
crosslinking density causes a reduction in the shape factor from ~ 0.9 to 0.6,28,29 while 
another article has shown that the crosslinking density had little impact on shape 
factor values 0.55-0.6.27 Small angle X-ray scattering (SAXS) has also been used to 
provide Rg measurement in the place of static light scattering.7 SAXS has also been 
used to investigate how the dispersion polymerization synthesis conditions of 
PNIPAM influence the internal structure, showing that the larger nanogels tended to 
have more heterogeneous structures than smaller nanogels.30 It has been suggested 
that this heterogeneity is due to the different rates of monomer and crosslinker 
incorporation into the particles.31 The application of AF4 to the analysis of the internal 
structure of nanogels provides a number of potential benefits over the use of batch 
SAXS and SLS. Firstly, it provides high resolution fractionation of the particles which 
provides insight into the size distribution of a samples. Secondly, the use of the DLS 
and MALS detectors online gives a shape factor value for a sample much faster than 
a SAXS measurement.  
In this work, we sought to develop a versatile AF4 method to characterize PNIPAM 
nanogel sample with Z-average hydrodynamic diameters from 65 to 310 nm that 
would also provide insight into the internal structures of samples. Therefore, we 
evaluated separation conditions using different eluents and cross-flows with online 
MALS and DLS detectors for analysis. We demonstrate a method that can effectively 
fractionate different nanogel samples. Additionally, this approach provides a clear 





Figure 3.1. Characterizing poly(N-isopropylacrylamide) nanogels by asymmetric 
flow field flow fractionation, A: Fractionation and analysis of nanogels using 
asymmetric flow field flow fractionation. B: The internal structure of the 




3.2.1. Materials  
 
N-isopropylacrylamide (NIPAM, ≥99%), N,N-methylenebis(acrylamide) (BIS, 99%), 
potassium persulfate (KPS, ≥99%), sodium chloride (NaCl, ≥99.5%), sodium nitrate 
(NaNO3, ≥ 99, sodium dodecyl sulfate (SDS, ≥99%) were purchased from Sigma-
Aldrich Company Ltd, Gillingham (Dorset) UK, a subsidiary of Merck KGaA, 
Darmstadt, Germany. Phosphate buffered saline tablets (PBS) were purchased from 
Fischer Scientific.  Milli-Q water obtained from a water purification system had a 
resistivity of > 18 MΩ cm-1 (PURELAB option R, Veolia). Spectra/por 2 (MWCO = 12-
14 kDa) and spectra/por 3 (MWCO = 3.5 kDa) dialysis tubing was purchased from 
Spectrum Europe B.V., Breda, The Netherlands. Corning bottle top vacuum filter 
system with cellulose acetate membrane (pore size 0.22 µm) was purchased from 
Sigma-Aldrich Company Ltd, Gillingham (Dorset) UK, a subsidiary of Merck KGaA, 




3.2.2. Synthesis of PNIPAM nanogels 
 
The PNIPAM nanogels samples with four different mean diameters were synthesized 
by dispersion polymerization. The compositions used in the synthesis of each nanogel 
can be found in Table 3.1. The NIPAM monomer (7000 mg, 61.9 mmol), BIS 
crosslinker (700 mg, 4.5 mmol) and SDS surfactant (PNIPAM310 = 78.8 mg, 
PNIPAM160 = 260.2 mg, PNIPAM100 =701.6 mg, PNIPAM65  = 939.1 mg) were 
dissolved in distilled water (470 mL) in a 1 L two-neck round bottom flask equipped 
with a stir bar and reflux condenser. This was then sealed and nitrogen was bubbled 
through the aqueous solution for 1 hour whilst stirring (400 rpm) to remove dissolved 
oxygen. The solution was then heated to 70 °C. Separately KPS initiator (280 mg) was 
dissolved in distilled water (30 mL) and degassed with N2 for 1 hour before being 
transferred to the flask containing the monomers. The reaction was maintained 
under a N2 atmosphere for 4 hours at 70 °C before being cooled down to room 
temperature. The solution was then filtered through glass wool. To remove 
unreacted impurities, the nanogel suspension was dialyzed for 5 days using 
regenerated cellulose dialysis tubing (12-14 kDa MWCO for PNIPAM310 and 
PNIPAM160 and 3.5 kDa MWCO for PNIPAM100 and PNIPAM65), (Spectrum Labs), 
replacing the distilled water every 12 hours. The purified suspension was then 


































PNIPAM160 7000 0.52 700 280 500 
PNIPAM310 7000 0.16 700 280 500 
a KPS dissolved at 9.3 mg ml-1 in distilled water. 
bTotal volume of water, including addition of KPS dissolved in water. 
 
3.2.3. Characterisation of PNIPAM nanogels by AF4 
 
Asymmetric flow field flow fractionation (AF4) experiments were performed on an 
MT2000 with RI and UV-Vis detectors from Postnova Analytics, Landsberg/Germany.  
A multi-angle light scattering detector (MALS) PN3621 from with a detector with 21 
angles (from 7° to 164 °) operating at 532 nm power wavelength was coupled online 
to AF4. An autosampler (PN5300) was used with the system. The hydrodynamic 
radius of the samples were obtained by dynamic light scattering (DLS) using a 
Malvern Zetasizer Nano ZS (running Malvern Zetasizer software V7.12) (Malvern 
Instruments, Malvern, UK) with 633 nm He–Ne laser and the detector positioned at 
173°. The DLS measurements have been obtained using flow cell ZEN0023 with flow 
rate 0.5 mL/min at 28°C, coupled online to the MT2000. A 350 µm spacer and 10 kDa 
regenerative cellulose membrane were installed in the separation channel.  
The conditions used for the separations was based on a method existing in the 
literature.19,32 Briefly, the mobile phase was 0.1 M NaNO3 or 1 x PBS (phosphate 
buffer saline) in Milli-Q H2O. Type I distilled water was obtained from a water 
purification system had a resistivity of > 18 MΩ cm-1 (PURELAB option R, Veolia).  
The solutions were filtered using Corning bottle top vacuum filter system with 
cellulose acetate membrane with pore size 0.22 µm. The injected volume was 20 µL 
of a 4 mg/mL sample by autosampler. Each samples was analysed three times to 
check the reproducibility. A blank was measured between injections of new sample 
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to ensure that system was clean. The UV-Vis detector measured two wavelengths 
250 and 300 nm. The conditions used for the separations was as follows: The 
injection/focusing time was 3 min using a cross flow from 2 to 0.5 mL min -1. The 
chosen cross flow rate (initial values of 2 mL/min to 0.5 mL/min were tested) was 
kept constant for the first 0.2 minutes (t0-t0.2), and thereafter, the cross flow was 
decreased in a power manner (exponent 0.2) from its initial value to 0.1 over a period 
of 40 minutes. Following the complete reduction in cross flow, the tip-flow 0.1 
mL/min continued for an additional 40 minutes. The optimized method for 
fractionation conditions of the nanogels is shown in Figure 3.2.  
 
 
Figure 3.2. The method chosen for separation of samples. The graph present a 
change of cross-flow with time. 
 





Where A is the peak area of the nanoparticles with cross flow, A* is the peak area 

























3.2.4. Dynamic Light Scattering in Batch 
 
Characterization of the nanogels was carried out using dynamic light scattering (DLS) 
and laser Doppler electrophoresis (LDE). DLS and LDE were performed using a 
Malvern Zetasizer Nano ZS (running Malvern Zetasizer software V7.12) with 633 nm 
He-Ne laser and the detector positioned at 173°. Dialyzed samples were diluted to 1 
mg mL-1. The Z-average diameter was recorded in the range (15-55 °C) using  
a thermal equilibration time of 600 seconds in 1 cm path length disposable 
polystyrene cuvettes. Measurements were repeated in triplicate to give a mean Z-
average diameter and polydispersity index (PdI). Zeta potential measurements were 
performed using DTS1070 folded capillary cells (Malvern, UK). Capillary cells were 
flushed with ethanol and water prior to usage. The zeta potential measurement was 
made with a minimum of 10 and maximum of 40 runs, with a voltage of 150 V at 
25°C. The Smoluchowski approximation was used to calculate zeta potential. The 
measurements were conducted in 0.01 M NaCl.   
3.3. Results 
 
3.3.1. Synthesis of PNIPAM nanogels 
 
The PNIPAM nanogels were synthesized by dispersion polymerization in the presence 
of varying concentration of sodium dodecyl sulfate (SDS, 0.16-1.88 mg/mL) as 
surfactant. This method of synthesis nanogels was first reported by Pelton et al.34 
and as reported in the literature, increasing the concentration of SDS reduced the 
size of particles. The resulting four different samples were analysed by batch dynamic 
light scattering (DLS) to obtain the hydrodynamic diameter in water at 25 °C.  
All nanogels had a narrow distribution according to data obtained from DLS. The four 
samples were named corresponding to their mean approximate diameter at 25 °C. 
The hydrodynamic diameter and polydispersity index of the samples are shown in 




Table 3.2. The four PNIPAM nanogel samples as measured by batch DLS at 25 °C.   
Sample  Hydrodynamic 
diameter (nm) 
Polydispersity index 
PNIPAM65 63 ± 1.2 0.13 ± 0.008 
PNIPAM100 95 ± 0.8  0.14 ± 0.010 
PNIPAM160 165 ± 1.2 0.02 ± 0.012 
PNIPAM310 314 ± 4.0 0.01 ± 0.016 
 
Thermoresponsive PNIPAM nanogels presents a characteristic behaviour where 
particles de-swell during the heating above their volume phase transition 
temperature (VPTT)35 (see SI, Figure 3.8). VPTT is similar feature to the lower critical 
solution temperature (LCST) of linear PNIPAM.  Moreover, PNIPAM nanogels can also 
demonstrate dual-stimuli responsive behaviour where the combination of two 
stimuli such as temperature and ionic strength results in the nanogels losing colloidal 
stability and cause aggregation into a gel matrix material.5,36 However, aggregation 
must be avoided during analysis by field flow fractionation. Therefore, the change in 
hydrodynamic diameter of these nanogels in response to a rise in temperature when 
dispersed in solution of 0.1 M NaNO3 in water was measured by DLS.  Nanogels 
showed volume phase transition temperature around 34 °C (see Figure 3.3). The 
temperature of separation was chosen for 28 °C to avoid an aggregation and to 
ensure that the multi-angle light scattering detector maintains a constant 
temperature (it only can regulate temperature by heating rather than cooling 
therefore the temperature inside of the system should be higher than a temperature 




Figure 3.3. Hydrodynamic diameter of nanogels in 0.1 M NaNO3 measured using 
DLS at 1 mg ml-1 with respect to the nanogel concentration. The sample of the 
nanogels aggregated at 34 °C and produced particles sizes that could not be 
accurately measured by DLS. 
 
3.3.2. Effect of mobile phase  
 
In order to evaluate the influence of different mobile phases previously used in the 
literature both PBS37,38 and 0.1 M NaNO319,39 were tested for fractionating a nanogel 
sample. The reproducibility between three repeat injections in each mobile phase 
was checked (Figure 3.4.). This showed considerably more variability between repeat 
injections for PBS compared to NaNO3. This difference may be attributed to increased 
interaction of the nanogels with the surface of membrane when dispersed in PBS. All 
the other nanogel samples also displayed highly reproducible separations in NaNO3 
(see supporting information (SI), Figure 3.9). Therefore NaNO3 was selected as the 
mobile phase for further experiments. The thermoresponsive behaviour of PNIPAM 































their volume phase transition temperature.35 Moreover, PNIPAM nanogels can also 
demonstrate dual-stimuli responsive behaviour where the combination of two 
stimuli such as temperature and ionic strength results in the nanogels losing colloidal 
stability and aggregating.40 The consideration of this behaviour is critical as 
aggregation must be avoided during AF4 analysis. Therefore, the colloidal stability of 
the nanogel samples was assessed by using batch DLS to monitor the change in 
hydrodynamic diameter in response to increasing temperature when dispersed in 
solution of 0.1 M NaNO3. All the nanogel samples showed a dramatic increase in the 
diameter at 34 °C, the volume phase transition temperature, which revealed that the 
particles were aggregating. Therefore 28 °C was chosen as the temperature of 
separation for use in the AF4. This avoided the potential for aggregation and ensured 
that the multi-angle light scattering detector (which can only can regulate 
temperature by heating) maintained a constant temperature. The choice of NaNO3 
as the mobile phase and 28 °C produced highly reproducible measurements and 








Figure 3.4. Comparison of the reproducibility using PBS (A) or NaNO3 (B) as the 
mobile phase for characterizing PNIPAM160 with a crossflow of 1.0 ml/min. The 
different data series are repeat runs of the same sample. 
 
3.3.3. Effect of cross-flow rate  
 
The cross-flow is main factor controlling retention time of particles and their effective 
separation in the AF4.41 Appropriate selection of this parameter needs to consider 
effect separation while also not causing adsorption of particles onto the 
membrane.33 Additionally, PNIPAM nanogels are soft materials42 and might be 
susceptible to damage. As such, a range of cross-flows from between 0.5 mL/min to 
2 mL/min were tested for all five samples. Figure 3.5 shows the separation behaviour 
of PNIPAM65 at the different crossflows as an example. Being the smallest in 
diameter, this sample would need the strongest separation force in order to 
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fractionate the sample. The fractograms for the other nanogels are shown in SI Figure 
3.10. In the case of all samples, with increasing crossflow the retention time was 
increased. Additionally, increasing the crossflow reduced the concentration of 
particles that were eluting in the void peak (seen at ~5 minutes). Both of these 
behaviours were due to the increased separation force that is obtained by increasing 
the crossflow. 
 
Figure 3.5. Effect of changing the crossflow on the separation behaviour of 
PNIPAM65 in NaNO3. 
 
As the objective of this work was to obtain a versatile single method to separate 
nanogel samples with a wide range of sizes we wanted to choose a single crossflow 
for all samples. We therefore also determined the recovery during separation of 
samples. Typically, recovery can be obtained from UV–Vis absorbance, differential 
refractometer, fluorescence, or ICP–MS, where changes of analyte mass can be 
detected.33 We used an inline UV–Vis detector to quantify the recovery, the 




Table 3.3. The calculated recovery for 3 samples PNIPAM65, PNIPAM160, 
PNIPAM310 (replicated 3 times) based on area of peak obtained from UV-Vis 
detector with different initial crossflow values.  
                            Recovery (%) 
Crossflow 
(mL/min) 
PNIPAM65 PNIPAM160 PNIPAM310 
0.5 98 ± 2 99 ± 1 70 ± 5 
0.8 98 ± 2 99 ± 1 70 ± 5 
1 98 ± 2 98 ± 1 70 ± 5 
1.5 98 ± 2 98 ± 1 65 ± 5 
1.8 98 ± 2 97 ± 1 63 ± 5 
2 98 ± 2 97± 1 60 ± 5 
 
The recovery for smaller nanogels (diameter <160 nm) showed good recovery R>98% 
for all tested cross-flows. However, for the nanogels with higher diameter (>160 nm) 
the recovery decrease with higher cross-flows. This finding was due to the separation 
force being too strong for larger nanogels which likely led to adsorption of the 
nanogels onto the membrane and lower recovery R<65%. An initial crossflow of 1 
mL/min displayed high recovery for all samples and displayed effective separation 
for all samples, as seen in the comparison of the fractograms for the largest and 
smallest nanogels in Figure 3.6.. Additionally, an increase in Rg with elution time was 






Figure 3.6. A crossflow of 1 ml/min led to effective fractionation with normal 
mode separation occurring for all samples. 
 
3.3.4. Relationship between particle size and internal structure 
 
Comparison of the fractograms for the four differently sized nanogel samples 
combined with the data obtained from MALS and DLS analysis (Figure 3.7.) provided 
insight into the structural differences between the samples. The signal obtained for 
90° light scattering detector gives an indication of particle concentration. The online 
MALS and DLS detectors allow the measurements for both the Rg and Rh, of the 
nanogels exiting the AF4 separation channel. The Rg values was calculated based on 
sphere fit. The elution time for different nanogels can be seen to increase with 
increasing mean diameter; 16 min (PNIPAM65), 19 min (PNIPAM100), 26 min 
(PNIPAM160) and 37 min (PNIPAM310). This increase of the nanogels size with the 
elution time indicated that the cross flow solvent and the method used was optimal 
to achieve a satisfactory separation of the nanogels. Each nanogel sample also 
showed an increase in the Rh with increasing elution time. AF4 separates based on 
the diffusion coefficients of the particles and therefore particles with a larger Rh are 
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closer to the membrane and experience a reduced flow rate along the channel. 
Therefore the larger the Rh and longer the elution time.15 Some inconsistency was 
observed in the values for Rh obtained at either end of the size distribution, which 
was due to the reduced signal-to-noise at lower concentrations. That said, the width 
of the particle size distributions were relatively narrow for all the samples except 
PNIPAM310, with the difference between the smallest and largest particles in a 
population being <20 nm. For PNIPAM310, the smallest particles eluting at 30 
minutes were ~90 nm but this quickly increased to ~120 nm at an elution time of 35 
minutes. It is interesting to compare the widths of the distributions found by 
fractionation to the polydispersity index values obtained by batch DLS, the latter 
measurement indicated that the two smallest nanogel samples (PNIPAM65 and 
PNIPAM100) had the highest polydispersity index values (0.13 and 0.14) compared 
to the larger nanogels (PNIPAM160, PNIPAM310, at 0.02 and 0.01, respectively). This 
overestimation on the polydispersity index values by batch DLS was likely due to the 
weaker light scattering from the smaller particles, this might allowing any signal from 
dust contamination to contribute a larger component of the data of the overall 
sample. The Rg values for all samples also increased with increasing elution time. For 
populations of nanoparticles with consistent internal structure this was expected; for 
a population of nanoparticles with consistent internal structure, i.e. a constant shape 
factor, the Rh and Rg should increase at the same time. However, for a number of the 
nanogel samples this was not the case. For PNIPAM65, the Rh displayed a constant 
gradient with elution time, but the Rg increases faster than expected, with the values 
for Rg>Rh from elution times of ~18 minutes. This indicates that the internal structure 
of the nanogels was within the single population of nanogel particles changing with 
increasing size. A plot of the shape factors for all samples can be seen in SI Figure 
3.10. Such differences in the internal structure of the particles in the distribution 





Figure 3.7. AF4-MALS-DLS analysis of nanogels. Fractograms showing the light 90◦ scattering detector signal (black line, left hand scale), 
radius of gyration (red dotted line, right hand scale) and hydrodynamic radius (green dotted line, right hand scale) obtained from AF4-
MALS-DLS measurements for PNIPAM65, PNIPAM100, PNIPAM160, PNIPAM310 and PNIPAM400 for cross-flow 1 mL/min.
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The values for the modes of the distributions can be considered to give an indication of the 
properties of the majority of the particles (Table 3.4) in the distribution. The Rh values for the 
mode of the distribution generally agreed closely with the Rh obtained by the batch DLS 
measurement. The exception to this agreement was the difference between the online and 
batch values for the Rh for PNIPAM310, this difference might be due to an underestimation 
of the Rh in the flow measurement. It has previously been reported that the detector flow 
rate leads to a translational component in the measurement cell that may be recorded as 
Brownian motion by the DLS. For larger nanoparticles the translational component of particle 
movement increases relative to the diffusional component of particle movement.43 This 
potentially leads to the underestimation of Rh in larger samples.  The comparison of the shape 
factors for the differently sized nanogel samples reveal values ranging from 0.58-0.73 which 
are in agreement with literature values.27,28,44 The smallest nanogel possessed the largest 
shape factor with a value of 0.73 which is similar to that of a hard sphere with a constant 
internal polymer density (0.78), therefore indicating a close to homogeneous internal 
crosslinking density. The larger nanogels provided lower values for the shape factor, ranging 
between 0.58-0.66. These values are typical for swollen nanogel with a denser inner core 
compared to the outer shell.44 All the nanogels were made at the same monomer composition 
however, the larger nanogels were obtained by using a lower concentration of the surfactant 
SDS in the dispersion polymerization. It has previously been shown that using larger amounts 
of SDS during the dispersion polymerization route used for nanogels creates smaller more 
homogeneous partices,30 while using less SDS generates larger particles with a more 
heterogeneous structure which contains a dense gel particle core.29 Therefore, this AF4 










Table 3.4. The mode values of Rg, Rh and 𝜌 for nanogels obtained from AF4-MALS-DLS for 
fractionation with 1 mL/min cross-flow. 
Sample Rg [nm] Rh [nm] Rh [nm] 
batch*  
𝝆 
PNIPAM65 25 ± 0.1 35 ± 1.0 31 ± 0.6 0.73 
PNIPAM100 26 ± 0.1 43 ± 0.3 43 ± 0.4 0.61 
PNIPAM160 42 ± 0.1 73 ± 1.0 75 ± 0.6 0.58 
PNIPAM310 80 ± 0.5 137 ± 0.3 180 ± 2.0  0.59 
Rh [nm] batch* have been measured by DLS using 1 mg/mL concentration of nanogels, at 28 
°C in 0.1 M NaNO3.   
3.4. Conclusion  
 
This study has demonstrated the value of AF4 coupled online with MALS and DLS for analysing 
nanogel samples from 65-310 nm in diameter. The diameters of particles and information on 
the internal structure of the nanogels can be easily obtained by using a single AF4-MALS-DLS 
fractionation method. In the research, we have successfully fractionated PNIPAM nanogels 
obtaining radius of gyration, hydrodynamic radius and shape factors for all five samples. The 
chosen mobile phase 0.1 M NaNO3 and method showed good reproducibility and high 
resolution of sizes for AF4-MALS-DLS measurements. The fractionation of the samples 
revealed that the internal structure of some of the samples varied within the distribution. 
Such information cannot be obtained through the use of bulk analysis methods such as SAXS. 
Determination of the mode values of Rg/Rh for the distribution of the nanogels showed that 
diameters higher than 100 nm had values ~0.61 indicating that the particles showed more like 
core-shell structures. The analysis of the smallest nanogel (65 nm) gave Rg/Rh values 0.78 
indicating more homogenous structures. The measurements showed differences in internal 
structure of nanogels depending on the synthesis conditions which also controlled the 
hydrodynamic diameter. This work will be of importance to researchers working with aqueous 
nanogels/microgels by providing a versatile method for obtaining a clear insight into the 
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Figure 3.8. The thermoresponsive behaviour of the PNIPAM nanogels in water as 
characterised by dynamic light scattering. The particles undergo a deswelling transition at 
the volume phase transition temperature of 34 °C. This behaviour is exemplified by 






























Figure 3.9. The reproducibility data for three repeat measurements of the different 
nanogel samples. A) PNIPAM65, B) PNIPAM100 C) PNIPAM160 D) PNIPAM310 E) 







Figure 3.10. The effect of varying the crossflow on the elution time for the PNIPAM100, 






Figure 3.11. AF4-MALS-DLS analysis of nanogels. Fractograms showing the light 90° scattering 
detector signal (black line, left hand scale) and shape factor (blue dotted line, right hand scale) 


















The synthesis and characterisation of degradable  




I would like to thank: Dr Emma L. Owen, Marissa Marissa Morales Moctezuma and 
Dr Seb Spain from University of Sheffield for providing 2-








PNIPAM nanogels have well-characterised thermoresponsive behaviour where the 
particles deswell when heated above their volume phase transition temperature 
(VPTT).1  Additionally, dual-stimuli responsive behaviour of the nanogels has also 
been demonstrated by combining temperature stimuli with either ionic strength2 or 
pH3,4 causing aggregation to form a gel matrix. This dual-responsive behaviour has 
previously been exploited as per the formation of in situ forming implants (ISFI).2,5,6 
These PNIPAM nanogels underwent aggregation when stimulated by body 
temperature and physiological ionic strength, leading to the formation of a solid 
implant. Ideally, these ISFI drug delivery systems should be degradable so that they 
do not accumulate in the body otherwise they are required to be removed after the 
drug release is complete, which can lead to patient non-compliance due to the 
physically invasive removal procedure. In order for removal to occur through renal 
excretion, the cross-linked nanogels need to degrade into low molecular weight 
polymers (<40 kDa)7 or smaller nanogels (< 20 nm).8  The nanogel network can be 
degraded by either cleavage of the polymer backbone or the crosslinker. The carbon-
carbon backbone of PNIPAM is extremely resistant to degradation, and previous 
studies have tried to increase the degradability of the polymer backbone by insertion 
of a either a degradable main-chain group or polymer blocks.9 However, as more 
commonly shown, the use of a degradable crosslinker is preferable. There have been 
a range of different crosslinkers reported which can degrade in response to various 
conditions and be easily incorporated into the nanogel structure during synthesis. 
For example, ketal crosslinked nanogels, which degrade in response to a low pH,10 
hydrolytically degraded glycolate ester based biodegradable crosslinkers11 and many 
others.12–14 One biodegradable crosslinker that can be incorporated into a PNIPAM 
network is N,N’-bis(acryloyl)cystamine (BAC), which contains a biodegradable 
disulphide bond.15–18 In the body, this disulphide bond can be reduced by glutathione 
(GSH). In this process, GSH is oxidised to form the dimer glutathione disulphide, 
cleaving a disulphide bond into two thiols.19 Dithiothreitol (DTT) is often used 
alternatively to GSH in order to study in vitro reduction of disulphide bonds,17,18 with 
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reduction of the disulphide bond achieved via a thiol-disulphide exchange reaction 
forming a six membered ring in DTT (see Figure 4.1).20 
 
 
Figure 4.1  Disulphide exchange reaction between nanogel disulphide and 
dithiothreitol (DTT).21 
 
Controlled radical polymerisations such as reversible addition−fragmentation chain-
transfer (RAFT) afford significant control over polymer molecular weight (Mw) and 
the polydispersity (PdI).22,23 By utilising a well-controlled polymerisation of PNIPAM 
nanogels, would allow the linear polymer chains regained after degradation of the 
nanogel network to be well-defined and below 40 kDa to allow for successful removal 
via renal excretion.7  This criteria is necessary for the synthesis of degradable 
materials which can then be used as ISFIs.2,6,16,17,24,25  The aim of this chapter is to 
produce degradable PNIPAM nanogels by RAFT polymerisation with well-defined 
length of polymer chains, that might be used as ISFIs. Nanogels were synthesised in 
the presence of two chain transfer agents (CTA); poly(N-hydroxyethyl acrylamide) 
macro CTA and poly(ethylene glycol) methyl ether 2-(dodecylthiocarbonothioylthio)-
2-methylpropionate. The polymerisation was conducted in the presence of a 
degradable BAC crosslinker to form crosslinked PNIPAM nanogels. Different ratios of 
NIPAM:BAC are used to study the influence of crosslinking density on the 
hydrodynamic diameter (Hd) of the synthesised nanogels, as characterised by 
dynamic light scattering (DLS). The nanogels were further characterised using nuclear 
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magnetic resonance (NMR) and AF4. The degradation studies were conducted in the 
presence of DTT and studied by AF4-MALS and DLS. The polymer structure 
synthesised using the poly(N-hydroxyethyl acrylamide) as macro CTA which is 





Figure 4.2. The structure of PNIPAM synthesised by RAFT polymerisation in the 






4.2. Experimental  
 
4.2.1. Materials  
N-isopropylacrylamide (NIPAM, ≥ 99%), N,N’-bis(acryloyl)cystamine (BAC, 98% 
HPLC), 4,4’-azobis(4-cyanovaleric acid), poly(ethylene glycol) methyl ether 2-
(dodecylthiocarbonothioylthio)-2-methylpropionate (average Mn = 1100 g mol-1; PEG 
CTA), dithiothreitol (DTT), sodium hydroxide (NaOH), sodium chloride (NaCl, ≥ 
99.5%), sodium nitrate (NaNO3, ≥ 99%), sodium dodecyl sulphate (SDS, ≥ 99%) were 
purchased from Sigma-Aldrich Company Ltd, Gillingham (Dorset) UK, a subsidiary of 
Merck KGaA, Darmstadt, Germany. Poly(N-hydroxyethyl acrylamide) macro chain 
transfer agent (HEMP CTA, Mn = 7140 g/mol) was kindly provided from the University 
of Sheffield. Phosphate buffered saline tablets (PBS) were purchased from Fischer 
Scientific. Milli-Q water obtained from a water purification system had a resistivity of 
> 18 MΩ cm-1 (PURELAB option R, Veolia). Spectra/por 2 (MWCO = 12-14 kDa) and 
spectra/por 3 (MWCO = 3.5 kDa) dialysis tubing was purchased from Spectrum 
Europe B.V., Breda, The Netherlands. Corning bottle top vacuum filter system with 
cellulose acetate membrane (pore size 0.22 µm) was purchased from Sigma-Aldrich 
Company Ltd, Gillingham (Dorset) UK, a subsidiary of Merck KGaA, Darmstadt, 
Germany.   
 
4.2.2. Synthesis of 2-(hydroxyethylthiocarbonothioylthio)-2-
methylpropanoic acid chain transfer agent  
 
The 2-(hydroxyethylthiocarbonothioylthio)-2-methylpropanoic acid chain transfer 
agent was kindly provided by University of Sheffield. The synthesis was as follows: 2-
mercaptoethanol (6.1 mL, 87.54 mmol) and potassium phosphate tribasic (19.16 g, 
87.54 mmol) were dissolved and stirred in acetone (150 mL). After 30 mins, carbon 
disulphide (11 mL, 0.17 mol) was added and the mixture was left to stir for another 
30 min. 2-bromoisobutyric acid (14.92 g, 87.54 mmol) was finally added and the 
mixture was left to react at ambient temperature. After 18 h, the mixture was purged 
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with N2 for 2 h. The mixture was filtered and the acetone was removed under in 
vacuo. The product was acidified by adding a 1M solution of hydrochloric acid  
(2x 100 mL) and the organic phase was extracted with DCM (2 x 100 mL). The organic 
phase was then washed with a saline solution (100 mL). All the organic phases were 
collected and dried using (Na2SO4). DCM was then remove in vacuo. Finally, the crude 
product was recrystallised using a mixture of hot hexane and ethyl acetate (7:3 v/v 
ratio) to give a bright yellow solid as product (17.2 g, 86%); m.p. 62-64 °C; 1H NMR 
(400.2 MHz; CDCl3, 25 °C), δH (ppm): 3.86 (m, 2H, CH2OH), 3.53 (t, 2H, CH2SC), 1.73 
(s, 6H, SC(CH3)2). 13C (100.25 MHz; CDCl3, 25 °C), δC: 25.19 (C(S)SC(CH3)2), 39.31 
(CH2SC(S)S), 60.48 (CH2OH), 177.50 (C(O)OH), 220.60 (SC(S)S).  
 
4.2.3. Synthesis of poly(N-hydroxyethyl acrylamide) (HEMP 
CTA) macro chain transfer agent 
 
The poly(N-hydroxyethyl acrylamide) (HEMP CTA) macro chain transfer agent was 
kindly provided by University of Sheffield. The synthesis was as follows; 
azobisisobutyronitrile (0.0079 g, 0.04 mmol), 2-(hydroxyethylthiocarbonothioylthio)-
2-methylpropanoic acid (3.09 g, 26.1 mmol) and N-hydroxyethyl acrylamide (0.1047 
g, 0.43 mmol) were dissolved and stirred in ethanol (9.33 g).  The mixture was stirred 
(400 rpm) and purged with N2 for 30 min. The solution was then heated to 70 °C. The 
reaction was maintained under a N2 atmosphere for 1.5 hours at 70 °C before being 
cooled to room temperature. The product was precipitated 3 times in ethyl ether to 
remove unreacted monomer and then freeze dried. 1H NMR (500 MHz; D2O 25 °C), 
δH (ppm): 4.7 (m, 2H, CH2OH), 3.8 (m, 2H, CH2SC), 3.58 (s, 6H, SC(CH3)2), 3.51 (m, 







4.2.4. Synthesis of degradable PNIPAM by RAFT polymerisation  
The PNIPAM nanogels were synthesised by RAFT dispersion polymerisation. The total 
solid content was kept at around 5 wt %. The nanogels were synthesised by reacting 
monomer NIPAM to form varying degrees of polymerisation (DP = 200, 250, 300) and 
the ratio between BAC crosslinker and macromolecular transfer agent were also 
varied. The composition used in the synthesis of each nanogel can be found in Table 
4.1 and Table 4.2. The NIPAM monomer, BAC crosslinker, SDS surfactant, HEMP CTA 
or PEG CTA were dissolved in distilled water in 25 mL vials with a stirrer bar and 
rubber septum. This was then sealed and nitrogen was bubbled through the aqueous 
solution for 30 min whilst stirring (400 rpm) to remove dissolved oxygen. The solution 
was then heated to 70 °C. Separately, ACVA initiator was dissolved in distilled water 
and degassed with N2 for 30 min before being transferred to the flask containing the 
monomers. The reaction was maintained under a N2 atmosphere for 19 hours  
at 70 °C before being cooled to room temperature. To remove unreacted impurities, 
the nanogel suspension was dialyzed for 5 days using regenerated cellulose dialysis 
tubing (12-14 kDa MWCO), (Spectrum Labs), replacing the distilled water every 12 
hours. The synthesised PNIPAM nanogels were analysed by DLS, AF4 and tested in 
degradation studies.     
Table 4.1. The composition used in nanogels synthesis using HEMP CTA as RAFT 
agent. 



























HEMP300:7 200 0.5 10.7 0.55 1.4 4.041 
HEMP200:5 200 0.5 11.5 0.82 2.1 4.075 
HEMP250:5 200 0.5 9.2 0.66 1.7 4.020 
HEMP300:5 200 0.5 7.7 0.55 1.4 3.983 
HEMP200:3 200 0.5 6.9 0.82 2.1 3.987 
HEMP250:3 200 0.5 5.5 0.66 1.7 3.949 
HEMP300:3 200 0.5 5.5 0.55 1.4 3.925 
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Table 4.2. The composition used in nanogels synthesis using PEG CTA as RAFT 
agent. 



























PEG250:3 200 0.5 5.5 0.66 7.7 4.065 
  
 
4.2.5. Characterisation of PNIPAM nanogels by DLS 
Characterisation of the nanogels was carried out using DLS. DLS was performed using 
a Malvern Zetasizer Nano ZS (running Malvern Zetasizer software V7.12) with 633 nm 
He-Ne laser and the detector positioned at 173 °. Dialysed samples were diluted to  
1 mg/mL. The Z-average diameter was recorded in the range 15-55 °C using a thermal 
equilibration time of 600 seconds in 1 cm path length disposable polystyrene 
cuvettes. Measurements were repeated in triplicate to give a mean Z-average 
diameter and polydispersity index (PdI). Measurements were repeated in triplicate 
to give a mean hydrodynamic diameter and polydispersity index (PdI). Zeta potential 
measurements were performed using DTS1070 folded capillary cells (Malvern, UK). 
The pH of the sample was measured before performing zeta potential 
measurements, and both samples fell in the range pH 7 ± 0.5. DTS1070 folded 
capillary cells were flushed with ethanol and water prior to usage. The zeta potential 
measurement was made with a minimum of 10 and maximum of 40 runs, and the 
voltage applied was automatically selected by the software. The Smoluchowski 
approximation where f(Ka) = 1.5 was used, and dispersions contained 10 mM NaCl 





4.2.6. Characterisation of PNIPAM nanogels by AF4 
Asymmetric flow field flow fractionation (AF4) experiments were performed on an 
MT2000 with RI and UV-Vis detectors from Postnova Analytics, Landsberg, Germany. 
Multi angle light scattering detector (MALS) PN3621 from Postnova Analytics with 21 
angle detection (from 7° to 164 °)  operating at 532 nm power wavelength were 
coupled online to AF4. Autosampler (PN5300) was purchased from Postnova 
Analytics. A UV-Vis detector was used to monitor wavelengths of 250 and 300 nm.  
The hydrodynamic radius of the samples was obtained by DLS using a Malvern 
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK)  running Malvern Zetasizer 
software V7.12 with 633 nm He–Ne laser and the detector positioned at 173°, 
coupled online to the MT2000. A 350 µm spacer and 10 kDa regenerative cellulose 
(RC) membrane were installed in the separation channel. The conditions used for the 
separations was based on a method existing in the literature,18,26 where, the eluent 
was 0.1 M NaNO3. Type I distilled water was obtained from a water purification 
system with a resistivity of > 18 MΩ cm-1 (PURELAB option R, Veolia). The eluents 
were filtered using a bottle top vacuum filter system with cellulose acetate 
membrane with pore size 0.22 µm. 20 µL of sample (1 mg/mL) was injected via the 
use of an autosampler. The samples were injected three times to check 
reproducibility. A blank sample was measured between sample injections to clean 
the system. The conditions used for the separations was as follows; the 
injection/focussing time was 3 minutes using a cross flow from 2 to 0.5 mL/min. The 
chosen cross flow rate was kept for the first 0.2 min (t0-t0.2) in a constant manner, 
and thereafter, the cross flow was decreased in a power manner (exponent 0.2) from 
its initial value to 0.1 mL/min over a period of 40 min. Following the complete 
reduction in cross flow, the tip-flow 0.1 mL/min continued for an additional 40 min. 
Hydrodynamic radius was calculated from translational diffusion coefficient 
according to Einstein-Stokes equation. Radius of gyration was measured on the MALS 
and calculated based on a spherical fit. 
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4.2.7. Nanogel degradation studies  
Nanogels were degraded as a 1 mg/ml pH 10 aqueous dispersion using 10 mM DTT, 
or 150 mM when immediate degradation was required. DLS was used to measure the 
mean count rate of a degraded and non-degraded sample at the same attenuator 
value and measurement position. Count rate was measured in kilo counts per 
second, which provides a measure of the fluctuation in scattered light intensity over 
time.27 The count rate is a function of particle size, concentration and the difference 
in particle to medium refractive index.28 The attenuator value was fixed at a value 
found to be suitable for the dispersion at the start of the degradation, and the 
measurement position of the laser was fixed at 4.65 mm (centre of the cuvette). 
Leber et al. and Chen et al. 10,11 previously showed that the count rate of a nanogel 
sample decreases as the nanogel degrades, assuming that a decrease in count rate 
over time was related to a change in particle to medium refractive index due to 
particle degradation. Polymers may be lost from the particle and replaced by solvent 
which can lead to a change in count rate.  
For DLS measurements, the percentage of nanogels remaining were calculated by 
dividing the derived count rate for samples before and after addition of DTT 
(concentration of nanogels 1 mg/mL) and then multiplying it by 100 %. The results 
from the AF4 were calculated similarly, by analysing the area under the curve for 
MALS90 ° for all samples before and after addition of DTT were divided by each other 
and multiplied by 100 %.  
4.3. Results  
4.3.1. Degradable nanogels synthesis and size characterisation  
To synthesise nanogels consisting of polymers with well-defined primary chain length 
and the ability to aggregate at about 37 ˚C at physiological ionic strength, a series of 
PNIPAM nanogels were synthesised by RAFT polymerisation with BAC as a 
degradable crosslinker (see Table 4.3). Two different RAFT agents were initially used 
for the nanogel synthesis, these were 2-(hydroxyethylthiocarbonothioylthio)-2-
methylpropanoic acid (HEMP, Mn=7,128 g/mol; see Figure 4.3A) and poly(ethylene 
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glycol) methyl ether 2-(dodecylthiocarbonothioylthio)-2-methylpropionate 
(Mn=1,100 g/mol; see Figure 4.3B). These two RAFT agents were chosen due to their 
solubility in water, the solvent for the dispersion polymerisation. In order to assess 
the effect of using a macro CTA, the CTAs were used in the RAFT polymerisation 
process. The full composition for PNIPAM nanogels made with macro HEMP CTA can 
be found in Table 4.4. The name of each sample indicates the ratio of monomer and 
crosslinker to the CTA.  For example, HEMP200:7 consists of 200 moles of monomer 
and 7 moles of crosslinker for each mole of CTA. The different ratios of BAC and 
NIPAM was used to investigate the influence of these variables on size, polydispersity 
and the degradability of the nanogels. The molar ratios between initiator, HEMP CTA 
and SDS was kept constant. A secondary PEG based CTA (Figure 4B) was also used in 
the synthesis of degradable PNIPAM nanogels, where the full nanogel ratios are 
highlighted in Tables 4.2 and 4.4. It was expected that the length of the primary 
chains would be controlled by the molar ratio of the monomer to the CTA.29 The chain 
ends in the nanogel would be either the R or Z group of the CTA as shown in Chapter 
1, Figure 1.10 or the initiator fragment as schematically presented in Figure 4.4. The 
reaction scheme is presented in Scheme 4.1. 
Table 4.3. The molar ratio of chemicals used for the preparation of PNIPAM 
nanogels with the presence of HEMP CTA. 
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1 
HEMP300:7 300 1 7 0.33 1 
HEMP200:5 200 1 5 0.33 1 
HEMP250:5 250 1 5 0.33 1 
HEMP300:5 300 1 5 0.33 1 
HEMP200:3 200 1 3 0.33 1 
HEMP250:3 250 1 3 0.33 1 





Table 4.4. The molar ratio of chemicals used for the preparation of PNIPAM 
nanogels with the presence of PEG CTA. 
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Scheme 4.1. Generalised RAFT polymerisation of NIPAM (green) in the presence of BAC as crosslinker (red), ACVA as initiator and HEMP CTA 










Figure 4.4. Cartoon representation of HEMP200:5. The comparative lengths of the polymer 
chains represent their comparative degrees of polymerisation. Black lines indicates 
PNIPAM repeating units, red lines represents BAC crosslinker, green lines shows HEMP 




The samples were characterised by DLS as discussed in Section 4.2.7, and the data is 
presented in Table 4.5. When RAFT polymerisations were conducted in the presence of a PEG 
CTA, at a monomer:crosslinker ratio of 250:3, no formation of nanogels were apparent. As 
the molar concentration of BAC was increased (≥ 5), samples contained large insoluble 
aggregates, which were unable to be accurately characterised via DLS. This could possibly be 
due to the fact that the RAFT agent was not compatible with monomer or poor reactivity of 
RAFT agent.30  
RAFT polymerisations conducted with HEMP CTA and crosslinker ratio of BAC > 3, produced 
nanogels with a hydrodynamic diameter (HD) in the range of 318 - 457 nm and PdI ≤ 0.15. The 
low PdI and high derived count rate (>11000 kcps) suggest a single population of nanogels 
with good monodispersity. The samples were turbid in appearance caused by light scattering 
of particles, indicating successful synthesis. Samples prepared with the lower molar ratio of 
BAC (samples HEMP200:3-HEMP300:3), showed much lower derived count rates (< 140 kcps) 
with high PdIs (from 0.48 to 0.8; see Table 4.5). This is in comparison to literature values, 
where the typical PdI for PNIPAM nanogels has been shown to be less than 0.15.2,31–33 
HEMP200:3-HEMP300:3 nanogels were also visually transparent. It is likely due to the lower 
concentration of crosslinker in the nanogel synthesis, may have resulted in branched or linear 
polymers chains, rather than the fully crosslinked networks that make up nanogels. 1H NMR 
was used to analyse the structure of a PNIPAM nanogel synthesised in the presence of HEMP 
CTA, the spectrum for the nanogel was rather complex with many overlapping peaks. It was 
challenging to gather conclusive information from solution NMR on nanogels as they are 
crosslinked and some of the chains may not be mobile enough to show up on the NMR (see 









Table 4.5. DLS analysis of PNIPAM nanogels synthesised with varying ratios of monomer:crosslinker in an aqueous solution (1 mg/mL). The 
black colour of font indicates successfully synthesised nanogels and red font represents obtained linear polymer chains or branched 
polymers. 
 
Sample  HEMP200:7 HEMP250:7 HEMP300:7 HEMP200:5 HEMP250:5 HEMP300:5 HEMP200:3 HEMP250:3 HEMP300:3 PEG250:3 
D (nm)  437 ± 2 369 ± 11 361 ± 3 457 ± 12 352 ± 2 318 ± 4 427 ± 51 415 ± 116 1213 ± 870 182 ± 2 







































The HD values of successfully synthesised nanogels were found to slightly decrease when 
higher ratios of monomer to crosslinker were used (BAC ≥ 5), which would be expected to 
result in longer primary PNIPAM chains. This may be due to the influence of the CTA on the 
colloidal stability during the dispersion polymerisation, the hydrophilic CTA might be 
disrupting the aggregation of the primary nucleated chains resulting in less dense crosslinking 
and larger nanogel particles. However, the influence of the ratio of crosslinker to monomer 
did not show a significant impact, which may be due to the fact that the changes in the molar 
ratio of crosslinker were not large enough to see an effect.  
In next part of this chapter, the six samples that had successfully formed nanogels 
(HEMP200:7, HEMP250:7, HEMP300:7, HEMP0200:5, HEMP250:5, HEMP300:5) were taken 
forward for further analysis. These samples had three different degrees of polymerisations 
(DPs) and two different crosslinker contents and the effect of these variables on the 
temperature responsive behaviour and degradation behaviour were assessed via DLS and 
AF4.  
4.3.2. Dynamic light scattering measurements to investigate 
temperature responsive behaviour 
 
The temperature responsive behaviour of the nanogels was analysed by using gradual heating 
within the Malvern Zetasizer and measuring the change in mean diameter. When the 
nanogels were heated in water they all showed characteristic deswelling at the volume phase 
transition temperature (VPTT) (Figure 4.5) and remained colloidally stable as first shown by 
Pelton et al.,34 where the VPTT was determined as the halfway point in the slope.35 The VPTT 
for all the PNIPAM-RAFT nanogels was around 34 ˚C, which agrees with literature findings.2 
Typical values of VPTT for PNIPAM nanogels has been previously shown as around 34 ˚C,36 
with some dependence on crosslinker structure as well as crosslinking density.37,38 Below the 
VPTT the nanogels exist as hydrophilic particles with the network swollen by water molecules, 
due to favourable hydrogen bonding between the amide units and water.39 These solvated 
polymer chains are also able to provide steric stabilisation of the particles. Above the VPTT 
the polymer–polymer hydrogen bonding becomes more favourable and the particles de-swell 
as they expel solvent, decreasing the diameter of the particle. In the deswollen form the 
potential for steric stabilisation from the PNIPAM chains is lost and typically, electrostatic 
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repulsion between particles provides colloidal stability.40 In the case of the samples in this 
work, the electrostatic stabilisation is caused by the presence of SDS salt in the system during 
the polymerisation. This SDS is then removed during the dialysis purification step and 
therefore the colloidal stability comes from the polymer chains and initiator fragments that 
make up the nanogels. These nanogels therefore contain a small number of ACVA initiator 
fragments which provide carboxylic chain ends. The pKa of these groups is 3.8541 which 
indicates partial dissociation into its ions in a natural aqueous solution which would provide 
some surface charge to the nanogels.42 Additionally, the nanogels also contain the poly(N-
hydroxyethyl acrylamide) macro CTA which could act as a steric stabiliser, these two factors 
must provide the electrostatic stabilisation above the VPTT. However, they appear to have 
limited impact on the temperature responsive behaviour compared to PNIPAM nanogels 
prepared by free radical dispersion polymerisation. The polydispersity index was found to be 




Figure 4.5. Graph showing the change in HD (nm) versus temperature for PNIPAM 
































The swelling ratios of the nanogels in aqueous solution were calculated from DLS 
measurements of hydrodynamic diameters, where the nanogels showed similar swelling 
ratios (1.9-2.0). Verga et al. showed that for PNIPAM nanogels, swelling ratio is related to 
crosslinking density.40 However, the experimental data showed that such changes to 
crosslinking density did not cause an observable different in our samples. It may be due to 
the range of crosslinking densities in the samples not being not sufficient enough to have a 
significant impact on the swelling ratios.  
 
Table 4.6 Swelling ratio for PNIPAM nanogels in water 
Sample HEMP200:7 HEMP250:7 HEMP300:7 HEMP200:5 HEMP250:5 HEMP300:5 
Swelling 
ratioa 
1.9 2.0 2.0 2.0 2.0 2.0 
a Swelling ratio calculated from DLS measurement of hydrodynamic diameter (Hd) 
using 1 mg/mL aqueous dispersion, swelling ratio = Hd (25°C) / Hd (55°C) 
 
The temperature responsive behaviour of the nanogels was then assessed when dispersed in 
PBS which was conducted by heating the samples in 1 °C intervals to determine the 
temperature at which the particles aggregated. This aggregation temperature was indicated 
by a dramatic rise in hydrodynamic diameter and PdI (see Figure 4.6). The aggregation 
temperature was 28 °C for almost all nanogels, except HEMP300:5. Sample HEMP300:5 
underwent aggregation at 27 °C. It is not fully understood why this sample had a different 
aggregation temperature in comparison to the other nanogels tested. There was a clear 
difference in the VPTT between the samples analysed in aqueous dispersions and the 
aggregation behaviour in PBS. It is known that the VPTT can be decreased by introduction of 
hydrophobic group into the polymer chains.43 In PBS and above the VPTT, the increased 
concentration of ions means that the charges that provided electrostatic stabilisation in 
aqueous conditions were screened and therefore flocculation occurs.44 The presence of salt 
also decreased the VPTT of PNIPAM nanogels due to the increased ionic strength of the 
solvent making it a worse solvent for the nanogels as suggested by earlier research.33  
Town et al. showed that VPTT of PNIPAM nanogels in PBS was 31 °C for samples prepared by 
dispersion polymerisation using potassium persulphate as initiator and  
N,N-methylenebis(acrylamide) as crosslinker where the ratio between monomer and 
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crosslinker was 10:1.33 In the RAFT nanogels discussed in this work a macro CTA was used 
during synthesis, which can act as steric stabiliser and the more hydrophobic crosslinker (BAC) 
means that a direct comparison in the VPTT behaviour cannot be made in comparison to 
previous studies. However, generally the VPTT of nanogels can be reduced through the 
incorporation of a greater number of hydrophobic components. This reduction in the VPTT 
might suggest that the CTA and initiator used in this work were less polar in character 
compared to the end groups obtained using potassium persulphate as the initiator. The 
aggregation behaviour of the RAFT nanogels was consistent with the aggregation behaviour 
of PNIPAM nanogels made by free radical polymerisation, showing that the macro CTA did 




Figure 4.6. Change in hydrodynamic diameter (nm) versus temperature for PNIPAM 
nanogels with varying monomer:crosslinker ratios in PBS (1 mg/mL). 
 
Zeta potential measurements were carried out to investigate the colloidal stability of the 
nanogels. The zeta potential showed values between -1.9 and -2.3 mV for all samples (see SI 
Table 4.9). For particles to have good electrostatic stabilisation zeta potential values should 
































by steric stabilisation.46 The nanogels had both the solvated PNIPAM chains and the non-
temperature responsive macro CTA offering steric repulsion. 
 
4.3.2. Degradation studies by dynamic light scattering 
 
In order to investigate the degradation process for RAFT-PNIPAM nanogels over time, DTT 
was used at different concentrations (10 and 150 mM) while under constant basic pH 
conditions (pH 10). The conditions were kept at pH 10 as the reducing power of DTT is limited 
by the reactivity of negatively charged thiolate S- form. The thiols of DTT have pKa of 9.2 and 
10.1 which means that pH > 9 should be used to maintain DTT in the active thiolate form.20 
The nanogels were degraded at room temperature over 72 h. The example of HEMP300:7 
nanogels before and after degradation is shown in Figure 4.7. In the picture, the changes in 
turbidity and colour from white (left hand side) to a less turbid sample with a blue tint (right 
hand side) are visible and it can be attributed to Tyndall scattering effect. The samples contain 
the same concentration of nanogel (1 mg/mL). The change of turbidity may be caused by 
degradation of nanogels into smaller particles and potentially soluble polymer chains.   
 
 
Figure 4.7. HEMP300:7 before and after degradation (72 h) in the presence of 10 mM DTT 
at pH 10. 
  
The degradation process was monitored by DLS, observing the changes in diameter and the 
derived count rate of samples. The changes in hydrodynamic diameter (%) for samples before 
and after addition of DTT over 72 h are shown in Figure 4.8. It was found that the majority of 
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samples increased in diameter with increased concentration of DTT added to the samples. 
This can be explained by the effects from crosslink scission of the nanogels; the nanogels swell 
as the disulphide bonds forming the crosslinker are broken. The higher concentration of DTT 
resulted in larger nanogel, potentially caused by more crosslink scission. Previous work has 
showed that the maximum size to which a nanogel can swell is constrained by the density of 
crosslinking present.47,48 It is possible that within the samples there are heterogeneity in 
structure (i.e. crosslinking density) of the particles and therefore some of the nanogels are 
dissolving while others are swelling. Therefore it was important to quantify changes in the 
light scattering intensity by measuring the derived count rate. 
 
 
Figure 4.8. Changes in size (%) versus concentration of DTT for RAFT-PNIPAM nanogels, 
with varying monomer:crosslinker ratios after 72h. 
 
Changes in the derived count rate provide information about the degradation of the nanogels. 
A reduction in count rate would indicate that the particles are reducing in size, reducing in 
concentration, or the difference in refractive index between the particles and the continuous 
phase is reducing. Of course, it is possible that these variables may also be changing 
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simultaneously. It may be expected that partial scission of the crosslinked network would 
result in swelling which would increase the mean diameter of the particles but also reduce 
the difference in refractive index between the particles and the continuous phase. This might 
lead to a slight increase in the derived count rate. It was found that the derived count rate of 
samples generally increased after addition of 10 mM DTT after 72h (see Figure 4.9). This may 
indicate that 10 mM DTT was not sufficient to allow full degradation of the crosslinked 
network in the nanogels. The nanogel samples that had shown an increase in diameter also 
had the most dramatic increases in derived count rate, this indicates that the majority of the 
nanogel particles are swelling. The nanogels may be still able to form a stable polymer 
network, even in the case for absence of crosslinking agents. The PNIPAM probably formed a 
stable polymer network by interchain self-cross-linking through chain transfer reaction, both 




Figure 4.9. Changes in derived count rate versus concentration of DTT for RAFT-PNIPAM 
nanogels after 72h. 
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The addition of 150 mM DTT showed a decrease in count rate for most of the samples 
analysed. However, in two samples analysed, increased scattering was observed (see Figure 
4.9, HEMP200:5, HEMP250:7). The normalised count rate showed values 1.9 for HEMP200:5 
and 1.19 for HEMP250:7. This could indicate that DTT might have changed the refractive index 
or that the nanogels changed structure, thus resulting in an increase in the refractive index of 
the nanogels. Werner et al. showed that refractive index can be changed during a coil to 
globule transition.51 A second possibility may be that the larger swollen particles resulted in 
more intense scattering and that this signal obscures the weak scattering from the soluble 
polymer chains. Another possibility as previously mentioned, is that self-crosslinking through 
chain transfer reaction could have occurred during polymerisation of PNIPAM, resulting in 
some non-degradable crosslinks and therefore complete degradation could not occur. The 
analysis of the samples by DLS meant that the presence of some non-degradable nanogels 
within a sample would potentially mask the degradation of other nanogels due to the 
relationship between size and scattering intensity in DLS analysis.  
Previously in the literature, the degradation studies of nanogels have also been carried out 
using AF4.18,31 The AF4 coupled with MALS and DLS detectors were shown to produce more 
accurate results compared with DLS batch measurements (see Chapter 3 ‘The separation 
behaviour of non-spherical nanoparticles in asymmetric flow field flow fractionation’).  In the 
next part of these studies, the degradation of nanogels was tested using AF4 measurements 
to obtain information about radius of gyration, hydrodynamic radius, shape factor and the 
attempt to quantify the amount of degradation of the nanogels in the sample.  
 
4.3.3. AF4 measurements  
 
The AF4 separation conditions were chosen based on measurements and data from a 
previous chapter (Chapter 3 Insights into the Internal Structures of Nanogels Using a Versatile 
Asymmetric-Flow Field-Flow Fractionation Method). The hydrodynamic diameter versus 
temperature in 0.1 M NaNO3 as mobile phase was firstly measured to make sure that the 
aggregation process does not appear in the AF4 system (see SI, Figure 4.14). The data showed 
that temperature of aggregation for nanogels was 31.5 °C in 0.1 M NaNO3. Therefore, 28°C 
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was chosen as the set temperature throughout these experiments, to avoid the onset of 
aggregation.  Sample measurements were performed at least in triplicate and showed good 
reproducibility. The fractograms display time of elution for particles versus the signal 
obtained for 90° light scattering detection, the online MALS and DLS detectors allow the 
measurements for both Rg and Rh of the nanogels exiting the AF4 separation channel. Nanogel 
samples were analysed both before and after the degradation process caused by the addition 
of 10 mM DTT or 150 mM DTT. The increase of the nanogel Rh with the elution time indicated 
that the cross flow (1 mL/min), eluent and the method used was optimal to achieve a 
satisfactory separation of the particles. Figure 4.10 shows an example of AF4-MALS-DLS 
fractograms obtained for sample HEMP200:5, HEMP250:5 and HEMP300:5. These samples 
were chosen to illustrate three types of behaviour found during the DLS analysis; i.e. swelling, 
and indication of either higher or lower degradation. Unfortunately, the amount of Rh data 
obtained for samples after degradation was very limited due to the weak scattering which is 
the reason why Rh is not presented on the graph. The non-degraded (i.e. before addition of 
DTT) sample HEMP200:5 showed two peaks after 40 min of elution and 55 min from MALS90ᵒ 
signal, which indicated two populations of nanogels. The Rg increased with elution time, which 
indicate normal elution according to AF4 theory. The addition of 10 mM DTT to HEMP200:5, 
showed increased and shifted signal to 50 min of elution for MALS90ᵒ, which may be 
explained by swelling behaviour. An extra small peak was also visible on MALS90ᵒ after 30 
min of elution, which may be attributed to small amount of swelled crosslinked soluble 
polymers or smaller nanogels. The Rg values increased compared with Rg data obtained before 
addition of DTT, which could also indicate swelling behaviour. The addition of 150 mM DTT, 
shifted the modes of the signals of MALS90 ᵒ to longer elution times (45 min and 58 min) and 
the signal intensities also decreased compared to the non-degraded sample, indicating 
degradation and swelling of the nanogels. The Rg values slightly decreased compared with Rg 
obtained for sample before addition of DTT. HEMP250:5 showed main peak of MALS90 ᵒ after 
40 min of elution with smaller shoulder compared with sample HEMP200:5 after 50 min of 
elution. The non-degraded HEMP250:5 sample showed elution of nanogels after 40 and 45 
min for MALS90ᵒ. The second population of nanogels was smaller compared with HEMP200:5 
which may indicate better control of the polymerisation process. The addition of 10 mM DTT 
shifted the peaks to 45 and 55 min of elution, indicating swelling behaviour. The addition 150 
mM DTT, decreased the area under curve compared with undegraded nanogels for MALS90ᵒ 
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signal. This may indicate the degradation of nanogels in the presence of 150 mM DTT.  
The non-degraded sample HEMP300:5 showed two peaks at 30 min and 50 min of elution 
obtained by AF4-MALS-DLS measurements. The second smaller peak may indicate some 
aggregation of particles due to the fact that Rg is higher (Rg ~ 300 nm) compared with first 
peak (Rg ~ 100 nm) or a population of particles with different structure. When the nanogels 
had been treated with DTT, the intensity obtained from MALS90° decreased with higher 
concentrations of added DTT. The concentration of nanogels in the samples prior to DTT 
treatment was the same (1 mg/mL) which means that the nanogels were degraded in the 
presence of DTT; scission of crosslinks reduced the scattering of the samples as the nanogels 
dissolved. The second peak on AF4 fractogram disappeared with increasing concentration of 
DTT, indicating that a small residue of nanogels left after at ~40 minutes elution time. This 
loss of the second peak might indicate that the second peak represents different structure of 
particles containing fewer non-degradable crosslinks. The Rg slightly increased also after 
addition of DTT which can be explained by the slight swelling behaviour of nanogels due to 
the breaking of the sulphur bonds in crosslinker. The polymer chains have more space and 
their conformation is more elongated as shown by an increase in the radius of gyration. To 
understand more about internal structure and the shape of the nanogels, the shape factor 
was calculated from Rg and Rh at the modes for the populations as determined from the AF4 
measurements. Shape factor after degradation was not calculated because as previously 
mentioned the amount of obtained Rh was not sufficient and it may cause some discrepancies 




Figure 4.10.   AF4-MALS-DLS analysis of HEMP300:5 nanogel. Fractograms showing the 90 ◦ light scattering detector signal (blue, red, green 
solid line; left hand scale) and radius of gyration (blue, red and green dotted line, right hand scale) obtained from AF4-MALS-DLS 
measurements. The sample was measured before (blue lines) and after degradation with the presence of 10 mM DTT (red line) and 150 mM 
DTT (green line). 
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Table 4.7. The mode values of hydrodynamic radius, radius of gyration and PdI obtained 
from AF4-MALS-DLS measurement for PNIPAM nanogels before degradation.  Shape 
factor is calculated only for the first population. 
Sample Rg/ nm Rh/ nm Shape factor 
HEMP200:5 77 & 184 226 0.34  
HEMP250:5 70 & 124 179 0.39  
HEMP300:5 65 & 186 170 0.38  
 
 
Table 4.7 showed mode values for Rg, Rh and shape factor. The mode Rg was taken from first 
and second peak. The Rh did not show second peak on DLS measurements, so the Rh value 
represents first peak. The example of fractogram, showing lack of Rh is presented in Figure 
4.11.  
 
Figure 4.11. AF4-MALS-DLS analysis of HEMP200:5 nanogel. Fractograms showing the light 
90◦ scattering detector signal (blue solid line; left hand scale) and radius of gyration (green 
dotted line, right hand scale) and hydrodynamic radius (red dotted line, right hand scale) 
obtained from AF4-MALS-DLS measurements. 
 
The lack of Rh data for the second peaks was likely due to the low concentration of these 
species and the lower sensitivity of the DLS instrument compared to the MALS. The Rh data 













































obtained from AF4-DLS measurements was only a few nm higher compared with batch 
results. The AF4-MALS-DLS measurements showed that the nanogels have core-shell 
structure due to shape factor ≤ 0.65. In literature, typical values for core-shell particles are 
<0.65.52 The really low value of shape factor can indicate really dense core and less dense 
shell. Generally, hydrodynamic radius obtained after fractionation matches with batch DLS 
measurements which also was shown in previous chapters.  
 
4.3.4. Comparison of degradation data from DLS and AF4 
 
The data obtained from the degradation process from batch DLS measurements was 
compared with AF4 data. All data is presented in Table 4.8. The DLS data showed that derived 
count rates had not reduced for degradation process in the presence of 10 mM DTT but the 
AF4 results indicate degradation for samples HEMP250:5 and HEMP300:5. Interestingly, the 
trend between the samples is the same in both techniques. This difference between DLS and 
AF4 results could be caused by changing the size of particles or refractive index during the 
swelling and degradation process. In that case, data obtained from AF4-MALS-DLS studies will 
be discussed. The AF4 measurements showed that the nanogel with lowest amounts of 
crosslinker relative to the PNIPAM primary chains (HEMP300:5) was the most degradable 
sample obtained from the synthesis. At the highest concentration of DTT, the amount of 
remaining nanogels was 15% for HEMP300:5.  Lower concentrations of DTT showed less 
degradation of nanogels; the amount of remaining nanogels was smaller for samples treated 
with 10 mM compared with 150 mM DTT. The influence of the ratio of NIPAM to BAC can also 
be noticed. The nanogels with higher amounts of NIPAM compared with BAC showed higher 
degradation. This can possibly be attributed to the better ability of DTT to penetrate through 
the polymer network. The nanogels with a higher ratio of NIPAM to BAC would likely have 
longer primary chains and should have larger spaces between the crosslink chains which 
might assist degradation of the disulphide bonds. The higher molar content of BAC showed a 
higher tendency to swell rather than degrade. Previous work by Gaulding et al. showed also 
that PNIPAM nanogels synthesised by precipitation polymerisation and crosslinked with BAC 
were not fully degradable unless low temperature redox polymerisation was employed.18 The 
studies showed the ability for the PNIPAM RAFT nanogels to degrade. The most degradable 
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sample showed a high affinity for degradation, with only 15 % of the nanogels remaning. 
However, the data also showed that some self-crosslinking may have also been occurring due 
to the swelling behaviour of sample after addition of DTT.  
 
Table 4.8.  Summary of finding for PNIPAM-RAFT nanogels. 
Sample HEMP200:5 HEMP250:5 HEMP300:5 
      Degradation studies DLS 
Derived Count 
Rate before DTT 
(kcps) 
9528 ± 467 26718 ± 1291 36619 ± 1868 
Derived Count 
Rate 10 mM DTT 
(kcps) 
22681 ± 841 44979 ± 3208 35666 ± 686 
% of left after 
degradation, 
72h, 10 mM DTT 
238% 168% 97% 
Derived Count 
Rate, 150 mM 
DTT (kcps) 
18095 ± 153 14441 ± 326 23386 ± 895 
% of left after 
degradation, 
72h, 150 mM 
DTT 
189% 54% 63% 
          Degradation studies AF4  
% left after 
degradation, 10 
mM DTT 
126 % 56 % 26% 
% left after 
degradation, 
150 mM DTT 








PNIPAM nanogels were successfully synthesised by RAFT polymerisation. The nanogels were 
synthesised with varying amounts of monomer and crosslinker. The HEMP CTA showed better 
ability to create nanogels compared with PEG CTA. The hydrodynamic diameters for 
synthesised samples were between 318 and 457 nm with narrow PdI values (< 0.15).  
The swelling ratio was similar for all samples ~ 2.0, indicating that the changes in crosslinking 
densities were not large enough to shown any influence. The synthesised nanogels showed  
a characteristic deswelling at 33 °C. The aggregation temperature for all samples in the 
presence of PBS was around 28 °C, showing potential for the use of these nanogels as in situ 
forming implants and delivery vehicles for poorly water-soluble drug.  The AF4 measurements 
showed that nanogels have a core-shell structure due to the value of the shape factor being 
≤ 0.65 for all samples. The degradation studies were conducted in the presence of 10 mM and 
150 mM DTT. AF4-MALS-DLS measurements showed good degradation of PNIPAM nanogels. 
The most degradable sample (HEMP300:5) was shown to contain only 15 % nanogel after the 
degradation process. Generally, the samples degraded better in the presence of 150 mM DTT, 
showing that excess of DTT allows for faster degradation. This work has shown that the 
degradation process could be monitored over time using AF4 to measure particle 
hydrodynamic radius, radius of gyration and shape factor. DLS degradation studies showed 
that the derived count rates for samples cannot be directly compared before and after 
degradation, probably because of changes of refractive index. RAFT polymerisation showed 
potential to control the size of nanogels and degradation behaviour. The RAFT polymerisation 
in aqueous media is still developing and it requires deeper understanding. The limitation 
which was presented is associated with the choice of RAFT agent and initiator. Unfortunately, 
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Figure 4.13. The graph shows changes of polydispersity (PdI) versus temperature for 





































Figure 4.14. The graph shows the hydrodynamic diameter vs temperature for HEMP200:5 




Figure 4.15.  The graph shows concentration of DTT (mM) vs derived count rate (kcps) for 























































Figure 4.16. AF4-MALS-DLS analysis of nanogels. Fractograms showing the light 90◦ 
scattering detector signal (blue, red, green solid line; left hand scale) and radius of 
gyration (blue, red and green dotted line, right hand scale) obtained from AF4-MALS-DLS 
measurements. The samples have been measured before (blue lines) and after 





Table 4.9. Table shows zeta potential, hydrodynamic diameter and polydispersity index 
(PdI) in 10 mM NaCl for PNIPAM nanogels. 
 
Sample HEMP200:7 HEMP250:7 HEMP300:7 HEMP200:5 HEMP250:5 HEMP300:5 
Zeta potential 
(mV) 
-2.25 ± 0.38 -1.95 ± 0.11 -1.97 ± 0.83 -1.91 ± 0.29 -1.94 ± 0.87 -2.27 ± 0.42 
Hydrodynamic 
diameter (nm) 
in 10 mM NaCl  
475 ± 16 386 ± 19 354 ± 7 462 ± 19 351 ± 20 327 ± 5 











































The separation behaviour of non-spherical nanoparticles in 
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The shape of micro/nanoparticles is known to be important in applications for drug 
delivery. For example, elongated or non-spherical particles have shown potential 
benefits for use in drug delivery systems.1 Ellipsoidal particles showed better 
adhesion to aortae when tested in vivo compared to spherical micro and 
nanoparticles.2 In another example, non-spherical particles have been shown to load 
more hydrophobic drug than spherical ones.3 The characterisation of non-spherical 
particles typically utilises electron microscopy which allows the shape and aspect 
ratio (defined as ratio between major axis and minor axis for ellipsoidal particles)4 of 
the sample to be determined. However, this technique is time-consuming, may be 
influenced by drying effects and is limited to a relatively small number of particles 
that may not be representative of the complete sample.5,6 Analysis approaches based 
on the bulk sample can address these issues.7 However, there are few effective bulk 
methods for providing information about the shape of non-spherical particles as 
many bulk characterisation techniques assume spherical particles. AF4 is a promising 
tool in the field of analytical chemistry and it is based on hydrodynamic principles 
and interaction of particles with a cross flow and parallel (tip) flow of carrier liquid.8 
The samples are injected into the flat channel containing permeable membrane and 
filled with eluent. Particles can be separated by combination of two flows (i.e. cross-
flow and tip flow) of eluent due to the differences in diffusion coefficients, then 
analysed by range of detectors. Coupling AF4 with different detectors such as MALS 
and DLS can give information about size and shape of particles.9–11 A MALS detector 
can provide the radius of gyration (Rg) while a DLS instrument determines the 
hydrodynamic radius (Rh). It has been shown that Rg/Rh, defined as shape factor, can 
give information about shape of particles and internal structure.12,13 Gigault et al. 
used this approach to measure the length of carbon nanotubes by AF4.14 The 
calculation of length and diameter of carbon nanotubes was based on correlation 
between Rg and Rh.14 The results showed that longer carbon nanotubes have higher 
values for shape factor.  The shape of nanoparticles has also been shown to influence 
the separation behaviour, with different separation behaviour found for gold 
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nanorods compared with spherical nanoparticles.15 It has been proposed that non-
spherical gold nanorods with larger aspect ratios were located higher in the channel 
and therefore elute faster.15 In other work, theoretical experiments were conducted 
to understand accurate mechanism of fractionation for elongated particles.16–20 
These studies showed that separation of anisotropic particles cannot be obtained by 
‘normal’ mode. Therefore, a steric-entropic mode was proposed as it considers the 
transition between normal and steric mode. Due to this combination of factors it was 
predicted that elongated particles would have lower retention times than a sphere 
of the same mass. However, experimental confirmation of this theory was 
challenging due to a difficulties of finding suitable well-characterised uniform non-
spherical particles.20 Therefore, the steric-entropic theory is still being 
developed.18,21  Up to date, there is small amount of articles focused on AF4 analysis 
of particles with different shapes and shape factors. 14,22,23 
This chapter is focussed on the analysis of a range of nanoparticles made of different 
materials with different sizes and shapes. The particles were fractionated by AF4-
MALS-DLS, with the aim of better understanding the relationship between particle 
size, shape and separation behaviour. The samples analysed were gold nanoparticles, 
gold nanorods, silver nanoparticles and silver nanoprisms. Batch DLS measurement 
were conducted to characterise hydrodynamic radius of particles. The development 
of a sufficient method for separation of the differently sized samples by AF4 was 
studied to understand a retention behaviour for particles with different shapes. The 
particles were also characterised by scanning electron microscope (SEM) and 
scanning transmission electron microscopy (STEM) to characterise morphology and 
structure. This data was used also to compare with the shape factors obtained by 
AF4-MALS-DLS measurements. We believe that it is first time that silver nanoprisms 







5.2. Experimental  
5.2.1. Materials  
 
Gold nanoparticles stabilised in citrate buffer solution were purchased from Sigma 
Aldrich with a mean hydrodynamic diameter of 58-66 nm and core size 50 nm. Silver 
nanoparticles stabilised in sodium citrate were purchased from Sigma Aldrich with 
particles size 60 nm from TEM, according to provider. Gold nanorods, silver 
nanoplates, silver prisms were kindly provided from Surface Science Research 
Centre, University of Liverpool.  Gold nanorods were synthesised by methods already 
existing in literature.24 The method for preparation of silver nanoplates and silver 
nanoprisms was also adopted from the literature.25 Typical synthesis for gold 
nanorods, silver nanoplates and silver nanoprisms are discussed below.  
 
5.2.2. Synthesis of gold nanorods_A 
 
The synthesis of gold nanorods  A were adapted from methods previously detailed in 
literature.26 In a typical procedure, for synthesis of seed solution, 0.250 mL of an 
aqueous 0.01 M solution of HAuCl4,3H2O was added to 7.5 mL of a 0.10 M 
cetyltrimethylammonium bromide (CTAB) solution in a glass vial. The solutions were 
gently mixed, appearing bright brown-yellow in colour. Then, 0.600 mL of an aqueous 
0.01 M ice-cold NaBH4 solution was added all at once, followed by rapid inversion 
mixing for 5 min. Then the vial was kept in a water bath maintained at 25 °C for future 
use. This seed solution was used for up to 2 h after its preparation. Next, 4.75 mL of 
0.10 M CTAB, 0.200 mL of 0.01 M HAuCl4‚3H2O, and 0.030 mL of 0.01 M AgNO3 
solutions were added in that order to a vial, followed by gentle mixing. Then 0.032 
mL of 0.10 M L-ascorbic acid (AA) was added to it. Finally, 0.010 mL of seed solution 
was added, and the reaction mixture was gently mixed for 10 s and left undisturbed 
for at least 3 h. To the nanorods stock solution 0.1 ml of a PSS stock (10 mg PSS in 1 
ml 0.01 M NaCl) and 0.05 ml of 0.01 M NaCl solution was added with gentle vortexing, 
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and maintained at 4 ᵒC with stirring for 24 h. The sample was then centrifuged and 
the supernatant with unbound PSS was discarded.  
 
5.2.3. Synthesis of gold nanorods_B  
 
The synthesis of gold nanorods_B with smaller particle sizes have previously been 
published in literature. 24 Gold nanorods seed and growth solutions were prepared 
from the 0.1 M CTAB. For the seed solution, after adding 25 mM HAuCl4 (10 µL) to 
warm 0.1 M CTAB (990 µL) in a 2 mL microcentrifuge tube, the seed HAuCl4–CTAB 
mixture was vortexed. 600 µL of ice-cold NaBH4 were added to the seed HAuCl4 –
CTAB mixture and vortexed again.  The resulting light brown solution was kept at 
room temperature. For the growth solution, 25 mM HAuCl4 (200 µL) was added to 10 
mL of 0.1 M CTAB in each of six 15 mL centrifuge tubes, the growth HAuCl4–CTAB 
mixture was vortexed until the colour of the solution turned clear orange. Addition 
of 300 µL of 4 mM AgNO3 followed by 150 µL of 80 mM ascorbic acid to the growth 
HAuCl4–CTAB mixture turned the solution colourless after gentle mixing. Once both 
the seed and growth solutions were prepared, 12 µL of the seed solution was added 
to each tube of growth solution and kept at 33 °C. Within 15 minutes, the colour of 
the solution mixture changed from clear to dark brown, indicating nanorod 
formation. The solution mixture was left in the water bath for next 1 hour, to finalise 
the formation of the rods. Afterwards, the six vials of mixed seed and growth 
solutions were centrifuged in the 15 mL centrifuge tubes, at 8,000 revolutions per 
minute (rpm) for 20 minutes. Once centrifugation was complete, the supernatant 
was carefully removed leaving behind pellets of nanorods. The pellets were 
resuspended in 1 mL of water, and centrifuged again at 7000 rpm for 15 minutes. 
This time, the pellets containing larger material, including large impurities and 
nanorods, were discarded. The supernatant was retained as it contained the desired 






5.2.4. Synthesis of silver nanoplates and silver nanoprisms  
 
All solutions for synthesis were prepared fresh, straight before synthesis. Solution 
containing distilled water (1.965 mL), 100 μL of trisodium citrate (75 mM), 9.3 μL of 
AgNO3 (10 mM), and 12.8 μL of H2O2 (0.6%) was prepared in 14 mL vial equipped with 
a stir bar. In next step, 9.6 μL of NaBH4 (100 mM) was added rapidly during vigorous 
stirring. After 5 min, 200 μL of L-ascorbic acid (5 mM) was added, followed by 
dropwise addition of 150 μL of AgNO3 (10 mM) for silver nanoplates and 50 μL of 
AgNO3 for silver nanoprisms.   
 
5.2.5. Characterisation  
 
AF4 experiments were performed on an MT2000 with RI and UV-Vis detectors from 
Postnova Analytics, Landsberg/Germany. MALS detector PN3621 from Postnova 
Analytics, Landsberg, Germany with 21 angles (from 7 ° to 164 °) detector operating 
at 532 nm power wavelength were coupled online to AF4. Autosampler (PN5300) 
was provided from Postnova Analytics, Landsberg/Germany. The hydrodynamic 
radius of the samples were obtained via DLS using a Malvern Zetasizer Nano ZS 
(running Malvern Zetasizer software V7.12) (Malvern Instruments, Malvern, UK) with 
633 nm He–Ne laser and the detector positioned at 173 °, coupled online to the 
MT2000. A 350 µm spacer and 10 kDa regenerated cellulose membrane were 
installed in the separation channel. The conditions used for the separations were 
based on a method existing in the literature. Briefly, the mobile phase was Milli-Q 
H2O for gold particles and 0.05 % NaCl + 0.05 % NovaChem was used for fractionation 
of silver particles. Type I distilled water was obtained from a water purification 
system had a resistivity of > 18 MΩ cm-1 (PURELAB option R, Veolia). The solutions 
were filtered using Corning bottle top vacuum filter system with cellulose acetate 
membrane with pore size 0.22 µm. The injected volume was 20 µL of sample by 
autosampler. The samples were injected three times to obtain good reproducibility. 
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Blank samples were measured between injections of new sample to make sure that 
system was clean.  The UV-Vis detector measured two wavelengths 520 and 700 nm 
for silver and gold samples. The conditions used for the separations was as follows; 
the injection/focussing time was 3 min using a cross flow 0.5 mL min-1. The cross flow 
rate was kept for the first 4 min (t0-t4) in constant manner, and thereafter, the cross 
flow was decreased in a linear manner (exponent 1.0) from its initial value to 0.1 over 
a period of 30 min. Following the complete reduction in cross flow, the tip-flow 0.1 
mL min-1 continued for an additional 10 min. The z-average diameter and count rate 
were measured by an inline Malvern Zetasizer ZS DLS at 3 second intervals. DLS 
calculates the z-average size of particles using the Stokes-Einstein equation. 
Characterisation of the bulk (unfractionated) samples was carried out using DLS using 
a Malvern Zetasizer Nano ZS (running Malvern Zetasizer software V7.12) with 633 nm 
He-Ne laser and the detector positioned at 173°. The Z-average diameter was 
recorded using a 1 cm path length disposable polystyrene cuvettes. Measurements 
were repeated in triplicate to give a mean Z-average diameter and polydispersity 
index (PdI). Zeta potential measurements were performed using DTS1070 folded 
capillary cells (Malvern, UK). The capillary cells were flushed with ethanol and water 
prior to usage. The zeta potential measurement was made with a minimum of 10 and 
maximum of 40 runs, and the voltage applied was automatically selected by the 
software. The Smoluchowski approximation where f(Ka) = 1.5 was used, and 
dispersions contained 10 mM NaCl and were measured at 25 °C. 
 
A Hitachi S-4800 cold Field emission (FE-SEM) scanning electron microscope (SEM) 
was used to image gold and silver particles. The samples to be analysed were put into 
a silicon wafer stuck onto an aluminium stub using PELCO Conductive Silver Paint 
(Agar Scientific, Essex, UK) and left to evaporate overnight. The prepared samples 
were coated with gold for 2.5 minutes at 20 mA using an EMITECH K550X Sputter 
Coater. 
The annular dark-field (AD) and bright-field (BF) scanning transmission electron 
(STEM) images were obtained with aberration-corrected Field Emission transmission 
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electron microscope JEOL 2100F operated at 200 kV. The samples were dispersed, 
sonicated and drop-casted onto a 400 mesh copper grid with a Lacey carbon film. 
Spectrophotometric absorbance measurements between 300 and 750 nm were 
made using a NanodropTM 2000 c spectrophotometer (Thermo Fisher Scientific). 
Samples were vortexed immediately prior to measurement in order to avoid 
artefacts from sedimentation of agglomerates. The absorbance of samples was 
measured directly in a 1 cm path length polystyrene cuvette. Water was used as the 
background measurement.   
5.3. Results  
 
The results section is divided into two subsections. In the first section, the results of 
the physical characterisation of gold samples are presented. The three gold samples 
were analysed: gold nanoparticles (gold NPs) and two different sizes of gold nanorods 
(gold nanorods_A and gold nanorods_B). In the second section, three different types 
of silver nanoparticles (silver nanoparticles (silver NPs), silver nanoplates and silver 
nanoprisms) were characterised and the results discussed.  
5.3.1. Gold particles 
 
The gold samples with different shapes were characterised by DLS batch and SEM to 
obtain information about samples before AF4 analysis. The commercially sourced 
gold NPs are supplied stabilised in citrate buffer and their specified hydrodynamic 
diameter was 58-66 nm with a core size of 47-53 nm. Unfortunately, provider did 
not mentioned how core size was measured, but it would be expected that it was 
determined by electron microscopy. Our DLS measurements (Figure 5.1) showed a 
similar diameter (70 nm) compared with information provided by the supplier. The 
difference in the hydrodynamic diameter compared to the core was likely due to the 
coating by citrate around the nanoparticles which increases the hydrodynamic 
diameter.27 The zeta potential for gold nanoparticles was -26 mV, indicating colloidal 
stabilisation through electrostatic repulsion. Gold nanorods_A and gold nanorods_B 
were also measured by DLS, showing mean hydrodynamic diameters of 192 nm and 
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10 nm and zeta potentials of -8.2 mV and -55.5 mV respectively. The DLS traces are 
presented in Figure 5.1, showing bimodal distributions for both samples of gold 
nanorods and monomodal distribution for gold nanoparticles. The measurements of 
PdI have shown high values for nanorods i.e. 0.505 and 0.495. Gold nanorods 
showed high PdI potentially due to different potential diffusion behaviour of rods.28 
It is important to note that the hydrodynamic diameter as determined by DLS of a 
non-spherical particle is the equivalent diameter of a sphere that has the same 
translational diffusion speed. In this case, it is extremely important to compare DLS 
hydrodynamic diameters with sizes obtained from SEM images. Lie et al. tried 
previously to measure hydrodynamic diameter of gold nanorods by DLS. However, 
they showed that hydrodynamic diameter cannot be deducted from DLS due to the 




Figure 5.1. DLS analysis of gold NPs, gold nanorods_A and gold nanorods_B. 
 
The morphology of gold samples was then analysed by SEM and is shown in Figure 
5.2. The SEM images showed spherical morphology for gold NPs and ellipsoidal 
structures for gold nanorods. The diameters of particles obtained from SEM was 





















Gold NPs Gold nanorods_A Gold nanorods_B
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obtained from DLS was higher compared with SEM values. This was likely due to the 
solvation sphere of citrate stabiliser. Gold nanorods_B showed higher diameter from 
DLS data compared with SEM length and width. As it was mentioned before, the 
value provided by DLS is a measure of the hydrodynamic diameter, a value that is not 
necessarily directly related to either the length or width of the nanoparticle. Gold 
nanorods_A appeared as aggregates when dried so this sample is hard accurately to 
characterise by SEM. However, ellipsoidal shape of individual particles was clearly 
visible on the surface of aggregates. 
 
 
Figure 5.2. SEM characterisation of the gold nanomaterials, A) gold nanoparticles, 




Due to the issues with detection of single particles on SEM, gold nanorods_A were 
analysed by scanning transmission electron (STEM) microscopy. The resulting image 
is shown in Figure 5.3. The STEM images showed non-spherical morphology of 





Figure 5.3. Bright-field (BF) scanning transmission electron (STEM) image of gold 
nanorods_A.  
 
SEM images showed that gold nanorods_B have two population of particles i.e. 
ellipsoidal nanorods and particles with a slightly more spherical morphology. It 
agrees with bimodal distribution obtained by DLS measurements. The aspect ratio 
was also measured from the images for non-spherical particles. Gold nanorods_A 
showed a mean aspect ratio of 2.4 and non-spherical particles with smaller 
hydrodynamic diameter had aspect ratio of 3.3. The data for samples is summarised 




Table 5.1. DLS and SEM characterisation of  gold NPs, gold nanorods_A and gold 
nanorods_B.  
 






















-8 ± 2.3 47.5 ± 11 
(length) 
20.1 ± 3 
(width) 







-55 ± 0.4 33 ± 5 
(length) 
10 ± 2 
(width) 
3.3 ± 3 
 
 
The three of gold nanoparticle samples were then fractionated and characterised by 
AF4-MALS-DLS. Each sample was measured at least in triplicate and showed good 
reproducibility. Figure 5.4 shows the results obtained from AF4-MALS-DLS 
measurements for the three gold samples. The fractograms plot the time of elution 
for particles against the signal obtained for 90° light scattering detector. The online 
MALS and DLS detectors allow the measurements Rg and the Rh of the particles 
exiting the AF4 separation channel. Rg was calculated based on sphere fit for gold 
nanoparticles and random coil for gold nanorods due to the most appropriate fit. In 
the following section the AF4-MALS-DLS data will be compared with SEM and DLS 
findings. In the subsequent sections, the separation behaviour and then shape factor 
of the samples will be discussed. 
The fractogram for gold NPs showed the presence of void peak at 5 min, followed by 
main peak centred at 12 min with slight shoulder at 17 min elution time (see Figure 
5.4). The second smaller shoulder indicates gold NPs with a slightly larger size. This 
observation agreed with SEM findings as the gold NPs showed a polydisperse 
population of particles (see Figure 5.2A). The values of Rg and Rh increased with 
elution time, with the mode of the MALS90° showing values for Rg of 19 nm and Rh 
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32 nm. The mode hydrodynamic value obtained from AF4 measurements showed 
good comparison with size values obtained from SEM images (mean radius was 30 
nm from the SEM images). The differences between mean size obtained from SEM 
and Rh at the mode of the distribution was only around 2 nm. The separation of gold 
nanorods_A showed population of two particles – after 9 min and 11 min of elution. 
The MALS90° signal also showed void peak around 7 min of elution. The Rg values 
increased in the first peak and then dropped dramatically and then increased again 
in the beginning of second peak, an indication of two population of particles. The 
mode Rg value obtained for first population was 117 nm and 132 nm for second 
population of particles. The mode Rh obtained from flow measurements for first peak 
was 19 nm and 86 nm for the second population of particles. Two populations of 
particles agrees also with SEM analysis because the samples appear to contain two 
populations: one non-spherical population and a second less common population of 
more spherical particles (see Figure 5.3). These flow measurements showed better 
comparison of Rh values with size obtained from SEM values (52 nm - length and 25 
nm – width), than DLS batch measurements (Rh = 96 nm). The previously published 
theoretical research has suggested that elongated particles can be oriented in 
different positions in separation channel.16,30 The issue which was reported before, 
showed that contribution of rotational diffusion should be taken into account for 






Where D is diffusion coefficient, ƞ is the viscosity of the solvent, kB the Boltzmann 
constant, T the temperature of the sample and L is the major axis of particles. FD is a 
geometrical coefficient depending on the shape of particles.33 For spherical particles 
FD = 1. Currently, the calculations within the DLS software does not take into account 
FD and improving of measurements for non-spherical particles is still in progress.34,35 
AF4-MALS-DLS measurements for gold nanorods_B showed one peak after 5 min of 
elution with a small shoulder at higher elution times (7 min of elution), indicating 
population of particles with increasing size or the presence of a small amount of 
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aggregates. The Rg showed an initial decrease with elution time, followed by an 
increase for shoulder of the peak. The mode value of Rg was 16 nm. Rh showed 
increase with elution time and mean value was 12 nm. The size of gold nanorods_B 
was smaller compared with gold nanorods_A as determined by electron microscopy, 
the AF4 measurements agrees with those results. Rh obtained from online AF4 
measurements showed that gold nanorods_B are smaller compared with gold 
nanorods_A.  
    
Figure 5.4.  AF4-MALS-DLS analysis of gold particles. Fractograms showing the 
light scattering 90° detector signal (black line, left hand scale), radius of gyration 
(red dotted line, right hand scale) and hydrodynamic radius (green dotted line, 
right hand scale) obtained from AF4-MALS-DLS measurements for gold 
nanoparticles, gold nanorods_A, gold nanorods_B for a cross-flow of 0.5 mL/min. 
 
Comparison of the Rh values for the samples with the calculated hydrodynamic radius 
(Rh calc) based on AF4 theory may provide an insight into the different separation 
behaviour of the three different samples. The Rh calc has therefore been plotted on 











Where Rh calc is theoretical hydrodynamic radius, tR is retention time, kB is Boltzmann 
constant, T is absolute temperature, ɳ is dynamic viscosity of solvent, ω is channel 
thickness, Fx/ Fc is the ratio of cross-flow rate Fx to channel flow Fc.    
 
This equation for the Rh calc can only be accurately applied for a separation method 
that uses a constant cross-flow throughout fractionation.8 The method used in this 
work uses a cross-flow that changes with elution time. Therefore, the Rh calc for all 
the gold samples did not match with the data obtained from flowing mode, the Rh 
calc underestimated the values for Rh compared with measured Rh.  However, the 
value for Rh calc can assist in the comparison of the separation behaviour of the 
samples with different shapes. As seen for the spherical sample, gold NPs, the Rh calc 
consistently underestimates the measured Rh by 40 % for all the particles in the 
population. However, for both the gold nanorod samples elute much earlier than 
would be expected for a spherical sample.15,36 Additionally, for both non-spherical 
samples the discrepancy between the calculated and measured values increased 
with increasing Rh. This may indicate that larger non-spherical nanomaterials may 
reside higher in the AF4 channel than expected for a spherical particle and thus 




Figure 5.5.  AF4-MALS-DLS analysis of gold particles. Fractograms showing the 
light 90◦ scattering detector signal (black line, left hand scale), hydrodynamic 
radius (red dotted line, right hand scale) and hydrodynamic radius calculated 
(blue dotted line, right hand scale). 
 
The online data obtained from MALS and DLS allows for determination of the shape 
and internal structure of particles by calculating the shape factor (ratio of the Rg/Rh). 
The fractograms and the calculated shape factors (blue dotted line) are shown in 





Figure 5.6. Fractograms showing the light 90 ◦ scattering detector signal (black 
line, left hand scale) and shape factor (blue dotted line, right hand obtained from 
AF4-MALS-DLS measurements for gold nanoparticles, gold nanorods_A, gold 
nanorods_B for cross flow 0.5 mL/min. 
 
The shape factors for gold NPs increased from ~0.4 to ~1.0 which indicates that the 
there is some differences in the shape/structure of particles in the population, with 
the smallest nanoparticles possessing the lower shape factors. The expected shape 
factor for a hard sphere is 0.77 and therefore these measurements indicate that 
there are differences in the morphologies of the particles in this sample. Smaller 
nanoparticles would be expected to have the same corona thickness as larger 
particles and therefore for a smaller NP this would represent a large contribution to 
the total particle size,37 this might give lower shape factor values. The schematic 
representation of difference in corona contribution for gold particles is presented in 
Figure 5.7. While the gold NPs can be seen to have a generally spherical shape in the 
SEM images (Figure 5.2A), it is apparent that they possess an angular/irregular 
surface and some particles displayed a more rod-like shape. These morphologies 























































might explain the shape factor values approaching ~1 found for the larger particles 
in the distribution. 
 
Figure 5.7.  Cartoon representation of differences in corona contribution for gold 
particles. Blue line represents citrate stabiliser and gold spheres represents gold 
nanoparticles. 
 
For gold nanorods_A, the ratio Rg/Rh decreased along with elution time for the first 
population of particles, followed by increasing and then decreasing again after ~12 
mins. The first peak showed values of shape factor from ~ 12 to ~ 4. The second peak 
for gold nanorods_A showed a decrease in shape factor from ~ 10 to ~ 1.5. It may 
indicate that first peak was representative of more elongated gold particles and 
larger particles in the second peak presented more spherical structures. The SEM 
image suggested that there are some particles in the sample which are longer and 
some which are shorter gold nanorods (see Figure 5.3). The mean aspect ratio 
obtained from SEM was 2.4 for gold nanorods_A, which is quite different compared 
with values obtained from AF4. However, the value of aspect ratio obtained from 
SEM measurements was done in dry form, which can decrease the value compared 
with shape factor obtained from AF4 technique. The aspect ratio and shape factor 
cannot be directly compared. The difference can come from citrate coating and 
solvation shell. For gold nanorods_B, ratio Rg/Rh decreased from 17 until ~ 5. Similar 
trend than for gold nanorods_A was visible, where shape factor was decreasing with 
elution time. The mean shape factor obtained from AF4 measurements was 1.4.  
177 
 
It was slightly lower compared with SEM value for aspect ratio of 3.3. It can be 
explained by the fact that MALS detector is able to detect Rg >8 nm, which can 
decrease the mean shape factor. 38 
Table 5.2.  The mode results of Rg, Rh and Rg/Rh for gold NPs, gold nanorods_A, 






Sample Rg/ nm Rh/ nm Rg/Rh Rg /nm 
Gold NPs 19 32 0.65 23  

















The shape factors values, Rg and Rh for the mode population (centre of the peak) 
obtained from AF4-MALS-DLS measurements for gold nanoparticles and gold 
nanorods are presented in Table 5.2. The spherical gold nanoparticles showed the 
mode value for shape factor 0.65, gold nanorods_A 6.95 and 1.46 and gold 
nanorods_B 1.33. In the literature general values of shape factors for hard sphere is 
0.775, random coil ~ 1.5 and rigid rod >2.0.39 The shape factor for core shell particles 
was shown previously as <0.7.40 The experimental data matched with theoretical 
values for shape factor for gold NPs as nanoparticles showed the shape factor <0.7 
which can be explained by thick solvation shell made of citrate stabiliser. However, 
the shape factor of gold nanorods showed different values compared with aspect 
ratio obtained from SEM images. It should be kept in mind that those two values 
cannot be directly compared to one another. Aspect ratio as previously mentioned is 
defined as ratio between length and width of particles.  While, shape factor is 
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determined as ratio of radius of Rg and Rh. Detailed equations for calculation of Rg 
and Rh particles with different shapes are given in SI section.  
The theoretical Rg was calculated for all gold samples based on diameter and length 
obtained from SEM images, where the values analysed are as follows:  gold NPs 23 
nm, gold nanorods_A 15 nm and gold nanorods_B 9.5 nm. The theoretical Rg values 
for gold NPs and gold nanorods_B matched relatively closely with the results 
obtained for mode values from AF4 measurements, showing a difference about 6 
nm. Gold nanorods_A showed a bigger difference, as Rg obtained from AF4-MALS 
measurements was 117 and 132 and theoretical value was 15 nm. This larger Rg can 
be attributed to formation of aggregates of gold nanorods_A. As previously showed, 
zeta potential of gold nanorods_A was -8 mV which can explain the fact that particles 
are not very colloidal stable over time. The sample of gold nanorods_A was found to 
have stability issues, as aggregates were noted with increasing storage time, the 
sample could be redispersed by sonication. Therefore, it is likely that the sample 
might show a propensity to aggregate during AF4 analysis perhaps during the 
focussing step. 
 
5.3.2. Silver particles  
 
The three different morphology of silver particles, silver nanoparticles, silver 
nanorods and silver nanoprisms, were characterised by DLS batch and electron 
microscopy to obtain information about size, zeta potential and morphology, this 
data is shown in Table 5.3. DLS measurements showed a monomodal distribution and 
low PdI for silver nanoparticles (see Figure 5.8). The DLS distributions for silver 
nanoprisms and silver nanoplates showed bimodal distributions of particles. The zeta 
potential of all samples was ≤ -13 mV which appeared to be sufficient to provide 
colloidal stability over the course of this work. The silver nanoprisms and silver 
nanoplates had high PdI (> 0.6) compared with the spherical particles. However, as 
previously mentioned for the gold nanorods, DLS obtains information of the 
hydrodynamic diameter for a non-spherical particle as the diameter of a sphere 
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which has the same translational diffusion speed as the particle according to Stokes-
Einstein equation. It may also indicate that particles have tendency to agglomerate. 
Another consideration is that the LSPR for silver nanoprism and nanoplates is around 
wavelength of laser (633 nm). In that case, particles can absorb light from DLS and 
this can lead to errors in the measurements.41  
 
Figure 5.8.  DLS analysis of silver NPs (blue line), silver nanoprisms (orange solid 
line) and silver nanoplates (grey solid line). 
 
The SEM images showed spherical morphology with narrow distribution for the silver 
nanoparticles. The hydrodynamic radius (Rh = 28 nm) agreed with the size obtained 
from SEM images (48 nm – diameter; see Figure 5.9A). The DLS showed a slight 
difference, with the diameter values analysed around 8 nm larger compared with 
SEM images, which can be attributed to solvation shell of citrate stabiliser in the 
aqueous media. The SEM analysis of the silver nanoprisms showed a mixture of 
triangle structures and spheres (see Figure 5.9B). The mean diameter obtained from 
DLS measurements was smaller compared with the diameters obtained via SEM. 
However, SEM images showed that the sample was a mixture of two different 
morphologies which was indicated by high PdI (~ 0.6) which would not be resolved 
as separate populations by DLS. The analysis of the silver nanoplates sample by SEM 
did not reveal individual nanoplates, it appeared that the particles had assembled 

















Silver NPs Silver nanoprisms Silver nanoplates
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(see Figure 5.9C). The individual plates were approximately 32 nm in thickness and 
12 nm width. The hydrodynamic diameter and PdI from DLS suggested the 
nanoplates sample was not as aggregated when dispersed as it appeared when dry. 
The morphology of all of the silver particles are shown in Figure 5.9.  
 
 







Due to the issues with imaging of single particles on SEM, silver nanoplates were also 
analysed by scanning transmission electron (STEM) microscopy. The obtained image 
is shown in Figure 5.10. The analysis of sample silver nanoplates showed the mixture 
of different shapes for particles like rods (~ 9.6 nm), triangles (~ 30 nm), hexagons (~ 
9.7 nm) and some potentially spherical nanoparticles (~ 5.2 nm). This observed 

















Table 5.3. DLS and SEM characterisation of silver NPs, silver nanoprisms and silver 
nanoplates. 
Sample Rh/ nm PdI Zeta Potential 
/ mV 
Size from SEM 
/ nm 




-13 ± 0.9 48 ± 6 








55 ± 10 
(spheres) 




-40 ± 1.3 32 ± 4 (length)  




In the next step, the three samples of silver nanoparticles were characterised by AF4-
MALS-DLS measurements. Figure 5.11 shows the fractograms obtained from AF4-
MALS-DLS measurements for three samples. The fractograms displays elution time 
for particles versus the signal obtained for 90° light scattering detector, Rg and Rh 
data. The Rg was calculated based on sphere fit for silver nanoparticles and random 
coil for silver nanoplates and nanorods. The fractogram for silver nanoparticles 
(Figure 5.11) showed the void peak at 6 min, followed by the presence of a main peak 
centred at 8 min. It is also worth mentioning that Rg was calculated only after 10 min, 
this can be caused by a limitation of detector as MALS can only measure Rg > 8 nm.38 
The mean Rh was around 20 nm which it matched with size obtained from SEM 
analysis (Rh = 24 nm). The SEM images showed one population of spherical silver 
nanoparticles, which it agrees with AF4 findings. Silver nanoprisms showed two 
broad populations with the first peak eluted at 20 min with mode Rg value 11 nm and 
second one 28 min with mean Rg value 13 nm for Rg and MALS90°. Interestingly, the 
Rh value showed little increase over the complete sample, this is unexpected as AF4 
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separates based on Rh and therefore larger particles should be eluted at longer 
elution times. This behaviour suggests that the shape of the nanoprisms is influencing 
the separation; the particles with a with a flat plate-like shape may be located closer 
to the membrane than expected purely for their Rh value, thus eluting at a later time. 
This AF4 data for the nanoprisms agrees with SEM images (see Figure 5.9B) as silver 
nanoprisms showed mixture of triangular and more like sphere particles. The main 
peak for silver nanoplates is presented at 10 min of elution. As previously mentioned, 
morphology of single silver nanoplates was detected by STEM, showing of mixture of 
triangular and hexagonal particles. The AF4 measurements showed single peak 
obtained from MALS90°, centred after 10 min of elution, preceded by void peak. The 
mode value of Rg was 28 nm and Rh was 22 nm.  
 
Figure 5.11. AF4-MALS-DLS analysis of silver particles. Fractograms showing the 
light 90◦ scattering detector signal (black line, left hand scale), radius of gyration 
(red dotted line, right hand scale) and hydrodynamic radius (green dotted line, 
right hand scale) obtained from AF4-MALS-DLS measurements for silver 





The fractograms (Figure 5.12), obtained from MALS90° for silver particles were 
plotted against the obtained data for Rh and Rh calc. As for the gold nanoparticles, 
the Rh calc for silver particles does not match with the data obtained from flowing 
mode. The Rh calc for silver NPs was an underestimation compared with Rh values 
obtained during flow measurements. As seen for the spherical gold NPs before, Rh 
calc is also underestimated for silver NPs about 40%. For the silver nanoprisms the 
Rh calc was much higher that the measured Rh. The SEM images suggest that these 
particles are relatively flat compared with the spherical particles and the gold 
nanorods. Silver nanoplates appear to have a more 3-D morphology, as gold 
nanorods, which could possibly be why the silver nanoplates were placed higher in 
the channel compared with silver nanoprisms. It can also be clearly seen that the 
silver nanoprisms elute much later compared with silver nanoparticles. It can 
therefore be explained that the shape, dimension and 3-D structure is critical for AF4 
measurements and it can play a crucial role in the separation of particles. Potentially 
the shape of the nanoprisms results in them being pushed closer to the membrane 
by the cross flow than would happen for spherical particles, this would mean that 





Figure 5.12. Fractograms showing the light 90◦ scattering detector signal (black 
line, left hand scale), hydrodynamic radius (red dotted line, right hand scale) and 
hydrodynamic radius calculated (blue dotted line, right hand scale) for silver 
particles. 
 
The fractograms with shape factors determined from the experimentally measured 
Rg and Rh values is shown in Figure 5.13. The shape factor for silver NPs was in range 
of 0.4-0.8 indicating that some particles appear to have a core-shell type structure. 
The shell can be associated with citrate buffer which it acts also as a stabiliser. The 
shape factors for silver nanoparticles and silver nanoprisms increase with the elution 
time from separation channel. In case of silver nanoprisms, there are two population 
of shapes. The first population (elution time between 18 and 25 min) was more 
closely related to spheres (Rg/Rh ~ 0.8) and second type of particles (elution time 
between 25 and 32 min) was more elongated (Rg/Rh values increased from 0.85 until 
4.0) which agrees with the SEM findings, where images showed two populations of 
particles more spherical and more triangular particles. For silver nanoplates, the 
shape factor increased with elution time and it showed values between 0.7 until 2.0.  
Shape factor values for silver nanoplates are smaller compared with silver 
186 
 
nanoprisms. This can be explained by the fact that silver nanoparticles are smaller 
and more spherical in shape. According to STEM analysis, morphology of particles is 
the mixture of triangles and hexagons.  
 
Figure 5.13. Fractograms showing the light 90◦ scattering detector signal (black 
line, left hand scale) and shape factor (blue dotted line, right hand obtained from 
AF4-MALS-DLS measurements for silver nanoparticles, silver nanoprisms, silver 
nanoplates for cross flow 0.5 mL/min. 
 
Table 5.4 provides average results for mode Rg, Rh and shape factors for all silver 
samples. Theoretical Rg was calculated for silver nanoparticles using equation (2) and 
it was 18.6 nm. The theoretical value of Rg was exactly as obtained from AF4 
measurements, proving the concept of successful separation of particles. 
Unfortunately, the theoretical Rg could not be calculated for silver nanoprisms and 



















































Table 5.4.  The results of Rg, Rh and Rg/Rh for silver nanoparticles, silver 
nanoplates, silver nanoprisms obtained from AF4-MALS-DLS. 
                                 Flow measurements 
Sample Rg/ nm Rh/ nm Rg/Rh 
silver NPs 18.6 23.6 0.79 






silver nanoplates 28.5 22.3 1.27 
 
In case of silver nanoprisms, there are two population of particles with similar values 
of shapes factor i.e. 1.11 and 1.16. It could be possible that first peak represents 
spherical particles and second one is representation of triangles. The assumption is 
based on the values of shape factors and size obtained from SEM, as spherical 
particles showed slightly smaller size compared with the triangular particles. For 
silver nanoplates, the shape factor was 1.27. According to STEM analysis, silver 
nanoplates have more varieties of shapes than the silver nanoprisms, which can 
increase shape factor. The AF4 analysis along with SEM images, showed that the 
silver nanoplates are smaller than silver nanoprisms.  
 
5.4. Conclusion  
 
The gold and silver particles with different morphology were characterised by range 
of techniques like DLS, zeta potential measurement, SEM, STEM, UV-Vis spectroscopy 
and AF4-MALS-DLS. The particles showed different shapes, morphology, 
hydrodynamic diameters and shape factors. The size obtained from DLS was usually 
slightly higher compare with SEM images due to solvate shell and non-spherical 
shapes of particles. AF4 measurements showed successful separation of particles 
with different shapes and the data matches with morphology obtained from SEM 
images. Gold and silver nanoparticles with spherical shapes showed that size 
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increases with elution time according to the AF4 theory. AF4 separation was able to 
fractionate different populations of particles in the samples of gold nanorods_A and 
silver nanoprisms, showing great potential in the nanotechnology area. The 
capability of AF4 to be coupled to MALS and DLS detectors is a really important 
measurement to obtain information shape and structure of nanomaterials. Before 
nanoparticles can be used for biomedical applications, size, size distribution, shape 
and other factors must be precisely known due to their influences within the body. 
Using AF4, it can be possible to overcome the inaccuracies that arise using batch DLS 
measurements. The data showed that AF4 analysis can be used for high-resolution 
characterisation of range of sizes and shapes of particles. However, alone it should 
not be used as an alternative to obtain morphology from SEM or STEM images.   
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Where L is the mean square end to end distance of rod length radius.  










Where D and a are the mean square end to end distance of sphere diameter and 
radius, respectively.  







T is the temperature, kB is the Boltzmann constant, η is the dynamic viscosity of the 










Figure 5.15. The absorbance spectrum for silver nanoparticles, silver nanoprisms 
and silver nanoplates. 
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6.1. Conclusions  
 
The focus of this thesis was to synthesise range of novel nanomaterials with range of 
shapes and morphologies and then to use asymmetric flow field flow fractionation 
(AF4) to obtain a detailed understanding of the structure of these materials. AF4 is 
relatively a new technique and therefore this thesis investigates the development of 
new methods to effectively fractionate and characterise the materials. These new 
methods allow about the measurement of Rg and Rh which allow the shape factor and 
internal structure of nanoparticles to be determined. This analysis provided 
considerable insight into the size distribution over batch DLS alone. It also offered 
information on how shape and morphology change within a size distribution that 
would not be possible by other techniques such as SAXS. The work presented in this 
thesis looked at three different types of materials: non-spherical nanocomposites 
made of multiwalled carbon nanotubes (CNTs) and polycaprolactone (PCL), poly(N-
isopropylacrylamide) (PNIPAM) nanogels and metallic nanoparticles with differing 
sizes and shapes. The conclusions for each of the results chapter can be found below.  
6.1.1. Chapter 2  
 
In Chapter 2, nanocomposites made of CNTS and PCL were prepared by a facile oil-in 
water emulsion solvent evaporation method. Up to now, the surface modification of 
CNTs was done in a few steps reactions.1–8 This simple, one pot method produced 
rod-like, non-spherical PCL-CNTs nanocomposites. SEM analysis of the 
nanocomposites indicated the non-spherical shape while AFM analysis revealed that 
the incorporation of the CNTs in the nanocomposites did not increase the modulus 
of the particles, including the successful surface coverage of the CNTs with PCL. 
Asymmetric flow field flow fractionation measurements showed good separation of 
particles and indicated that the shape of the particles appeared to influence 
separation behaviour, something that would be further investigated in chapter 5. The 
loading of docetaxel (DCX) in PCL, CNTs and the PCL-CNTs nanocomposites was 
determined by HPLC and showed high entrapment efficiencies (CNT = 95%, PCL= 81% 
and PCL-CNT = 89%). Moreover, faster release of DCX from PCL-CNTs was observed 
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with about 90% of the drug released from the nanocarriers after approximately 100 
h. This finding suggests that this synthesis approach might be used to attempt to tune 
the drug release behaviour. Overall, this research provides a simple synthesis of non-
spherical CNTs nanocomposites. The simplicity of this method means that it has 
potential to be used in the future for different non-spherical nanomaterials with 
alternative polymers for the coating, potentially allowing other novel 
nanocomposites to be prepared. PCL-CNTs nanocomposites showed potential to be 
used as anticancer drug delivery systems due to high entrapment efficiencies and 
relatively slow profile release of DCX.   
The AF4 measurements allowed for successful analysis of the different shapes and 
morphologies of the synthesised nanoparticles. This was a motivation to continue the 
development of AF4 methods for analysis of different materials like PNIPAM 
nanogels.  
 
6.1.3. Chapter 3 
 
In Chapter 3, a versatile asymmetric flow field flow fractionation method was 
developed to provide detailed characterisation of PNIPAM nanogels with different 
sizes from 65- 310 nm. In the literature, there are only a few examples where 
nanogels were characterised by AF4 technique.9–12 The diameters of particles and 
information on the internal structure of the nanogels can be easily obtained by using 
a single AF4-MALS-DLS fractionation method. Four PNIPAM nanogel samples from 
65-310 nm in diameter were successfully fractionated, obtaining radius of gyration 
(Rg), hydrodynamic radius (Rh) and shape factors (ρ) for all four samples. The chosen 
mobile phase (0.1 M NaNO3) and method showed good reproducibility and high 
resolution of sizes for AF4-MALS-DLS measurements. The fractionation of the 
samples revealed that the internal structure of some of the samples varied within the 
distribution. Determination of the mode values of Rg/Rh for the distribution of the 
nanogels showed that diameters higher than 100 nm had values ~0.61 indicating that 
the particles had more core-like shell structures. The analysis of the smallest nanogel 
(65 nm) gave Rg/Rh values of 0.78 indicating more homogenous structures. The 
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measurements showed differences in internal structure of nanogels depending on 
the synthesis conditions which also controlled the hydrodynamic diameter. The AF4 
analysis showed advantage over commonly used techniques like DLS and SAXS. The 
range of different sizes, Rg and Rh can be easily obtained by AF4, where SAXS and DLS 
provide only mean value in the sample. This work will enable other researchers to 
utilise this AF4 method to provide considerable insight into the size distribution and 
internal structure of their nanogels, additionally this method will serve as an excellent 
starting point for the analysis of other soft polymer samples in the size range ~50-400 
nms. The development of this AF4 method was then applied in the in next chapter, 
to characterise PNIPAM nanogels synthesised by different type of polymerisation 
(Reversible addition−fragmentation chain-transfer polymerization - RAFT) with the 
presence of degradable crosslinker.   
 
6.1.4. Chapter 4  
 
Chapter 4 focussed on the synthesis of degradable PNIPAM nanogels by RAFT 
polymerisation. The use of RAFT polymerisation offers the potential to obtain greater 
control of the internal structure of PNIPAM nanogels compared to free radical 
polymerisation.  The nanogels were synthesised with varying amounts of monomer 
and crosslinker. The poly(N-hydroxyethyl acrylamide) (HEMP CTA) macro chain 
transfer agent (HEMP CTA) showed better ability to create nanogels compared with 
poly(ethylene glycol) methyl ether 2-(dodecylthiocarbonothioylthio)-2-
methylpropionate macro chain transfer agent (PEG CTA). The hydrodynamic 
diameters for synthesised samples were between 318 and 457 nm with narrow PdI 
values (< 0.15).  The swelling ratio was similar for all samples ~2.0, indicating that the 
changes in crosslinking densities were not large enough to have any influence. The 
synthesised nanogels showed a characteristic deswelling at 33 °C. The aggregation 
temperature for all samples in the presence of PBS was around 28 °C, showing 
potential for the use of these nanogels as in situ forming implants (ISFIs) and delivery 
vehicles of poorly water-soluble drug.13,14 The AF4 measurements showed that 
nanogels have a core-shell structures due to the value of the shape factor (≤ 0.65) for 
197 
 
all samples. Degradation studies were conducted in the presence of 10 mM and 150 
mM DTT. AF4-MALS-DLS measurements showed good degradation of PNIPAM 
nanogels. The most easily degradable sample was shown to contain only 15 % 
nanogel after the degradation process. This work has shown that the degradation 
process could be monitored over time using AF4 to measure particle hydrodynamic 
radius, radius of gyration and shape factor. RAFT polymerisation showed potential to 
control the size of nanogels and degradation behaviour. The RAFT synthesis can also 
control the length of polymer chains which can be also analysed by GPC. The ability 
to control the length of polymer chains can be advantageous, enabling well-
characterised nanogels to be synthesised and further used as degradable ISFIs. The 
research again showed that the information about internal structure can be obtained 
by AF4 technique.   
 
6.1.5. Chapter 5  
 
Given the insight that AF4 had provided for the samples tested in earlier chapters, in 
Chapter 5, the technique was applied to analyse metallic nanoparticles (gold and 
silver). Here, the work focussed on insights into shape and separation behaviour that 
can be obtained for non-spherical metallic particles. Up to now, in the literature there 
is only a few examples where non spherical particles were fractionated and analysed 
by AF4 technique.15–17 The AF4 measurements were also supported by a range of 
techniques including DLS, zeta potential measurement, SEM, STEM, UV-Vis 
spectroscopy and AF4-MALS-DLS. The particles showed different shapes, 
morphology, hydrodynamic diameters and shape factors. The size obtained from DLS 
was usually slightly higher compared with SEM images due to solvate shell and non-
spherical shapes of particles. AF4 measurements showed successful separation of 
particles with different shapes and the data matches with morphology obtained from 
SEM images. Gold and silver nanoparticles with spherical shapes showed that size 
increases with elution time according to the AF4 theory. AF4 separation was able to 
fractionate different populations of particles in the samples of gold nanorods and 
silver nanoprisms, showing great potential in the nanotechnology area. The capability 
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of AF4 to be coupled to MALS and DLS detectors is a really important technique to 
allow for information on shape and structure of nanomaterials to be obtained. Before 
nanoparticles can be used for biomedical applications, size, size distribution, shape 
and other factors must be precisely known due to their influences within the body. 
Using AF4, it can be possible to overcome the inaccuracies that arise using batch DLS 
measurements. 
 
 6.2. Future work  
 
There are several areas where the research and development conducted could be 
expanded upon further. In Chapter 2, biological studies could be studied to check 
toxicity in vitro and in vivo studies, as this would allow a better understanding of the 
impact of the shape on the biological behaviour. The surface modification of PCL-
CNTs nanocomposites may be studied to prepare more hydrophilic particles and thus 
potentially more compatible with biological cells. Another opportunity would be to 
use a responsive hydrophilic polymer such as PNIPAM for modification of CNTs to 
check influence on synthesis method along with properties of nanocomposites. X-Ray 
Photoelectron Spectroscopy could be also used to give more evidence of surface 
modification of CNTs. In Chapter 3, PNIPAM nanogels with higher diameters (>310 
nm) could be synthesised and analysed by AF4 to check internal structure of 
nanogels. SAXS analysis could be conducted to compare Rg obtained from flowing 
mode in AF4 and static SAXS analysis to see if there will be any differences in Rg, 
caused by fractionation and interaction with eluent and membrane. Nanogels made 
of another polymer like for example poly(acrylic acid) could be fractionated by AF4 
method to check if the obtained condition will be appropriate for analysis following 
materials.  The research in Chapter 4 indicated that the CTA might influence their 
swelling behaviour and therefore the synthesis of PNIPAM nanogels with other CTAs 
soluble in water could be carried out in order to get a better understanding of this 
behaviour. An alternative degradable crosslinker may be also used to produce 
degradable nanogels for example (2-i-propyl-2-oxo-1,3,2-dioxaphospholane-co-2-(2-
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oxo-1,3,2-dioxaphosphoroyloxyethyl methacrylate) which is hydrolytically and 
nonenzymatically degradable.18 A different initiator for example potassium 
persulphate (KPS) could also be used to test the role of the initiator fragments on the 
colloidal stability of formed nanogels. KPS may provide more charge at the surface 
PNIPAM nanogels which could potentially provide better colloidal stability. The 
degradable products after addition of DTT could be analysed by GPC to check the Mn 
of polymer chains. In Chapter 5, the influence of shape of the separation behaviour 
might be better understood by the use of mathematical models to calculate 
theoretical Rh with a changing crossflow which could then be compared with Rh data 
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